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INTRODUCTION 
 Siddha system is one of the oldest traditional system of the medicine in India 
mostly folled.  Term “Siddha” means achievements and the “Siddhars” were saintly 
figures who achieved results in medicine through attainment of siddhi . 
 “Siddham” means “Arivu” or “Complete knowledge” 
  According to siddha predictions the siddha principles were presented to the 
followers of lord shiva and sakthi, to siddhars, starting with siddhar nantheesar.  Then to 
siddhar  thirumoolar, agathiyar and other disciples along with the 18 siddhars and so on. 
Fundamental principles 
 “n{<mk<kqZt<t!hq{<ml<< < < < << < < < << < < < <!
! ! hq{<mk<kqZt<tOk!n{<ml<< < < < << < < < << < < < <”!
 Anda pinda ottrumai, 96 thathuvams.  Including pancha poothams and three 
humoral concepts are the fundamental principles of this incomparatble which advocates 
curative, preventive measures and educates natural way of lifestyle. 
 According to siddha medical science the universe consist of 5 elements. 
 Earth, water, fire, air and ether which correspond to the five senses of the human 
body.  Man consumes water and food breathes the air and then maintains the heat in the 
body.He is alive because of the life force given by ether. 
 The earth is the  element which gives fine shape to the body.  Including  bones, 
tissues, muscles, skin hair etc. 
 Water is the  element representing blood.  Secretions of the glands vital fluid etc. 
 Fire is the element that gives emotion, vigor and vitality to the body.  It also helps 
digestion, circulation and stimulation besides respiration and the nervous system. 
Above all other is the characteristic of man’s mental and spiritual faculties. A 
suitable propostion of these five elements in combination with each other produce a 
healthy person. 
According to the theories of humoral pathology, all diseases are caused by the 
inharmonious  mixture of vadham, pitham and kapham. 
Their proportions in the body govern a person’s physical and mental disposition. 
It is evident from the following qoute. 
“uiklziK!Oleq!ogmiK”!–!Okjvbi</!
!
!
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Diagnostic tools in siddha 
 “lkqk<kqmx<!gVjl!uib<f<k< < < << < < << < < < !
! ! li{<giqgivolz<zif<< < << < << < <!
! Kkqk<kqm!U{i<f<kiOeEf<< < < << < < << < < <!
! ! Kgtxh<!h{qbqe<xe<jl< < << < << < < !
 hiqk<kqm!U{vieigqx<< << << <!
! ! hbExieigiziOe!
! uqkqk<kqM!hq{qk<kqxk<jk< < << < << < < !
! ! uqtl<HK!Lkx<g{<!le<Oei< < < << < < << < < < ”!
.! sqgqs<sivk<kqe!kQhl<!4!hg<gl<< < Q < < << < Q < < << < Q < < <!
  The above literature quotes that diagnosis is very indispensible for physicians to 
treat the diseases. 
 Noi nadal (to diagnose the affected disease) and noi mudal nadal (To find out the 
root cause of the disease) are the crucial approaches employed in siddha for diagnoses. 
 Therefore permanent remedy is also achievable since the treatment is focussed to 
cure the diseases and root cause of the disease. 
 “Envagai Thervugal” is the diagnostic tool followed in siddha for arriving right 
diagnosis.  It is evident from the following siddhars quotes 
  
“fi!fqxl<!olipq!uqpq!lz&k<kqvl<< < << < << < <!!
! ! fic!hiqs!lqju!lVk<KuviBkl<< << << <”!
.! Ofib<!fimz<!Ofib<!Lkeimz<!< < < << < < << < < < .364!
Treatment aspects in siddha 
 Siddha is the only system comprising 64 varieties of medicines i.e. 32 
classification of internal medicines and 32 classification of external medicines.  Varmam 
and thokkanam are exceptional treatment practices in siddhars to cure neuro-muscular 
skeletal disease. 
 Yoga, pranayamam, dhiyanam is adviced for chronic diseases and especially.  
Psychomotor diseases. 
 Siddhars developed in kayakarpam methods mainly for longevity with complete 
freedom form illness and for preventing ageing problems. 
 Kalanjagapadai which is correlated with psoriasis has been a challenge to medical 
world psoriasis and the clinical symptom  of  Kalanjagapadai are prominate to each other. 
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 Yugi one of the 18 siddhars speaks about Kalanjagapadai.  But he has not 
explained it as a separate disease. 
 The disease and its effects on the human system have been dealt with only in a 
sketchy fashion. 
 He has just made a mention in the classification eighty vadha disease such a 
kalanjaga vadha is one among them. 
 His dealing with this disease explain the nature of skin and its complication on 
joint as well (psoriatic arthritis). 
 Inspiteof lack literature about skin disease.  It can be clearly stated that the root 
cause of Kalanjagapadai in the aggrevation of vadha dosha. 
 The following pages sketch the research work done on Kalanjagapadai and the 
suggestion and recommendation offered for over coming it. 
  
4 
 
AIM AND OBJECTIVES 
AIM 
 The main aim of the study in to conduct an open clinical on kalanjagapadai to 
evaluate the efficacy of the trial medicines. 
 
OBJECTIVES 
Primary objectives 
 To evaluate the clinical efficacy of OMA LEGIYAM internal medicine and 
THAGARAI LEBAM   as external medcine for the diseases kalanjaga padai (psoriasis). 
Secondary objectives 
1. To study the efficacy of additional therapies like yoga meditation and asanas in 
healing the disease along with the internal and External medicines 
2. To compare the etiology, clinical features sign and symptoms of kalajagapadai in 
siddha systems of psoriasis in modern science. 
3. To screen the elements present in the trial drug. 
4. To access the siddha basic principles like mukkutrum, 7 udarkattukal, envagai  
thervu, neerkuri and neikuri. 
5. To confirm the diagnosis in siddha system with the help of modern parameters. 
6. To make an awareness among the patients in order to avoid for their recurrence of 
the disease. 
7. To analysis of the trial medicine on basis of  
Biochemical analysis 
Pharmacological studies for 
 Anti histamine 
 Anti inflammatory 
 Analgesic 
 Acute toxicity 
8. To find out whether there are any side effects/adverse effects produced by the trial 
drugs.  OMA LEGIYAM (Internal drug) and THAGARAI LEBAM  (External 
Drug)during the course of treatment. 
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REVIEW OF LITERATURES 
SIDDHA ASPECTS 
Definition 
 Based on the siddha literature, Kalanjagapadai is non infectious inflammatory 
disease of the skin characterized by well defined slightly raised dry, erythematous plaques 
with large adherent scales. 
Kalanjaga padai 
 It is one of the teadious diseases that affects the most of the people. 
 About 2 – 3% of teh total population in predominantly by this disease. 
 It may affect both sex.  But predominantly affecting the females. 
 It mostly affect in the age of 5-35 years. 
 It mainly affect the skin and mucous membrane. 
Vernacular name’s (OuXohbi<gt<*< << << < !
ou{<hVs<!oskqz<Ofib<?!oskqz<!dkqi<Ofib<! ! ! !!!!!!!! !!!!!!!!!!
. !!sqk<k!lVk<Ku!sqxh<H!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!! osl<him<M!Okizpx<sq?!oskqz<!dkqi<Uh<hjm?!sil<hz<?!hjm?!F{<{qb!okix<X!
oskqz<hjm/!
.! nVr<gjzs<!osiz<!ngvLkzq!
LITERATURE EVIDENCES 
Siddha based definition 
 In siddha medicine the pancha bootham are elaborately described. According to  
siddha principle, Thole (skin) is a part of prithivi.  Skin is the largest organ in the body. 
 In siddha system, skin disorders are brought under the clinical entity “Kuttam”.  
Among the siddha literature “Yugi Muni vaithiya kaviyam, Thirumoolar vaithiyam, 
Thanvanthiri are some of the source of information on causes  and 18 types of kuttam. 
 In the text book “Aathma Ratchamirtham ennum vaithya sarasangiragam” and 
“Thanvanthiri vaithiyam” the characteristic of kuttam are described clearly. 
 T.V. Sambasivam pillai has mentioned that in Tamil medicine ‘Kuttam’ means 
cutaneous affections and so it is a comprehensive term used various skin diseases. 
 In this book “Sorikuttam” has been compared to psoriasis. 
(Sorikuttam – A kind of leprosy with diffuse papillary eruptions without ulceration on the 
entire surface of the body marked by intense itching and burning sensation followed by 
exfoliation of the epidermis or browny. 
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 Scales – Eczematous psoriasis lepra Itchyosis 
Among the 18 types of kuttam, thethru kuttam kajasarma kuttam and virpodaga 
kuttam resemble to that of kalanjgapadai. 
 
Aetiology 
 According to siddha literature, aetiology have been described below. 
 In “Thirumoolar vaithiyam” the aetiology is given as follows 
1.  uqbikqBt<!&uiX!uqtr<gqb!Gm<mr<Ogt<< < < < << < < < << < < < <!
! Sbikqg<!gqvf<kq!Spz<!Olgk<ki!ziXl<< < < < << < < < << < < < <!
! hbikq!l{<[th<!hz!u{<cei!ozm<Ml<< < < < << < < < << < < < <!
! fqbikq!HPfizib<!fqe<xkqg<!Gm<mOl!< < < << < < << < < < –!kqV&zi</< << !
  !!!!
3/!! “Gm<mLme<!kqOvgolz<zil<!hxg<Gl<OhiK< < < < < << < < < < << < < < < < !
! GpqGpqbib<!gqVlqbqeix<!ogit<Tl<!Ht<tq!< < < < << < < < << < < < < –!:7!GVfic/!
!!!!
4/!! hbqz<!olipqbQI!kqOvgk<kqz<?!gqVlqkiOe< Q < << Q < << Q < < !
! hvf<Kkqiq!Gm<ml<!Ohiz<!Ht<tq!gi[l<< < < < < << < < < < << < < < < <!
! lbzKUl<!gqVlqBf<ki!fmf<K!Hg<gqz<< < < < << < < < << < < < <!
! OleqbK!svsove!ouck<K!H{<{iGl<!< < << < << < < .!:3!GVfic/!
!
5/!! “gqvf<kq!Spe<!Olgk<ki!ziXl<< < < << < < << < < <” 
 Six types of skin diseases are caused by venereal disease. 
 “hbikq!l{<[th<!hz!u{<cei!ozm<Ml<< < < < << < < < << < < < <”!
! Eight types of skin disease are caused by insect bites. 
 “fqbikq!HPfizib<!fqe<xkqg<!Gm<mOl< < < << < < << < < < !
! Four types are caused by worms infestations. 
 
IN THANVANTHIRI VAITHIYAM 
 “nxquqe<xq!uqbiQkR<!Osvigivl<!Hsqg<gziZl<< Q < < < << Q < < < << Q < < < <!
! Kjxbqe<xq!Okimik!okie<jx!okim<mjuh<!< < < << < < << < < < .!Hsqg<gziZl<< << << <!
! Gjx!ogi{<m!fqsqk<klie!Gzlr<jg!< < << < << < <  bMg<gziZl<< << << <!
! fqjxogi{<m!ohiqObiI!kl<jl!fqk<kqk<K!OhsziZl<< < < < << < < < << < < < <!
! fqf<kqk<Kh<!Hxk<kqbix<!Osil!fqjzogmh<!< < < < < << < < < < << < < < < < hqiqg<gziZl<< << << <!
! uf<kqk<Kh<!H,Vui!osiz<lf<kqv!hiuk<kiZR<< < < < < < << < < < < < << < < < < < <!
! sf<kqg<gg<!gx<liki<!kr<gjtg<!gVkziZl<< < < < < < < << < < < < < < << < < < < < < <!
! okif<kqk<k!Gm<mOvigf<!okiMg<G!ole<Xjvk<kiI!Le<OeiI/< < < < < < < << < < < < < < << < < < < < < < !
.! ke<uf<kqiq!juk<kqb!Ovigl<< < < << < < << < < <!
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Guru Naadi Nool describes Aetiology as follows 
 “gqVlqbqz<!uf<k!Okiml<!ohVgU{<M< < < << < < << < < < !
! Ogm<gq!zke<!hqiqUkje!gqvlligh<< < << < << < <!
! ohiVlq!uVl<!uiBouz<zil<!gqVlqbiOz< < << < << < < !
! HPg<gc!Ohiz<!gi[lK!gqVlqbiOz< << << < !
! osVlq!uVl<!hUk<kqvr<gt<!gqVlqbiOz< < < << < < << < < < !
! Okglkqz<!osiiqg<Gm<ml<!gqVlqbiOz< < < << < < << < < < !
! KVlquVf<!SOvi{qkr<!gqVlqbiOz< << << < !
! $m<sLme<!gqiqjsh<hiz<!okipqz<!osb<uQOv< < < < < < Q< < < < < < Q< < < < < < Q !
.! GVfic!
 Intake of contaminated foods 
 Scolding the elders 
 Thinking of females 
 Destiny (Kanma vinai) 
 Intake of allergic foods 
  The text book of “Sirappu Maruthuvam”  describes the following etiological 
factors of kalanjaga padai. 
hvl<hjv!Ofibig!–!of unknown aetiology and may be genetic 
&uiqz<!yVuVg<G!
Beta hemolytic streptococcal in guttate psoriasis. 
Anti hypertensive drugs – Beta blockers 
They are 
1. Propanolol 
2. Atenolol 
3. chloroquine 
4. Red oxide of copper  
5. Polio vaccine  
!! Lkzqb! lVf<Kgt<! GVg<gjtBl<! hjmjbBl<! d{<M! h{<{zil<! we<X!
%xh<hm<Mt<tK/!
  In Guru naadi nool says generally siddhars mentioned all the skin disease are 
caused by micro organism and macroorganism. 
“gqVlq”!–!Micro organism and Macro organism 
Kuttam is named as a common word of chronic skin lesion as for the siddha text books. 
 Agasthiar had mentioned kanmam is the main cause for kutta noi. 
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 Kanma varalaru (Psycho social cause) 
 “hpuqjebiz<!uqmh<!H,s<sq!gck<kiZl<< < < < << < < < << < < < <!
! ! hikgi<g<G!yVfiTl<!kQIukqz<jz< < < Q << < < Q << < < Q < !
! dt!uqjebiZ~ihqg<!ogit<t!uf<k< < << < << < < !
! ! d{<jlb!kuxqbilz<!< << << < &Ig<ge<!osb<uiI< < << < << < < !
gtuqjeBt<!kQIukqz<jz!gceolk<k< Q < << Q < << Q < < !
! ! gVj{Bt<t!H,v{k<kqz<!g{<gim<sq< < < < << < < < << < < < < !
ntuqje!fQ!gi[Le<Oe!ngzs<!osiz<ZQ < < <Q < < <Q < < < !
! njmbitl<!uqvz<!GXG!hqe<eiz<!OgOt< < < << < < << < < < !
uqvz<!GXGl<!ginz<!fqlqXl<!uql<!OhiOzXl<< < < < < << < < < < << < < < < <!
! hivie!Okgolz<zif<!kck<K!gi[l<< < < << < < << < < <!
hikolz<zif<!ouck<K!lqgh<!H{<{ib<!gi[l<< < < < < < << < < < < < << < < < < < <! !
svsLme<!osixq!gvh<hie<!hq{l<!Ohiz< < < << < < << < < < !
Oki[t<!sif<jkbiOl!uqf<jk!ogMk<kc!uQr<Gl<< < < < Q < << < < < Q < << < < < Q < <!
! fi!fz<gqzqf<!Ofib<g<G!lVf<kbviOk< < < < << < < < << < < < < !
fz<Ozijv!hQcg<Gr<!Gmr<!ge<lliOl< Q < < < << Q < < < << Q < < < < ”!
.! ngk<kqbi<!hiqH,v{l<!511/< < << < << < < !
“Thirumular has mentioned that the skin diseases are mentioned in three ways. 
1. Venereal origin and other mega diseases. 
2. Insect bites. 
3. Infection and infestations. 
“Gm<mlK!uqm!gvh<hie<!uqm!fQI!$jz< < < Q< < < Q< < < Q !
! SOvi{qkk<kiz<!kiK!ogm<Mk<!kch<H{<miGl<< < < < < < << < < < < < << < < < < < <!
lm<mxOu!gqVlq!ose<X!lVUl<!OhiK< < << < << < < !
! ujgbib<!gqVlqBm!uqm'I!ose<X!< << << < !
Gm<mLme<!Okgolz<zil<!hxg<Gl<!OhiK< < < < < << < < < < << < < < < < !
! GpqGpqbib<!gqVlqbqeQIg<!ogit<Tl<!Ht<tq< Q < < < << Q < < < << Q < < < < !
km<mxOu!gqVlqBm!'viz<!uf<k< < << < << < < !
! sgz!Gm<ml<!uqm!gvh<hie<!six<xziOl< < < < << < < < << < < < < !
.! kqV&zi<<<<!
 Hereditary also plays a important role in breeding Kalanjaga padai which appear 
in generations affecting several siblings and in such families the condition tends to be 
severe and persistant. 
  The psychic tranquility of the individual depends upon the harmony of social 
movements. 
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  The main factors behind the reasons are manifestations of stress which can be 
considered as precipitating factor. 
 In yugi chinthamani, among the eighteen types of skin disease three types seen to 
be varients of kalanjaga padai. 
 But no description is available in agasthiar kanmakandam, he mentions. 
 “Osi<f<k!Gm<moliM!GjxOfib<gt<!uf<k< < < < < << < < < < << < < < < < !
! OskqOgt<!lzvik!nVl<H!ogib<kz<< < < << < < << < < <!
! kiiqk<k!s<<< QQ QQu!osf<K!ujkgt<!osb<kz<< < < << < < << < < <!
! kib<!kf<jk!leK!ofif<K!Ovigf<kiOe< < < << < < << < < < ”!
.! ngk<kqbi<!ge<lgi{<ml<< < < < << < < < << < < < <!
 Plucking buds 
 Domestic violence 
 Hurting the parents 
 
In Manmurukiyam, he mentions 
 “-ml<!ohiP!K{U!okipqOziM!hVul<< << << <!
! Welqju!OuXhMk!ziZl<<<<!
! fR<$xz<!fR<S!%cbK!ohiXl<< < < << < < << < < <!
! hq{qBx!ziXl<!fqxl<!ohbi<kMOl< < << < << < < ”!
 Change of place, food, work, climate and diurnal.!
 Toxins  by animal bites.!
In agasthiyar vaithyam he mentions 
 Gbz<uib<!G< << << < ]<ml<!sbr<Gtl<!fQiqpqU!Svg<gqvi{q< < < < Q << < < < Q << < < < Q < !
! ! fQvjmh<H!hi{<M!&z!uib<UQ < < <Q < < <Q < < < !
! gbz<!uiB!uVr<g{<{qz<!Gk<kib<!gcf<!ksuiB< < < < < < << < < < < < << < < < < < < !
! ! g{uig!Le<!osb<k!dbqi<!uqjekiOe< < << < << < < ”!
.! ngk<kqbi<!juk<kqbl<< < < << < < << < < <!
 Skin disease 
 Tuberculosis 
 Diabetes 
 Fever 
 Diarrhoea 
These diseases occurs due to destiny 
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Other cause 
 Excessive intake of allergic foods 
 Change of climate 
 Excessive intake of sweets, fried foods. 
 Chocolates and milk 
(B-lactone globulin – allergen in children) 
.! Unavu maruthuvam 
In pararasa sekaram, He mentions 
 Kanmam 
 Stress 
 Excessive sleep 
As the causes 
Finally concludes,  
 In our siddha system, siddhars not specified, the etiology for separate skin disease 
commonly they mentioned kanmam is one of the etiological factor.  Kanmam denoteds 
the genetic transmission. 
CLASSIFICATION 
Ofib<!ujg<<< !
B,gqLeq.29!ujg!
H{<miQgl<! sqGvl<! l{<mzl<! gqChl<!
uqx<Ohimgl<! gv{l<! nhiqsl<! si<lkzl<!
hill<! gqVm<c{l<! uqsIs<sqgl<! kk<KV!
g\si<ll<! nUKl<hvl<! uqhikqgl<! sqk<Kli!
skiV! SOukl<! ! !
!
ke<uf<kqiq!juk<kqbOvigl<!< < < << < < << < < < .!29!ujg!
ghizl<! skiQg! Okk<KV! hil!
siIOlg! uqsi<s<sqg! H{<miQg! Sgiff<kq!
dKl<hv! l{<mz! uqx<Ohimg! ou{<!
gqCh! nVOfib<! si<lkz! sqk<Kli!
nzs! uquikqg! ! !
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T.V.sil<hsqul<!hqt<jt!< < << < << < < –!29!ujg!
fQI! osr<! uqvz<Gjx! uqv{!
ou{<!! ohixq! sjm! gpq!
osixq! uiq! bije! gqVlq!
gVr<! wiq! kqlqi<! NG!
! !
hvvis!Osgvl<!<<< .!29!ujg!
ou{<! H{<!! hmi<! Nj{!
gVr<! osixq! hR<sui<{! uxm<sq!
osr<! Htq! ouc! sx<h!
gvh<hie<! Oklz<! &z! Smjz!
sqr<gue<e! Ljt! ! !
 
Nk<lvm<silqi<kl<!juk<kqb!sivsr<givl<!< < < < < < << < < < < < << < < < < < < .!5!ujg!
ou{<Gm<ml<!!! gVr<Gm<ml<!
osr<Gm<ml<! ! ohVuqbikq!
!
IN THANVANTHIRI VAITHIYAM 
 uik!hqk<k!Ozx<hek<kqe<!uivOvigf<!kieoeeqEl<< < < < < << < < < < << < < < < <!
! kQK!Gm<m!olPf<kQVr<!Gm<ml<!hkqoeie<XQ < < Q < < < <Q < < Q < < < <Q < < Q < < < < !
! OliKr<!Gm<ml<!hkqoem<Mme<!ofib!jubqEx<!huLl<< < < < < < << < < < < < << < < < < < <!
! Ohkg<!<<< G{Ll<!uqbikqe<!Le<!hqxg<Gr<!G{Ljmh<OhOe/< < < < < << < < < < << < < < < < !
Gm<m! Ofib<! uik! hqk<k?! sqOzk<lk<kqEt<! uikl<! hqk<kl<! Ngqbux<xiz<!
d{<mieju!we<Xl<?!8!ujg!Gm<mr<gt<!kQviK?!22!ujg!Gm<mr<gt<!kQVl<!we<Xl<!
%xh<hm<Mt<tK/!
nsik<kqb!Gm<ml<!< < << < << < < .!8!e<!ohbi<< << << <!
! osiz<Zr<!G< << << < ]<mr<!WPujgOhi<!osiz<zqx<!gu< < < < << < < < << < < < < izR<si<lQgl<< < Q << < Q << < Q <!
! ouz<Z!LKl<Ohi!Olgqchl<!uqsi<s<sq!l{<mzig<gqvL< < < < < < << < < < < < << < < < < < < !
! lz<zz<!kVlQsq!bGju!biGl<!ohbOvi!cbiGl<< < Q < << < Q < << < Q < <!
! uz<zuqbikqg<!G{lkje!uGk<K!hiiq!Zjvh<Ohe</< < < < << < < < << < < < < !
sik<kqbl<!hkqoeie<xqe<!)22*!ohbi<< < < < << < < < << < < < <!
! H,{<mkk<!KVuqOeiM!skiqsl<!H{<!miQgf<< < < < Q << < < < Q << < < < Q <!
! ki{<M!uqx<Ohil<!hiliUml<!jlkzl<!ou{<< < < < < << < < < < << < < < < <!
! %{<mM!gig!ff<kq!sqk<Kjl!bzs<!G< < < << < < << < < < ]<ml<!Gm<ml<< < < << < < << < < <!
! Ou{<cb!uquikqObiMl<!hkqoeie<Xl<!uqiqk<K!giOe< < < < << < < < << < < < < !
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 “Nk<lvm<silqi<kl<!juk<kqb!sivsr<gqvgl<< < < < < < << < < < < < << < < < < < <”!–!5!ujg!
2/! ou{<Gm<ml<!
3/! osr<Gm<ml<!
4/! gVr<Gm<ml<!
5/! ohVuqbikq!
!
kqV&zi<!<<< .!29!ujg!
gqvf<kq!Olgk<kiz<!uVhju!.!7!
u{<ceiz<! ! ! .!9!
HPuiz<!! ! ! .!5!
Comparative studies 
 Among the eighteen types of skin diseases (kuttam) described by yugi, clinical 
features of thethiru kuttam, virpodaga kuttam, sadharu kuttam resemble those of 
kalanjaga padai. 
Okk<KV!Gm<ml<< < << < << < <!
! “si<lf<kie<!squh<hig!um<m{qk<K< < < < < << < < < < << < < < < < s<!<<< !
! szju!Ohiz<!ouTg<GOl!kqeU{<miGl</< < < << < < << < < < !
! ui<lf<kie<!OviglK!lqgU{<miGl<< < < < << < < < << < < < <!
! lbqovz<ziR<!SV{<MOl!d{<jmbiGl<< < < < << < < < << < < < <!
gi<lf<kie<!hqk<k!Osk<Kl!lqGg<Gl<< < < < < < << < < < < < << < < < < < <!
! gibf<kie<!gkqk<KOl!kqlqV{<miGl<< < < < << < < < << < < < <!
! ki<lf<kie<!smolz<zi!&kziGl<< < < < << < < < << < < < <!
! kig<gie!Okk<kqVg<!G< < << < << < < ]<mf<kiOe< << << < ”/!
.! B,gq!Leq!juk<kqb!sqf<kil{q< << << < !911/!
Annular erythematous lesions with whitish appearance, itching, oedema of the 
body and rolling of hairs like balls are the characteristic clinical features in the entity. 
skiV!Gm<ml<< << << <!
! “wk<kie!ouiqh<OhiM!kqeUliGl<< < << < << < <!
! wtqkie!Osm<Mluikf<!Kx<hk<kq< < < << < < << < < < !
! hk<kie!<<< gm<ch<!H{<[liGl<< < < << < < << < < <!
! hil<H!Okiz<!Ohix<xqjvf<K!hVk<Kg<!gi[l<< < < < < < << < < < < < << < < < < < <!
!
! uqk<kie!&g<OgiM!giK!ge<el<!< < < << < < << < < < !
! lqgk<Kch<hiR<!skiV!G< < << < << < < ]<mf<kiOe< << << < ”/!
! ! ! ! .B,gqLeq!ohVF~z<!911/<<< !
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!
uqx<Ohimg!Gm<ml<< < << < << < <!
! “HKjlbib<s<!siQvolr<Gk<!kqeU{<miGl<< < Q < < < << < Q < < < << < Q < < < <!
! ohiVoucbib<k<!kqg<ogek<kQg<!ogiPf<K!Ohiz< < < < Q < << < < < Q < << < < < Q < < !
! olKjlbib<!<<< uqm<omiqBl<!fz<z!hil<hqe<< < < < << < < < << < < < <!
! uq]h<hml<!OhiOz!kck<K!ouVh<H!liGl<< < < < << < < < << < < < <!
! SKjlbib<!lqgs<!osiiqBf<!squh<HliGl<< < < < << < < < << < < < <!
! K~g<goliM!sR<szLl<!kch<H{<miGl<< < < < < << < < < < << < < < < <!
! gek<kuqx<!Ohimglie!Gm<mf<kiOe< < < << < < << < < < ”/!
.! B,gqLeq!ohVF~z<!911/<<< !
Characterized by elevated skin lesions with erythema and itching.  Burning 
sensation will be present on and off.  Usually these entities are associated with anxiety 
and despair. 
ghiz!uik!gvh<hie<< << << <!
! “we<eUjv!uiksqvk<!OkBr<g!vh<heK< < < << < < << < < < !
! lqe<ELgk<!kie<uQr<G!olb<GtqVl<!Oukjebil<< < < Q < < < << < < Q < < < << < < Q < < < <!
! hqe<eie!sf<K!mOe!hqmiqLk!zilqmr<gt<< < < << < < << < < <!
! ke<eig!ofif<Kl< << << < qgk<!kjzgeg<G!ole<xxqOb< < << < << < < ”!
.! hvvis!Osgvl<!<<< .!sqvOvig!fqkiel</<<< !
ohipqh<Hjv<<< !
! lqe<El<?! Lgl<! uQr<Gl<?! olb<GtqVl<?! Oukje! d{<miGl<?! sf<K?! hqmiq!
Lkzqb!-mr<gt<!ofif<K!kjz!g{g<Gl</!!!
“nxqOb!fQVl<!szLl<!hib<f<!kez<Ohi!ozxqf<K!Gk<K{<mil</Q < < < < < < < < <Q < < < < < < < < <Q < < < < < < < < < !
osixqBl<!hqe<ei<!lqgg<gib<k<K!K< < < < < << < < < < << < < < < < R<S!ofb<Ohix<!gpqf<OkiMl<< < < < << < < < << < < < <!
hxqBl<!ohiVg<Gs<!sil<hoveh<!hiqb!fiXl<!Hzeix<Xl<< < < < < < < << < < < < < < << < < < < < < <!
GxqBl<!uik!sqvgvh<hie<!ogi{<mivg<!Gx<x!G{lqz<jzOb< < < < < < << < < < < < << < < < < < < !
.! hvvis!Osgvl<!<<< .!sqvOvig!fqkiel<<<<!
ohipqh<Hjv<<< !
! lzl<?! sqXfQI! osz<Zl<! OhiK! nez<! Ohiz<! wiqBl</! ! nk<OkiM! Gk<kz<!
osixqBl<! d{<miGl</! ! Okib<k<K! juk<k! ofb<! Ohiz<! sQp<! gsqf<OkiMl</! ! Hziz<!
fix<xl<! uQSl</! ! -ke<! GxqG{r<gt<! gitiR<sghjm! Ohiz<! )Pastular psoriasis) 
gi{h<hMgqxK/!
ghiz!ou{<Gm<ml<< < << < << < <!
! “Okix<Xou{<!Gm<mR<!osb<Bl<!G{k<kqjes<!osiz<zg<!Ogtib<< < < < < < < < < < << < < < < < < < < < << < < < < < < < < < <!
! fQx<xqMr<!gzl<!Ohizs<!osixqf<kqM!fQVl<!hiBl<Q < < < < < Q < <Q < < < < < Q < <Q < < < < < Q < <!
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! Wx<<<<xlib<s<!sil<hz<!uQP!lqpqHzie<!lqeOu!fiXl<< < < < Q < << < < < Q < << < < < Q < <!
! lix<xlib<g<!ghiz!Ole<Olz<!ux{<Mgi!kqjvs<s!ziOl< < < < < < << < < < < < << < < < < < < ”/!
ohipqh<Hjv<<< !
! kqVfQX!jug<Gl<!lvg<gzl<!Ohiz<!out<jtbig!-Vg<Gl</!!osixqObiM!fQVl<!
hiBl<?! sil<hz<! Ohiz<! uqPl</! ! -ke<! GxqG{r<gt<! gitiR<sg! hjm! Ohiz<!
gi{h<hMgqxK/!
ghiz<!ou{<<< <gvh<hie<< < << < << < <!
! “uQXl<!sqvk<kqz<!ou{<gvh<hie<!G{k<jkg<!Ogtib<!olz<zqbOzQ < < < < < < < < < <Q < < < < < < < < < <Q < < < < < < < < < < !
! %Xl<!Ht<tq!fqxl<!ouTh<hib<g<!GXofx<!oskqz<Ohiz<!ogikqk<K!uqPl<< < < < < < < < < < << < < < < < < < < < << < < < < < < < < < <!
! DX!'Vf<!kqeU{<mi!OliOm!obiMh<Ohix<!gvgvg<Gl<< < < < < << < < < < << < < < < <!
! liX!Ohiz!Umz<ux<Xl<!uijk!bqKU!lsik<kqbOl< < < << < < << < < < ”!
.! hvvis!Osgvl<!<<< .!sqvOvig!Vkiel</<<< !
!
ohipqh<Hjv<<< !
! ou{<gvh<hieqz<! Ht<tq! Ohie<X/! ! ouVh<H{<miGl</! ! GVofx<! Ohiz<!
oskqz<gt<!ogikqk<K!uqPl</!!dmz<!Dxq!fQVme<!kqeU{<miGl<!liX!Ohiz<!dmz<!
ux<Xl</!!-ke<!GxqG{r<gt<!gitiR<sghjm!Ohiz<!)Exfoliative dermatitis). 
 According to thethuru kuttam, virpodaga kuttam, satharu kuttam, The clinical 
features are resemble to Kalanjagapadai. 
Clinical features 
 In the siddha text book sirappu maruthuvam, sirappu authored by Sri.Dr.R. 
Thiagaraja, Clinical features are described as, 
 The skin lesions are red in colour with raised margins and white ivory or silvery 
rough thick scales on removing the scales pin point blood-stained spots occurs.!
 The lesions vary in size either thin or thick layers.!
 In children these lesions may be like water drops.!
 In severe cases lesions occur in the face, scalp and sometimes all over the body. 
!
IN A CHRONIC CASE 
 The skin lesion occurs in the extensor aspect of forearm. 
 In some cases these lesions appear over the palms and soles. 
 In some cases these lesions appear all over the body. 
 The lesions are coin shaped and there may be small pus formed lesions can be 
found. 
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 In obese women, the lesions may occur over navel inguinal region and axilla with 
discharge.  Due to sweating, Itching may be associated. 
 The borders of the lesions are not be demarcated clearly. 
 On fourth of the patients have lesions over nails which are pink coloured and 
associated with ridges. 
 
PSORIATIC ARTHROPATHY (Kalanjaga Vatham): 
Kalanjaga padai is often associated with painful joints known as “Kalanjaga 
vatham”. It may affect any joint. The most often affected joints are inter-phalangeal 
joints. The terminal interphalangeal joints are usually involved as opposed to the 
proximal interphalangeal joints in “Uthira vatha suronitham” which is identical with 
rheumatoid arthritis.  
In these cases the affected fingers show nail changes. This condition is termed as 
“Psoriatic Arthropathica”.  The joints of fingers, ankles, knee and sacroiliac region are 
selectively affected. Those joints are swollen and painful with psoriatic lesions.  
Radiological changes are characteristic and consist of osteoporosis followed by 
increased density, diminished joint space, and erosion of joint surfaces followed by 
eventual destruction of the ends of bones. Ultimately, the joints become deformed.  
Yugi muni describes the clinical features of Kalanjaga vatham as follows; 
“uiklir<!giz<!jgbqz<!Gvr<gqv{<Ml<< < < < < << < < < < << < < < < <!
!!!!!!!!!!!uVk<K!sf<K!LXg<gqOb!Gjmf<K!ofif<K< < < < << < < < << < < < < !
fikli!fjm!kiEf<kie<!ogimilz<< < << < << < <!
!!!!!!!!!!fzqf<KOl!Lmligqg<!gvM!gm<cs<< < < << < < << < < <!
Osklif<!smf<kiE!lqg!< << << < ouTk<Kk<< << << <!
!! ! ! kqeOuiM!sqvr<Glib<s<!Osm<hligqg<< < < < << < < < << < < < <!
gikli!bVsq!obiM!lbg<gliGl<< << << <!
gVkqOb!gitiR<sglil<!uikliOl< << << < ”  
- osb<Bt<!36:< << << < !
“uiklir<!giz<!jgbqz<!Gvr<gqv{<Ml<< < < < < << < < < < << < < < < <”!
The joints of fingers, feet, ankles, knee and sacroiliac are selectively affected and 
these joints are painful. 
“fikli!fjm!kiEf<kie<!ogimilz<< < << < << < <!
! ! fzqf<KOl!Lmligqg<!gvM!gm<cs< < << < << < < ”!
The deforming erosive arthritis targets finger and toe. Marked cartilage 
destruction and bony articulation results in loss of joint space and marked instability.  
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!
“Osklif<!smf<kiE!lqg!< << << < ouTk<Kk<< << << <!
kqeOuiM!sqvr<Glib<s<!Osm<hligqg<< < < < << < < < << < < < <!
gikli!bVsq!obiM!lbg<gliGl<< << << <!
gVkqOb!gitiR<sglil<!uikliOl< << << < ”!
The whole body becomes pale (anemic). Well-defined erythematous papules 
which are sharply demarcated appear on the skin. There is also loss of taste and giddiness. 
 
SIDDHA PATHOLOGY: 
BASED ON DHANVANDHRI VAIDHYA ROGAM 
 “Le<eqjz!uik!hqk<k!sqOzk<le!&e<X!lr<Gl<< < < < < << < < < < << < < < < <!
! ! hqe<eqb!kXg<giBt<t!fvl<hqeqx<!hqvOusqk<K< < < < < << < < < < << < < < < < !
! le<eqb!vk<kl<!k{<{QI!lir<gq< < < < Q << < < < Q << < < < Q < ]f<!Okiz<!ogiMk<Ok< < << < << < < !
! ! be<eqb!ue<er<!gi[l<!lijgbqx<!Gm<mliOl< < < < < << < < < < << < < < < < ”!
.! ke<uf<kqiq!juk<kqb!< < << < << < < Ovigl<<<< 
uikl<?!hqk<kl<?!ghl<!&e<Xl<!Ogmjmf<K!fvl<hqz<!Osi<f<K!-vk<kl<?!k{<{QI?!
lilqsl<?!Okiz<!-ux<jx!ogMk<K!liXhiM!d{<mig<Gl</ 
! “Gm<mOvigf<kie<!uf<K!Gcogi{<mix<!siQvk<kqZt<t< < < < < < Q < << < < < < < Q < << < < < < < Q < < !
! ! Lm<MX!uqbi<ju!bQvl<!ux<xqb!$m<sR<$m<sR<< < Q < < < < < << < Q < < < < < << < Q < < < < < <!
! kqm<mlib<g<!gqVlqB{<mib<!Okgk<kqz<!lbqi<< < < < < < < << < < < < < < << < < < < < < <OkioziqU!
! ! sm<mlil<!fvl<H!kqe<X!siQvk<kqx<!gi[ole<Ox< < < < Q < < << < < < Q < < << < < < Q < < < ”!
.! ke<uf<kqiq!juk<kqb!Ovigl< < << < << < < < 
 uqbi<jubqe<jl 
 gqVlqB{<mikz< 
 Okiz<!wiqU 
 fvl<H!hikqh<H! 
Ngqbe!Gm<mOvigk<jk!okimi<f<K!uVl</!
Noi (Pini) 
 Definition : 
Whenever alterations occur in three vital humours, disease or noi occurs. 
“dmZme<!hqj{f<k!dbqi<!nEhuqg<Gl<< < < < << < < < << < < < < 
-e<h!d{i<s<sqg<G!lixie!d{i<s<sqOb!hq{q< < < < < << < < < < << < < < < < ”!
 “lqgqEl<!GjxbqEl<!Ofib<!osb<Bl<!F~OziI< < < < << < < < << < < < < !
utq!Lkzi!w{<{qb!&e<X< << << < ”/!
.! Gxt<<<<!
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Therefore the deranged vatha, pitha kapha denotes disease. The diseases are 
reflected through the pulses in the three humours !
Food variations:!
“Htq!Kui<!uqVR<Sr<gxq!biI!H,iqg<Gl<!uikl<< < < < < << < < < < << < < < < <!
ytq!Bui<!jgh<!Ohxqz<!hqk<Ks<!sQXl<!< < < < < Q << < < < < Q << < < < < Q < .!gqtq!olipqOb!
giIh<!hqeqh<H!< << << < uqR<sqx<!ghl<!uqR<SR<!sm<cvks<< < < < < < << < < < < < << < < < < < <!
Osv!H{i<!Ofib[giOk<<< ”!
 Sour and astringent increases vatham  
 Salt and bitter increases pitham  
 Pungent and sweet increases kabam 
 
Paruvakaalam (season): 
 The whole year is constituted by 6 seasons. They are 
 Karkalam  (August 16 to October 15)  
 Koothir kaalam (October 16 to December 15th)  
 Munpani kaalam (December 16 to February 15th)  
 Pinpani kaalam (February 16 to April 15th)  
 Elavenil kaalam (April 16 to June 15th)  
 Mudhuvenil kaalam  (June l6 to August 15th) 
  In each and every season routine changes will occur in the land, normal biological 
functions of individual, living things, plants, animals, human beings, which will modify 
normal physiology and make them susceptible to certain specific disease. 
In my dissertation maximum cases occur in munpani kaalam.  
Nilam (land): 
It is divided into five types. They are 
1. Kurinchi 
2. Mullai 
3. Marutham 
4. Neithal 
5. Palai 
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UYIR THATHUIYAL : 
Knowledge of three uyir thathus, seven udal thathus and six tastes will be helpful 
to do detailed study on the disease. 
For instance, the taste sweet is the combination of Mann and Neer. The kaba dosha 
also posses of same combination. So it is clear that excessive take of sweet will increase 
kaba kuttram. It can be balanced by the administration of  "Thee" bootham containing 
taste. Similarly, administration of sour taste increases vatha kuttram that can be alleviated 
by opposite taste. The vatham further divided into ten. 
The classification and its functions are,  
A. VATHAM 
1. Pranan ( Uyir Kaal) 
It is responsible for respiration and digestion. 
2. Abanan( Keezhnokku Kaal) 
It lies   below the  umbilicus   responsible for the   downward expulsion of stools, 
urine and constriction of anal sphincter. 
3. Viyaanan (Paravu Kaal) 
It is responsible for the action of all organs, sensation and absorption of food. 
4. Uthaanan( Melonkku Kaal) 
It is responsible for the absorption and distribution of food. 
5. Samaanan (Nadu Kaal) 
It is responsible for the balancing of the other vayus; absorption of nutrition's 
and water balance of the body. 
6. Nagan 
It is responsible for the movements for eyelids. 
7. Koorman 
It is responsible for the sight, closing of eyelids, yawning and closure of mouth. 
8. Kirukaran 
It is responsible for the secretion of mouth and nose, appetite, sneezing, cough. 
9. Devathathan 
It is responsible for aggravating of the    emotional disturbances anger, lust 
frustration, etc. 
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10. Thananjayan 
It escapes from the head on the third day after death. 
Increased vaatham 
Emaciation, desire to hot food, shivering, abdominal bloating, constipation, 
sleeplessness, giddiness and laziness.  
Decreased vaatham 
Pain all over the body, low voice,  loss of attentiveness, unconsciousness and other 
diseases of increased kabam.  
In the cases of Kalanjaga padai 
Abanan -  Habitual Constipation. 
Viyaanan  -  Erythematous in the affected lesions of skin.  
Samaanan  - Due to other Vayu it is affected.  
Kirakaran  -  Polydipsia, polyphagia, loss of appetite.  
Devathathan  -  Insomia.  
The above Vayus are commonly affected.  
B. PITHAM 
The pitha dosha is further divided into five as follows, 
1. Anala Pitham (Aakku Anal) 
Its action is characteristic of thee. This is responsible for digestion of food. 
2. Ranjaga Pitham (Vanna Aeri) 
It is responsible for the colour and contents of the blood. 
3. Saathagam (Atralanki) 
It lies in the heart. It is responsible for the action after thinking. 
4. Prasagam ( Ollolithee) 
It is responsible for the complexion of skin.  
5. Aalosagam (Nokkazhal) 
It is responsible for the vision. 
Increased Pitham 
Yellowishness of eye, stools, urine and skin. Excessive thirst and appetite, burning 
sensation of body and sleeplessness. 
Decreased Pitham 
Hypothermia, loss of skin complexion and causes derangement of kabam.  
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In the cases of Kalanjaga padai 
Anala pitham  - Indigestion of food. 
Ranjagam -  Paleness of conjunctiva and tongue. 
Sathagam  - Difficulty to do the routine works properly and sluggishness. 
Pirasagam  - Dryness and roughness of skin.  
The above pithams are commonly affected. 
 C KABAM 
1. Avalambagam  
It causes diseases of the respiratory system when it is affected thereby indirectly 
affecting the other lyyams. 
2. Kilethagam  
Appetite and digestion may not be normal when it is affected.  
3.  Pothagam  
Derangement causes anorexia, 
distaste. 
4. Tharpakam 
Memory and perception of senses may be affected when this is deranged. 
5. Sandhigam 
Mobility of joints is affected due to drying up of the synovial fluid when 
sandhigam is abnormal. 
Increased kabam 
Increased salivation, inactiveness, heaviness of the body, impaired joint movement, 
dyspnoea, coughs and increased sleep. 
Decreased kabam 
Giddiness, flattening of chest increased sweating and palpitation. It is also 
important to know that the taste and activities which increase the Vaatham, pitham and 
kabam for the proper treatment of the diseases. 
In the cases of Kalanjaga padai 
 Kilethagam - loss of appitite was mainly affected. 
 Tharpagam - Burning sensation of eyes was affected in few cases. 
 Santhigam - Pain in joint affected in few cases 
  The above kabam are commonly affected. 
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SEVEN UDAL KATTUGAL 
There are seven primary body tissues which constitute the entire human body and 
all the organs of the various systems. 
1. Saaram 
It is the end product of digestive process. It gives strength to the body and mind. 
2. Senneer 
The saram after absorption is converted into senneer. It is responsible for 
knowledge, strength and health complexion.  
3. Oon 
It gives figure and shape to the body. It is responsible for the, movement of the 
body. 
4. Kozhuppu 
It lubricates the organs and thus facilitates their function. 
5. Enbu 
Gives shape to the body helps locomotion and protects vital organs. 
6. Moolai / machai 
Present in the core of the bone and it gives strength maintains the normal 
condition of the bone. 
7. Sukkilam /Suronitham 
Responsible for reproduction 
In the case of Kalanjaga padai out of seven udal kattukkal  
Saaram : Dryness, roughness, tiredness.  
Senner  : Dryness, paleness of the skin.  
Oon   : Weakness of sense organ.  
Enbu  :Pain in the joints in chronic cases.  
UDAL VANMAI (Body Immunity) 
The Udal Vanmai is classified into 3 types. They are,  
 lyarkai Vanmai  
 Seyarkai Vanmai  
 Kaala Vanmai  
IYARKAI VAN MAI 
Natural immunity of the body itself by birth.  
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SEYARKAI VANMAI 
Improving the health by intake  of nutritious  food materials,  activities  and 
Medicines.  
KAALA VANMAI 
Development of immunity according to age and the environment. 
When Udalvanmai is affected there may be a possibility of Kalanjaga Padai. 
PINIYARI MURAIMAI 
The method adopted to find out a disease in Siddha is known as P1N1YARI 
MURAIMAI. It is based on the following principles. 
 Poriyaal Arindhal  
 Pulanaal Therdhal  
 Vinavudhal. 
"Pori" is the five organs of perception namely Nose, Tongue, Eyes, Ears and Skin. 
"Pulan" is the five objects of senses Smell. Taste, vision auditory and sensation, 
respectively corresponding to "Pore". Poriyalarithai and Pulanal Therthal go hand in hand 
with the concept to examining the patients. "Pori" and "Pulan" with that of the "patient's 
.Pori" and" physicians Pulan". 
"Vinathal" is a method of inquiring the details of either the patient's problem that 
made him to approach the physician from his own or his /her attendants who accompany 
them. 
Along with, above mentioned principles is also carried out inspection in modern 
medicine. Besides, Thottuparthal (Palpation) and Thattiparthal (Percussion) are also used 
to diagnose a patient. 
The prime method adopted to diagnose the disease is by means of "Envagai 
Thervugal" (Eight types of investigations). Envagai Thervugal a physician' instruments 
and can be understood by the following verses. 
“fich<!hiqsl<!fi!fqxl<!olipq!uqpq< < << < << < < !
lzl<!&k<kqvl<!lqju!< < << < << < < lVf<KuviBkl<< << << <”!
.! Okjvbi<<<<!
!sqk<k!lVk<Ku!Ofib<fimz<!Ofib<!Lkz<!fimz<!kqvm<M!higl<!.2!
Envagai Thervugal constitue 
1. Naa 
2. Niram
  
3. Mozhi 
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4. Vizhi  
5. Sparism  
6. Malam  
7. Moothiram  
8. Naadi 
1. Naa (Tongue) 
The colour, character and condition of the tongue change according to the changes 
of mukkutram. 
In Kalanjaga padai no abnormality is seen in Naa. 
2. Niram (Colour) 
Signs of Vatha, Pitha and Kaba colours, mixed colour cyanosis, pallor, flusing or 
Yellowish discoloration can be studies by means of Niram. 
In case of Kalanjaga padai white patches with silvery scales can be noticed at 
affected areas. 
3. Mozhi (Speech) 
  Constitutes high or low-pitched voice, slurring and incoherent Speech, nasal or 
crying, hoarseness of voice etc. 
In case of Kalanjaga padai, no abnormalities was ruled out in Mozhi. 
4. Vizhi (Eye) 
  Along with sight, anatomical lesions are noted, Burning of the eyes, lacarymation, 
mutation, colour change of the eyes also noted. In case of Kalanjaga padai, no 
abnormalities was ruled out in vizhi. 
5. Sparism (Palpation) 
  By palpation and inspection, the following information's were elicited. 
Temperature of the skin, whether uniformly hot or cold, thickness. Fissures soft/hard 
swelling, wrinkles, pigmentation of hairs etc. 
  In case of  Kalanjaga padai well defined macules, papules, thickening, roughness, 
pain and white silvery scaling of skin can be noticed at affected area. 
6. Malam (Stools) 
Vatha type      -  Hard, rough, dry, scanty and black. 
Pitha type       -  Loose stools, moderate in quantity. Yellowish red with  
     fermenting odour. 
Kaba type       -  Clay or white coloured stools, huge in quantity with  
slimy, mucous and frothy bubbles. 
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Thontha type - Faecal matter possesses some of the features of two doshas. 
In case of Kalanjaga padai constipation was reported in some cases. 
 
7. Moothiram (Urine) 
The Examination of urine is classified under 2 headings. 
“nVf<K!lixqvkLl<!nuqOviklkib<< < << < << < <!
n0gz<!nzi<kz<!ngizU,e<!kuqi<f<kpx<< < < < < < << < < < < < << < < < < < <! !
Gx<xt!uVf<kq!dxr<gq!jugjx< < << < << < < !
Ncg<!gzsk<!kiuqOb!giKohb<< < << < << < <!
okiV!L%Ik<kg<!gjzGm<!hMfQiqe<< < < Q << < < Q << < < Q <!
fqxg<Gxq!ofb<g<Gxq!fqVlqk<kz<!gmOe/< < < < << < < < << < < < < ”!
.! sqk<k!lVk<Kuir<g!SVg<gl<< < < < << < < < << < < < <!
Neerkuri - Niram, Edai, Manam, Nurai, Enjal  Neikuri   
Neerkuri 
 “uf<k!fQIg<giq!objm!l{l<!Fjv!wR<soze<< Q < < < << Q < < < << Q < < < <!
! jxf<kqb!Ztju!bjxGK!LjxOb<<< ”/!
.! sqk<k!lVk<Kuir<g!SVg<gl<< < < < << < < < << < < < <!
 Niram indicates the colour of the urine voided. 
 Edai indicates the specific gravities of urine. 
 Manam indicated the smell of the urine voided. 
 Nurai indicates the frothy nature of the urine voided. 
 Enjal indicates the quantity (increases or decreased) of urine voided. 
In addition, frequency of Micturation, abnormal constituents, such as sugar, protein, 
presence of blood, pus, renal crystals also to be noted. 
In Kalanjaga padai patient straw coloured urine is noted. Poly urea can be noted in 
some cases. 
(b) Neikuri: 
The specialty of neikuri is stated in the following verse: 
 “Jg<Gxq!ogiMum!uieqp!zli<f<OkiI< < << < << < < !
! jgg<Gxq!okiqf<k!fr<!gmUjtk<!Kkqk<Ok< < < < << < < < << < < < < !
! olb<Gxq!fqxf<okieq!uqpq!fiuqVlzl<< < << < << < <!
! jgg<Gxq!LpuK~!dr<gx<xiI!kl<lqEl<< < < < << < < < << < < < <!
! ohib<g<Gxq!olb<Gxq!HgZol!ui<g<Gl<< < < < < << < < < < << < < < < <”!
.! sqk<k!lVk<Ku!Ofib<!fimz<!Ofib<!Lkeimz<!< < < < < << < < < < << < < < < <
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kqvm<M<<< !
The collected specimen as said above is to be analysed by following method. The 
specimen is kept open in a glass dish or china clay container. It is to be examined under 
direct sunlight, without shaking of the vessel. Then add one drop of gingelly oil at a 
distance of 1/2" or 3/4" height observe keenly the direction it spreads with in few 
minutes, and conclude the diagnosis.  
The character of Vatha Neer  
 “nvou{<!fQ{<c!e0Ok!uikl<”!
When the drop of oil spreads like a snake, it indicates Vatha Neer. 
The Character of Pitha Neer  
 “NpqOhix<!hvuqe<!n0Ok!hqk<kl<”!
When the drop of oil spreads like a ring, it indicates Pitha Neer.  
The Character of Kaba Neer  
 “Lk<okik<K!fqx<gqe<!olipqu!oke<!ghOl”!
When the drop of oil remains as that of a pearl, it indicates Kaba Neer. 
The Character of Thontha Neer  
 “nvuqz<!NpqBl<!Npqbqz<!nvUl<< < < << < < << < < <!
! ! nvuqz<!Lk<Kl<!Npqbqz<!Lk<Kl<< < < < < << < < < < << < < < < <”!
.! sqk<k!lVk<Ku!Ofib<!fimz<!Ofib<!Lkeimz<!kqvm<M< < < < < < << < < < < < << < < < < < < !
Thontha Neer 
Ring in the Snake Snake in the ring Pearl in the snake Pearl in the ring  
8. Naadi (pulse): 
Naadi is responsible for the existence of life and can be felt on inch below the wrist 
on the Radial side by means of palpation with the tips of index, middle and ring fingers 
corresponding to vatham, pitham and kabam. 
These humors vatham, pitham and kabam exist in the ratio 1: ½ : ¼ normally the 
arrangement in this ratio leads to various disease entities. 
In the Kalanjaga vatham he following types of naadi were observed. They are, 
i. Vatha kabam 
ii. Vatha Pitham 
LINE OF TREATMENT (NOI NEEKAM) The aim of noi neekam is based on 
1. To bring the three doshas in equilibrium. 
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2. Treatment of the disease accordingly the signs and symptoms. 
3. Pathiyam 
Siddha system of medicine is based on the mukkutra theory and hence the treatment 
is mainly aimed to bring down the three doshas to its equilibrium state and there by 
restoring the physiological consitions of several thathus. 
 “uqOvs{k<kiz<!uikl<!kiPl<< < < << < < << < < <!
! ulek<kiz<!hqk<kl<!kiPl<< < < < << < < < << < < < <!
! fsqb!nR<s{k<kiz<!ghl<!kiPl<< < < < << < < < << < < < <”/!
.! sqk<k!lVk<Kuir<gs<!SVg<gl<!h/w{</773< < < < < < << < < < < < << < < < < < < !
!
 Vatha disease can be brought down by Viresanam. 
 Pitha disease can be brought down by Vamanam.  
 Kaba disease can be brought down by Anjanam. 
“uiklziK!OleqogmiK”!
.! Okve<!Osgvh<hi< << << < !
sqk<k!lVk<Ku!Ofib<fimz<!Ofib<Lkz<!fimz<!kqvm<M!higl<!.2!h/w{</474!
Hence, Kalanjaga padai occurs due to the vitiation of vatham it can be set right by 
giving viresanam.  
Treatment of disease : 
In addition to this following medications are practiced in the Siddha system .  
 Aha maruthugal (Internal medicines)  
 Pura maranthugal (external medicines) 
 Restriction regarding food habits and routine day to day life style.  
 Sirappu Maruthuvam - a special feature of Siddha medicine like Pranayamam, 
Yoga. 
After the thiridoshas are brought down to its equilibrium state, the signs and 
symptoms of disease should be treated properly. For the study.  
AHA MARUTHUVAM 
 Oma legiyam 
PURA MARUTHUVAM  
 THAGARAI LEBAM .        
Restriction Regarding food and Habits 
1. Avoid bitter guard, guava, egg, fish, chicken 
2. Avoid alcohol, smoking etc., 
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3. Obese must be restricted. 
4. Since it is a chronic and not a life threatening disease, it should not be loaded with 
heavy drags. 
5. The meditations should calm the mind just free from stress and strain 
6. The patches should be washed with lukewarm water, to remove the scales 
everyday early morning. After the bath, external applications are to be applied 
there after. 
7. Avoid allergic food items. 
“ohVR<!Osit!lqXr<Gl<!ohVl<!gl<H< < < < << < < < << < < < < !
uvG!giVme<!uijpbqe<!giobiM< << << < !
djv!ogit<!higx<!ogtqx<X!lQe<!d{<ccz<< < < Q < < << < < Q < < << < < Q < < <!
uqiqukib<!gvh<hiE!lqGf<kkOk< < << < << < < ”!
.! hkiIk<k!G{!sqf<kil{q< << << < !
SPECIAL NON DRUG THERAPEUTICS 
Several special medicaments of non drug therapeutic like Yoga, Pranayamam, 
Asanas, Kalpa medicines are employed in Siddha systems. 
These are employed during diseased state and for the prevention of diseases during  
healthy  days.   In  Kalanjaga  padai,  patients   are   also   advised  to  follow 
Pranayamam, Yoga and Asanas, in order to avoid the remissions and exacerbation of this 
disease.  
PRANAYAMAM 
It is a form of Kayakalpa method. By practicing this one can prevent any disease. 
This is explained in the following verse, 
 
 
 
 
  
28 
 
 
 
 
PRANAYAMA 
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YOGA 
Yoga is maintained by the body in a particular posture for a particular period of time. 
This is totally different from the ordinary exercise. Yoga vitalises, both physical body 
and the mental set-up unlike exercise which tones only the muscles. The common 
benefits are, 
 It tones the internal organs. 
 It prevents obesity and disease. 
 It maintains normal circulation to all the organs of the body. 
 It is very safeguard for all the vital organs. 
 It avoids laziness, enhances pure mind and cleverness and memory power. There 
will be no problems like psychosomotive disturbances if practised daily. 
ASANAS 
Retarding skin disease the following Asanas can be advised  
I. - PADMASANA (LOTUS POSE) 
TECHNIQUE : 
1. Keep the right foot on the left thigh 
2. Start bouncing the right knee.  If the bouncing knee easily touches the floor, then 
bend the left knee, take hold of the left foot with both hands, gently glide it over 
the crossed right leg and place it on the right thigh. 
3.  This will give symmetrical placement of the Padmasana legs and you are in 
lotus position. 
4. The hands should be kept on the knees with palms open, and the thumb and 
second finger of each hand should touch forming a letter O.  
Benefits: 
1. This is an extremely good pose for meditation and concentration. 
2. It has a calming effect on the mind and the nerves. 
3. This pose keeps the spine erect. Helps to keep the joints in flexible condition. 
4. Helps to develop a good posture. 
5. It allows the body to be held completely steady for long periods of time. 
6. It holds the trank and head like a pillar with the legs as the firm foundation. 
 
! !
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3/!si<uir<gisel<!< < << < << < < .! SARVANGASANA (THE SHOULDER STAND) 
TECHNIQUE 
1. Lie flat on your back. Inhale deeply while raising your legs and spine until the 
toes point to the ceiling. 
2. The body rests on the shoulders and the back of the neck. The body is 
supported by the hands, which are placed on the center of the spine between 
the waist and the  shoulder blades. Keep your spine and legs straight. 
3. 3.Breathe slowly and deeply with the abdomen and concentrate on the thyroid 
gland. On a male, the thyroid gland is located behind the Adams apple. For 
women, it is located in the same area which is a few inches above the sternal 
notch (hollow of the neck where the neck joins the rest of the body.) or 
approximately half way up the neck from the sternal notch. Stay in this 
position for about two minutes. 
4. To come out of this posture, just bend your knees, curve your back and slowly 
return to lying on the floor while exhaling. First bend your knees, put the 
palms on the floor, then curving the spine, gradually unfold it the way one 
unrolls a caipet. When your entire back touches the floor, straighten the knees, 
take a deep breath and slowly lower your legs to the ground while breathing 
out. 
5. If you wish, you may go straight into the next posture (the 'reverse posture') 
instead of lying down. 
Benefits 
1. The main benefit of the shoulder stand is to get the thyroid gland working at 
peak efficiency. It's the thyroid gland which is mainly responsible for your 
correct weight and youthful appearance.  
2. The shoulder stand also regulates the sex glands.    
3. It vitalizes the nerves, purifies the blood and promotes good circulation, 
strengthens the lower organs and helps them to stay in place. 
4. It gives a healthy stretch to the neck muscles. 
5. It is beneficial for people suffering from poor circulation, constipation, 
indigestion,  asthma and reduced virility. 
6. This pose is especially recommended for women after childbirth and for those, 
from  painful menstruation, other female disorders, and seminal weakness. 
7. The sanskrit name for this posture sarvangasana means 'all the body' 
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3. suisel<!<<< .!The Corpse Posture (Shava-asana) 
Instruction 
1. Lie flat on your back with your legs together but not touching, and your arms 
2. close  to  the  body with  the  palms facing up. 
3. 2. Keep your eyes gently closed with the facial muscles relaxed and breathe      
deeply and slowly through the nostrils. 
4. Starling at the top of the head and working your way down to the feet, bring  
to each part of your body, consciously relaxing it before proceeding on to the 
next.  
5. Remain in the shava-asana for between 3 and 5 minutes or longer. If you 
become sleepy while in the shava-asana begin to breathe a bit faster and 
deeper. 
Comments 
1. The goal of the shava-asana is for the body and minds to be perfectly still and 
relaxed. Not only should the body be motionless and at ease, but the mind as well 
should be quiet, like the surface of a still lake. 
2. It goes without saying that the shava-asana will take some time to perfect. It will 
find the simple exercise of focusing your attention on each part of your body and 
consciously directing the breath there to be a great help with this posture. 
3. There are two common obstacles that can prevent you from fully benefiting from 
this posture: sleepiness and a restless mind. If our mind is restless or wondering 
focus your attention on all of the bodily sensations you're experiencing. Bring 
your mind to the sensation of the floor beneath you or on the rhythm of your 
breath. 
4. While practicing your Yoga-asana routine you should always begin and end each 
session with the shava-asana. 
 Durations/Repetitions: 
1. We recommend that you begin your period of yoga-asana practice with at least 3-5 
minutes of shava-asana. 
2. Return to it periodically thought your posture session to relax and rejuvenate the 
body/mind and then conclude your session with at least 3-5 minutes more.  
Benefits 
1. This asana relaxes the whole psycho-physiological system. 
2. It should ideally be practiced before sleep; before, during and after asana practice, 
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particularly after dynamic exercises such as surya namaskara. 
3. When the practitioner feels physically and mentally tired. It develops body 
awareness.  
4. When the body is completely relaxed, awareness of the mind increases, 
developing pratyahara.  
4.kqiqOgisel<!<<< - TRIKONASANA (TRIANGLE POSE) 
1. Stand erect with the feet about a meter apart.  Turn the right foot to the right side. 
2. Stretch the arms sideways and raise them to shoulder level so that they are in one 
straight line. 
3. Bend to the right, taking care not to bring the body forward. Simultaneously bend 
the right knee slightly.4. Place the right hand on the right foot, keeping the 
two arms in line with each other. 
Turn the left palm forward. Look up at the left hand in the final position.  
5. Return to the upright position with the arms in a straight line. 
6. Repeat on the opposite side, bending the left knee slightly. This completes one 
round. 
7. Practice 5 rounds. 
Respiration: 
1. Inhale while raising the arms. Exhale while bending. Hold the breath for a few 
seconds in the final position. 
3. In hale while raising the body to the vertical position. 
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ASANAS 
PADMASANAM SARVANGASANAM 
SHAVASANAM TRIKONASANAM 
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Benefits: 
1 . To tone of the entire body. 
2. It affects the muscles on the sides of the trunk, the waist and the back of the legs. 
3. It   stimulates   the   nervous   system   and   alleviates   nervous depression. 
4. It improves digestion, stimulating the appetite, activating intestinal peristalsis and 
alleviating constipation. 
5. It also strengthens the pelvic area and tones the reproductive organs. 
6. Regular practice will help reduce waistline fat. 
 
PATHIYAM 
Disease mainly occur due to wrong diet habits. Siddhars stressed this in every 
aspect of treatment and prevention from further occurrences. This view is well 
understood in this verse. 
“lVf<oke!Ou{<miuil<!big<jgg<G< < < < << < < < << < < < < !
nVf<kqbKbx<xK!Ohix<xq!B{qe<< < < << < < << < < <”!
.! Gxt<<<<!
During diseased states, diet restrictions or pathiyam are strictly to be followed. 
These are to be administered to normalize the deranged doshas and for the good 
manifestation of given medicines to be more effective. I his is given in the verse, 
“hk<kqbbk<kqeiOz!hze<!d{<miGl<!lVf<K< < < < < << < < < < << < < < < < !
!hk<kqbr<gt<!Ohieiz<!hze<!OhiGl<!< < < < < << < < < < << < < < < < .!hk<kqbk<kqz<< < << < << < <!
hk<kqbOloux<xq!kVl<!h{<cki<g<G!< < < < < << < < < < << < < < < < –!Nkzqeiz<<<<!
hk<kqbOl!dk<kqobe<X!hiI< < << < << < < ”!
.! Okjvbi<!ou{<hi/< << << < !
So it is very essential to and here pathiyam strictly for the early cure of the 
DIET 
  Food habits that reduce the vatham, pitham, kabam to the normal level has to be 
taken. Patients are strictly convinced to avoid all the non-vegetarian items except goat's 
flesh. Avoidance of the following food items were also strictly advised. 
Agathi keerai - Leaves of sesbania grandiflora. 
Seeni avaraikai - Cynampsis psoratoides. 
Pagarkai - Bitter guard. 
Poosanikai - Great pumpkin. 
Perum payaru - Cow - gram. 
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Solam - Maize. 
Kanam - Horsegram. 
Motchai - Flac bean. 
Elumicham pazham - Lemon (citrus medica) 
Rich protein foods - Consists of histidine. 
 
The rich proteins consists of glucogenic amino acids. This amino acids on 
metabolism undergoes decarboxylation to yield histamine in the presence of an enzyme 
histidine decarboxylase. 
Histamines acts on skin and causes urticaria and anaphylactic reactions. So in 
order avoid skin complications, avoid dietary foods which are rich in highly biological 
value proteins.  
Habits : 
Patients avoid smoking, alcohol etc., advised to have timely diet.   
 
ANUPANAM IN SIDDHA SYSTEM: 
 “nEhiek<kiOz!buqp<kl<!hzqg<Gl<< < < < << < < < << < < < <!
! -eqkie!Sg<G!ge<ez<!-R<sq!< < < << < < << < < < –!hqELkgiz<<<<!
! OgiOlbl<!hiz<!Ljzh<hiz<!Ogiofb<!Oke<!oux<xqjz!fQI< < < < < < < Q< < < < < < < Q< < < < < < < Q !
! Nlqjkbivib<f<K!osb<bzil<< < < << < < << < < <”/!
.! Okjvbi<!ou{<hi< << << < !
Siddha  system  considers   anupanam  as   an  important  and  sometimes  more 
important than the medicine itself, without a knowledge of the importance of anupanam, 
success in the treatment is not possible.  Oma legiyam is given with milk two times a day. 
 
gib!gx<hl<< << << <!
Advised to take (Rejuvenation) "gibgz<hl<" to render the body invulnerable. 
All patients were also advised to follow siddhers preventive measures which would 
give immortality of body and soul, quoted in "Pathartha Guna Chinthamani" as follows. 
 
 “kqe<e!lqv{<Mt<t!sqg<g!umg<gilx<< < < < < << < < < < << < < < < <!
! Oh{<{qe<hi!ozie<jxh<!ohVg<gilz<!< < < < < << < < < < << < < < < < .!d{<[r<giz<< < << < << < <!
! fQISVg<gq!OliI!ohVg<gq?!ofb<Bvg<gq!B{<hui<kl<Q < < < < < < <Q < < < < < < <Q < < < < < < <!
! OhVjvg<gqx<!OhiOl!hq{q< << << < !
.! hkiIk<k!G{!sqf<kil{q< << << < !
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STRUCTURE OF THE SKIN 
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MODERN ASPECTS 
SKIN ANATOMY 
The skin is the largest organ of the body, with a total area of about 2 square metres. 
It serves as a protective barrier that prevents internal tissues from exposure to 
trauma, ultraviolet (UV) radiation, temperature extremes, toxins, and bacteria. 
Other important functions include sensory perception, immunologic surveillance, 
thermoregulation, and control of insensible fluid loss. 
Skin has three layers:  
Epidermis 
The epidermis, the outermost layer of skin, provides a waterproof barrier and 
creates our skin tone. The epidermis is derived primarily from surface ectoderm but is 
colonized by pigment-containing melanocytes of neural crest origin, antigen-processing 
Langerhans cells of bone marrow origin, and pressure-sensing Merkel cells of neural 
crest origin. The epidermis contains no blood vessels. 
The epidermis is itself made up of several layers. From outer to innermost, they 
are the: 
 Stratum corneum 
 Stratum lucidum 
 Stratum granulosum 
 Stratum spinosum 
 Stratum basale 
Stratum basale 
The deepest layer of the epidermis is the stratum basale. It consists of a single 
layer of columnar epithelium which is adhered to the basal lamina. Nutrition is supplied 
from the underlying capillaries of the dermis. Migration of cells towards the surface 
begins here. 
Stratum spinosum 
Above the stratum basale is the stratum spinosum. Spinous cells are large 
polygonal cells with prominent desmosomal intercellular filaments, which act like 
bridges between the cells. When cells move into this layer, they shrink and move apart. 
Keratinisation begins in the stratum spinosum and continues in the stratum granulosum. 
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Stratum Granulosum 
External to the stratum spinosum, lies the stratum granulosum. Granular cells 
are thin, flattened keratinocytes with variably prominent keratohyaline granules. At its 
outer surface, the stratum granulosum secretes oragnelles called lamellar bodies, which 
are composed of lipid and enzymes which fuse with the plasma membrane and help to 
form the water concentration gradient that leads to transepidermal water loss. 
Stratum Corneum 
The outer layer, stratum corneum, consists of anucleate, thin cells filled with 
keratin filaments and proteins that form a cell envelope resistant to solvents and enzymes; 
there is also a permeability barrier to water and ions. For the stratum corneum to maintain 
a constant thickness, there is a constant turnover of exfoliated corneocytes, being 
replaced by new corneocytes. Enzymes in the lamellar bodies from the stratum 
granulosum help to break down the intercellular lipid 'glue’ that holds the cells in place 
and there is also some degradation of desmosomes. 
Stratum Lucidum 
The stratum lucidum layer is only present in thick skin where it helps reduce 
friction and shear forces between the stratum corneum and stratum granulosum. 
Dermis 
The dermis is derived primarily from mesoderm.  The dermis consists of dense 
fibrous tissue composed of collagen type I, III and V, with some elastin fibres and 
provides a supporting mattress for the carriage of blood vessels, lymphatic vessels, 
nerves and sensory receptors, hair follicles, sebaceous and sweat glands, with circulating 
white cells. 
Hypodermis 
The deeper subcutaneous tissue (hypodermis) is made of fat and connective tissue. 
Other components of the skin include: 
Blood vessels 
To keep our body a constant temperature, blood vessels in the skin dilate in 
response to heat or constrict in response to cold. 
Sebaceous glands 
The sebaceous glands secrete sebum, an oily substance that helps keep skin from  
drying out. Most of the glands are located in the base of hair follicles. Acne starts when 
the tiny hair follicles become plugged with these oily secretions. 
 
39 
 
Sweat glands 
When our body gets hot or is under stress, these glands produce sweat, which  to 
cool . Sweat glands are located all over the body but are especially "hundant in our 
palms, soles, forehead, and underarms. 
Hair follicle 
Every hair on our body grows from a live follicle with roots in the fatty layer billed 
subcutaneous tissue. 
Collagen 
Collagen is the most abundant protein in the skin, making up 75% of your skin. 
This is also our fountain of youth as it's responsible for warding off wrinkles and fine 
lines. Over time, environmental factors and ageing diminish our body's ability to produce 
collagen. 
Elastin 
  This protein is found with collagen in the dermis and is responsible for giving 
structure 
to your skin and organs. 
Keratin 
Keratin is the strongest protein in our skin. It's also dominant in our hair and nails. 
Colour 
The skin's colour is created by special cells called melanocytes, which  produce the 
pigment melanin. Melanocytes are located in the epidermis. 
 
PHYSIOLOGY 
The skin performs a multitude of functions. They are ;  
I. PROTECTIVE FUNCTION: 
In human beings, the tough horny and keratinized waterproof epidermis, and 
appendages like hair and nails, provides a sufficiently strong barrier against injury, 
penetration of harmful substances and bacterial invasion; they also protect the underlying 
structures. 
Another protective function of skin is to protect against sunlight by synthesis of 
melanin a pigment. 
There is about 70% of water in the epidermis and about 15% in the horny layer.  
The horny layer becomes hard and brittle when the water content falls below 10%. 
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2. SENSE ORGAN 
The skin is richly supplied with nerves and various types of specialized sense 
organ which provide information regarding environmental changes the body can adjust it  
accordingly. 
 
3. SECRETION AND EXCRETION: 
The skin posses various types of glands which pour secretion on the surface. The 
more important ones are the sweat and the sebaceous glands. The eccrine glands which 
are scattered all over the body surface secrete a thin transperant, watery, fluid, known as 
true sweat; while apocrine gland secrete a thicker milky and odoriferous solution. The 
secretory cells get hypertrophied during the premenstrual period and regress during the 
menstrual phase. 
SEWAT COMPOSITION: 
1. 1 -2%  Solids (organic 0.4 % and inorganic 0.8%)  
2. 98.8% water 
I important substances excreted in it are sodium chloride, sodium bicarbonate, keratin 
and a small amount of urea. Water and chloride are by the most important consituent. 
THERMAL SWEATING 
Direct studies on the amount of sweat secreted environments on the surface of the 
human skin shows that sweat glands react very strongly to changes in the atmospheric 
pressure known as thermal sweating. 
The sebaceous glands of the skin secrete sebum which is composed of fatty acids, 
cholesterol, alcohol etc., Fatty acid have mild fungi static activity. The sebum act as a 
lubricant for the drying effects of the atmosphere. 
4. BODY HEAT REGULATION 
The very important activity of warm blooded species like human being is 
independent of the temperature condition of the external environments It is achieved by 
the existence of a heat regulating mechanisms which adjusts the heat lost to the heat 
generated in it. 
The skin plays vital role in the regulation of heat loss.. 90% of the heat from the 
body is lost through the skin. 
The heat loss through the skin is regulated by various physiological mechanisms 
which include 
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(1) The reaction of the cutaneous vessels , 
(2) Perspiration and 
(3) The reaction of the smooth muscle fibre of the skin. 
The temperature of the skin depends upon the amount of blood flowing through the 
vessels. 
5. STORAGE FUNCTION OF SKIN: 
The dermis is conjunction with the hypodermis has a considerable capacity for 
Coring various materials, of these the best known are fat and blood. 
a) Fat is laid down in fat cells as a permanent store of subcutaneous adipose tissue.     
It provide the reserve store of body energy. It prevent heat loss, and is good shock 
absorber. 
b) Blood is stored in the rich subpapillary plexus. A rough estimate of its capacity in 
a normal adult comes to near about one litre. 
c) The skin is also  good storehouse of ergosterol (vitamin D) 
d) The other type of storage which occur in the skin is what has been called by 
Cannon storage by inundation.Thus in fact, is the storage of extra-cellular fluid in 
the interstitial space. 
Certain substances like glucose and chloride may also be stored in the skin 
temporarily when their level in the blood register a sudden rise. 
6. ABSORPTION: 
It is also almost an well-known fact that the intact skin is impervious to watery 
solution of salts or other substances. Skin can absorb substances dissolved in fatty 
solvents like vitamins and hormones. 
7. GASEOUS EXCHANGE: 
A small amount of gaseous exchange occurs through the skin. In man small amount 
of CO2 exchanged through the skin is negliable compared to the amount exhaled from the 
lungs. 
PSORIASIS 
Definition: 
It is characterized by sharply demarcated, scaly, red, coin sized lesion most often 
on the elbows, knees, scalp, hands and feet, (ref: World Health Organisation) 
Aetiology: 
 A family history of psoriasis is found in 30% patients 
 The genetic transmission is complex and it is as considered multifactorial 
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genetic disease that requires both polygenic & environmental factor for its 
clinical expression. 
 The histo compatibility antigens are regarded as the most important 
genetic markers for Psoriasis. 
 HLA-CW6 correlated with Psoriasis. 
 The presence of HLA-Brl7 has been correlated with a higher 
familial  incidence, more extensive skin involvement and advanced 
clinical disease and it is reported in those with generalized pustular 
Psoriasis. 
 HLA-B13 have been correlated with reversible disease and often give a history of 
antecedent streptococed infection. 
 HLA-BW 38 correlated with Psoriasis arthritis. 
Triggering factors: 
 Trauma, infection, endocrine factors climate & emotional stress.   
 Infection with Beta-hemolytic streptococci triggers guttate psoriasis 
  Drags  → chloroquine, carbonate, steroids, Iodides, nystatin, progasteone & β 
blockers also precipitate psoriasis. 
Pathogenesis 
Pathogenic mechanisms in psoriasis 
Defective epidermal cell surface                      Receptors 
              ↓                         ↓ 
Decrease in Camp     Increased production of arachidonic acid 
↓          ↓ 
Increase in protein    Increased activation of LTB4 (chemotactic factor) 
↓          ↓ 
Kinase and polyamine   Neutrophils emerge from the tip of capilary loop at  
the apex of the dermal papila 
↓             ↓ 
Exert a growth factor effect         Aggravated neutrophills in the stratum corneum 
       (Mono micro abscess) 
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Clinical features: 
 Psoriasis   is   characterized  by- well   circumscribed   sharply  demarcated 
erythematous papules & plaques. 
 The plaques are covered by dry, brittle silvery or grayish white, loosely adherent 
micaceous scales. The scales are disposed in lamellar fashion.  
 On grattage, white silvery scales come off in layers. 
 By removing this layer a characteristic coherance is observed, as if we scratches 
on a wax, Candle (candle grease sign). 
 On further grattage, a thin feel like membrane, Berkley's membrane, will 
present 
 By removing this, a wet surface with pin point bleeding is exposed called 
Auspitz sign. 
 The localization of the lesions over the extensor surface has been attributed to 
Koebner's phenomenon, the affinity to replicate the lesion over the site of trauma 
 Nail involvement - 30% of cases. 
 Psoriatic arthritis-nail involvement - 85 to 90%. 
Nail Changes: 
 Thick, brittle, lustureless nails. 
 Pitting of the nail plate. Due to the nvolvement of proximal part of the matrix. 
 The nail pits correspond to the small parakeratotic foci in the matrix..  
 Sub lingual  hyperkeratosis  Present  under  the  free  edge   of the  nail.lt  is 
macromorphological equivalent of the parakeratosis. 
TYPES OF PSORIASIS:, 
1. Based on Morphological types 
 Chronic stable plaque psoriasis (Psoriasis vulgaris) 
 Guttate psoriasis 
 Pustular psoriasis 
 Erythrodermic psoriasis 
 Rupioid, elephatine and ostraceous psoriasis 
2. Based on site of involvement 
 Scalp psoriasis 
 Flexural (Inverse) Psoriasis 
 Nail psoriasis 
 Palmoplantar psoriasis 
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 Genital psoriasis 
 Psoriatic arthritis 
3.Atypical forms of psoriasis 
 Linear and zonal lesions 
 Fallicular 
 Photosensitive 
 Seborrheic psoriasis 
 Annular psoriasis 
 Circinate psoriasis 
1. Plaque psoriasis, also known as psoriasis vulgaris or chronic stationary psoriasis or 
plaque-like psoriasis. 
It is the most common form and affects 85%-90% of people with psoriasis. 
Plaque psoriasis typically appears as raised areas of inflamed skin covered with 
Silvery-white scaly skin. These areas are called plaques 
Most commonly affected areas are the back of the forearms, shins, around the 
belly button, and scalp.  
2. Guttate Psoriasis 
       Guttate Psoriasis is characterized by numerous small, scaly, red or pink, deoplet – 
like lesions (papules). 
 These numerous spots of psorias’s appear over large areas of the body.  Primarily 
the trunk but also the limbs and scalp. 
 Guttate psoriasis is often triggered by a streptococcal infection, typically 
streptococcal pharyngitis. 
3. Erytherodermic psoriasis or Psoriatic erythroderma:  
It involves widespread inflammation and exfoliation of the skin over most of the 
body surface. 
 It may be accompanied by severe itching, swelling and pain. It is often the result 
of an exacerbation of unstable plaque psoriasis, particularly following abrupt withdrawal 
of systemic glucocorticoids. 
This form of psoriasis can be fatal as the extreme inflammation and exfoliation 
disrupt the body's ability to regulate temperature and perform barrier functions 
Fingernails and toe nails are affected in most people at some point in time. This 
may include pits in the nails or changes in color. 
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TYPES OF PSORIASIS  
Erythrodermic Psoriasis Nail Pitting Psoriasis 
Guttate Psoriasis Inverse Psoriasis 
Pustular Psoriasis Psoriatic Arthropathy 
46 
 
Pustular psoriasis 
 It appears as raised bumps filled with noninfectious pus. 
 The skin under and surrounding the pustules is red and tender. 
 It can be localized, commonly to the hands and feet (palmoplantar pustulosis). 
 Pustules erupting from red, tender, scaly skin found on the palms of the hands and 
the soles of the feet. 
 Generalized pustular psoriasis (pustular psoriasis of von Zumbusch), also known 
as impetigo. 
Herpetiformis during pregnancy. 
It is a rare and severe form of psoriasis. The development of generalized pustular 
psoriasis is often caused by an infection, abrupt withdrawal of topical corticosteroid 
treatment, pregnancy, hypocalcemia, medications, or following an irritating topical 
treatment for plaque psoriasis. 
This form of psoriasis is characterized by an acute onset of numerous pustules on 
top of tender red skin. This skin eruption is often accompanied by a fever, muscle aches, 
nausea, and an elevated white blood cell count.  
Annular pustular psoriasis (APP), a rare form of generalized pustular psoriasis, is 
the most common type seen during childhood period. 
APP tends to occur in women more frequently than in men, and is usually less 
severe than other forms of generalized pustular psoriasis such as impetigo 
herpetiformis. 
This form of psoriasis is characterized by ring-shaped plaques with pustules 
around the edges and yellow crusting. 
APP mostly affects the torso, neck, arms, and legs. 
Inverse psoriasis  
It also known as flexural psoriasis. 
It appears as smooth, inflamed patches of skin. 
The patches frequently affect skin folds, particularly around the genitals (between 
the  thigh and groin), the armpits, overweight abdomen intergluteal cleft,the 
inframammary fold. 
Heat, trauma, and infection are thought to play a role in the development of this 
atypical form of psoriasis. 
Napkin psoriasis is a subtype of psoriasis common in infants characterized by red 
papules with silver scale in the diaper area that may extend to the torso or limbs. 
47 
 
Guttate psoriasis is features are  numerous small, scaly, red or pink, droplet like 
lesions (papules). 
These numerous spots of psoriasis appear over large areas of the body, primarily 
the trunk, but also the limbs and scalp. It is often triggered by a streptococcal infection, 
typically streptococcal pharyngitis.  
Psoriatic arthritis  
It is a form of chronic inflammatory arthritis. 
It typically involves painful inflammation of the joints and surrounding connective 
tissue and can occur in any joint, but most commonly affects the smaller joints of the 
fingers and 
This can result in a sausage-shaped swelling of the fingers and toes known as 
dactylitis. 
It also affect the hips, knees, spine and sacroiliac joint. 
About 30% of individuals with psoriasis will develop psoriatic arthritis. 
Skin manifestations of psoriasis tend to occur before arthritic manifestations in 
about 75% of cases.  
COMPLICATION: 
Psoriasis may become complicated by the  development of the  arthropathy, 
erythroderma   and   several   other   systemic   complications   like   renel   hepatic   and 
cardiovascular etc  
ARTHROPATHY 
It is the most obstinate complication in about 5-10% cases seen in both sexes 
around the fourth decade of life.  
HEPATIC COMPLICATION 
Sometimes hepatic failure may be seen in psoriatic patient due to the direct effect 
of the psoriasis.  
RENAL COMPLICATION 
Nephritis may be caused as a co-exsiting infection with guttate psoriasis 
INVESTIGATION:  
1. ROUTINE INVESTIGATION 
(a) Raised ESR is specifically indicative of erythrodermic and generalized pustular 
type psoriasis. 
(b)  Leukocytosis indicates pustular psoriasis 
(c) Thorat swab culture for nthe detection of beta hemolyticus in guttate psoriasis.  
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(d) Rheumatoid factor may be found positive. 
Diagnosis 
The diagnosis of psorisis is clinical.lt is based on recognizing the cardinal 
morphological lesion of psoriasis characterized by erythematous scaly eruptions, single 
or multiple, disposed primarily on the extensor surface of the body.  The scales are 
lamellated and silvery white.  Auspitz sign is positive ,evident as pinpoint bleeding on 
grattate. 
DIFFERENTIAL DIAGNOSIS 
1. INTERTIGO  
 Since intertigo also occurs on flexors of the body, flexural psoriasis need 
to be differentiated from intertrigo and is characterised by itching and ringing sensation. 
2. NUMMULAR ECZEMA  
 It is common on extremities of middle aged men.The lesions are highly 
itchy. 
3. SEBORRHEIC DERMATITIS  
 It is always seen on hairy skin.  The lesions are not much defined and are 
seen as follicular yellowish red papules covered with greasy Allies. 
4. LICHEN PLANUS  
 It give rise to severely itchy lesions covered with thick hyperkeratotic 
scales which on removal do not show bleeding points as are seen in 
psoriasis. 
5. PITYRIASIS ROSEA  
 Lesions of pityriasis rosea are slightly raised mostly present in the rib 
lines.It begins with a herald patch.  These conditions shows spontaneous remission and 
rarely reoccurs. 
6. SECONDARY SYPHILIS    
         In secondary syphilis there will be a exposed of sexual contact and the 
presence of primary chancre .There will also be lymphadenopathy and  condyloma lata. 
7. DISCOID   LUPUS ERYTHEMATOUS  
  It is a connective tissue disorder characterized by erythematous plaques 
covered with thick adherant scales that dip into the patulous hair follicles. Removal of the 
scales show the characterstic "carpet rack sign”. 
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TREATMENT 
  Psoriasis is characterized by remission and relapses. Although it is difficult to 
cure yet topical and therpeutic regimens administered singly or in combination are in 
effective in maintaining the disease in remission.  Beside the active therapeutic measure, 
triggering factor should be identified and their removal should be attempted. 
 
PHOTOTHERAPY 
  Ultraviolet is an effective treatment of psoriasis.  UV radiation in the range of 
290- 320NM  is optimal.  UVR below 300 nm results in more erythema relative to the 
therapeutic effect and thus lowers the therapeutic index.  The ideal period for 
phototherapy is a young adult with a normal reaction to light and having guttate or plaque 
psoriasis.  Exposure is begin with a dose slightly less than the minimal erythema dose and 
each subsequent dose is increased by 20% to achieve mild erythematous response. 
 
TOPICAL CORTICOSTEROIDS 
Applications of topical corticosteroid is useful in the treatment of localized plaque 
psoriasis.  Treatment is usually intiated with a pottent corticosteroids like 
 Clobestal propionate 0.05% (tenovate) 
 Betamethasone dipropianate (Diplene)  
As the lesions flatten and scaling diminish corticosteroids may be applied 
intermittently on alternate days.  The steroids are effective in psoriasis and probably act 
by inhibiting mitosis and inflammation. 
COAL TAR     
Tars   inhibit DNA synthesis as well as sensitive the skin to long wave UV light 
and hence are effective in psoriasis.  Tar is an integral part of Goekerman's ien that is 
useful in the treatment of plaque psoriasis with moderately extensive 
SALICYLIC ACID  
It is a keratolytic agent and is concentration between 3 and 6% causes softening of 
the horny layer and shedding of the scales.  It produces this desqumation by solublizing 
the intercellular cement and enchances the shedding the corneocytes.  lt may be combined 
with corticosteroid or tar. Hence the Psoriatic ointment comprising 
1) Crude coal tar 6% 
2) Salicylic acid 3% 
3) Ammoniated mercury 1% 
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Anthralin 
It is most effective in the treatment of psoriasis. The exact mode of action is not 
known.  However it probably acts directly on the stem cell population of the epidermis. 
Dithranol inhibits key enzymes such as Glucose 6 phosphate dehydrogenase, but it may 
also act but it may also act by less specific effect such as depriving the cells of oxygen 
need for their proliferating activity. It also has effect on mitochondria. 
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MATERIALS AND METHODS 
The Clinical study on Psoriasis was earned out in the Post graduate department of 
Sirappu Maruthuvam, Govt Siddha Medical College, and Palayamkottai. In this study 40 
patients (who satisfy the inclusion criteria and exclusion criteria) were treated as OP and 
IP  patients. 
Selection of the Patients:  
Age: Between 15 years and 60 years  
Sex:  Both male and female.  
INCLUSION CRITERIA 
 Macules 
 Papules 
 Pustules 
 Plaques of erythema 
 Candle-grease sign 
 Auspitz sign 
 Itching 
 Keobner’s phenomenon 
  Patients wtih Silvery white patches, Coin shaped lesions, Scaling with or without 
itching.  
The detailed history was taken from the patient about. 
  The diagnosis was made by following Siddha diagnostic methods. Nilam, 
Kaalam, Poriyalaridhal, Pulanalarithal, Vinaadhal, Mukkutram, Udal Thathukal Nilai and 
Envagai Thervugal, and the diagnosis of Naadi nilai. 
EXCLUSION CRITERIA 
 Cardiac disease 
 Hypertension   
 Diabetes mellitus 
 Use of narcotic drugs 
 Pregnancy and lactation 
 Evidence of any skin condition other then psoriasis 
 Malignancy 
 Tuberculosis 
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ASSESSMENT OF PSORIASIS WITH SYMPTOMS : 
Severe  - Marked plaque elevation, Scaling present / Not present 
 erythema.  
Moderate - Moderate plaque elevation, Scaling present / Not present  
erythema.  
Mild  - Slight plaque elevation, Scaling present / Not present  
erythema,  
Almost Clear - Intermediate between mild and clear.  
Clear  - No signs of psoriasis. 
Investigation: 
The following investigations were done in all selected patients in the laboratory of 
Government Siddha Medical College, Palayamkottai.  
ROUTINE INVESTIGATION  
 BLOOD 
 Hb 
 ESR  
 Sugar-Fasting 
 Post prandial 
Renal functions tests: 
a. Blood urea : 
b. Serum creatinine: 
Liver function tests: 
SGOT   SGPT   Alk.Phosphatase 
Albumin       Globulin  Total Protein 
Serum Bilirubin: Total Direct Indirect 
URINE 
 Albumin 
 Sugar 
 Deposits 
INVESTIGATION BASED ON SIDDHA SYSTEM : 
1. Naa 
2. Niram 
3. Mozhi 
4. Vizhi 
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5. Malam 
6. Moothiram - Neerkkuri, Neikkuri.  
7. Sparisam  
8. Naadi  
Skin examination: 
Sitc- 
Colour 
Size 
Shape 
Border  
TREATMENT: 
Vellai ennai  15ml at morning with hot water was given on the first day of 
treatment. 
All the patients were treated with the following medicines. 
MEDICINE NAME:  
INTERNAL MEDICINE  : OMA LEGIYAM 
Reference  : Aathmaratchamirtham Vaidhiya Sara  
Sankiragam Research Medicine,  
Page No.446 
Dosage   : 5.1 gm twice a day 
Duration of the Treatment : 48 days 
EXTERNAL MEDICINE : THAGARAI LEBAM  
Reference   : Sarabendirar Vaithiya Muraigal 
     Pg.No.136 
All the patients were advised to follow dietary regimen (or) Pathiyam. 
Pranayama and simple Yogasana were advised as a supportive therapy. 
The Bio - Chemical analysis was done in the department of Bio Chemistry and 
  Pharmacological analysis was done in the Pharmacological laboratory of KMCH 
College of Pharmacy, Coimbatore 
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OBSERVATION AND RESULTS 
 For the clinical study 40 patients were selected and treated in PG III Sirappu 
Mruthuvam department, GSMC hospital  Palayamkottai.  Results were observed with 
respect to the following criteria, 
1. Gender distribution 
2. Family history 
3. Age distribution 
4. Kalam distribution 
5. Occupational distribution 
6. Seasonal variation 
7. Thinai 
8. Socio-economic status 
9. Dietary habits 
10. Precipitating factors 
11. Mode of onset 
12. Clinical features 
13. Other general clinical features 
14. Disturbances of kanmenthirium 
15. Derangement of vatham 
16. Disburbances of pitham 
17. Derangement of kabam 
18. Udal kattukal 
19. Envagai thervugal 
20. Selection of patients 
21. Effect of  therapy with trial drug alone 
22. Effect of therapy with trial drug along with complementary therapy  
23. Comparison between effective of trial drug and trial drug with complementary 
therapies. 
24. Overall results after treatment. 
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Table :1 
GENDER DISTRIBUTION 
S.No Gender No of Cases Percentage (%) 
1 Male 26 65 
2. Female 14 35 
 Total 40 100 
 
 
Inference 
 About 65% of them were male and 35% of them were women 
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Table :2 
FAMILY HISTORY 
S.No Criteria No of Cases Percentage (%) 
1 Family history (+ve) 3 7.5 
2. Family history (-ve) 37 92.5 
 Total 40 100 
 
 
Inference 
 About 7.5 % of them had positive family history 
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Table : 3 
AGE DISTRIBUTION 
S.No Age (Years) No of Cases Percentage 
1 21 - 30 2 5 
2. 31 – 40 12 30 
3 41 – 50 14 32.5 
4. 51 – 60  12 30 
 Total 40 100 
 
 
Inference 
 The prevalence of the disease was found to be higher in the age group 41 - 50 
years . 
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Table :4 
KALAM DISTRIBUTION 
 In siddha literature human life has been divided into three periods follows 
1.Vadham 
2. Pitham 
3.Kabam 
The duration of each period is said to be 33 years. 
S.No Kalam No of Cases Percentage 
1 Vadha kalam  5 12.5 
2. Pitha kalam  35 87.5 
3. Kabha kalam  0 0 
 Total 40 100 
 
 
Inference: 
 Out of 40 patients, 35patients reported in pitha kalam, 5 were in vadha kalam. 
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Table: 5 
OCCUPATIONAL STATUS 
S.No Occupation No of Cases Percentage (%) 
1 Farmer 7 17.5 
2. Business 3 7.5 
3 Home maker 9 22.5 
4. Coolie 13 32.5 
5. Farmer & manual labour 7 17.5 
6. Students 1 2.5 
 Total 40 100 
 
 
Inference  
 Out of 40 cases, in this study the rate of incidence is higher in coolie 
worker(32.5%) 
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Table: 6 
SEASONAL VARIATIONS 
S.No Seasons No of Cases Percentage (%) 
1 Kaarkaalam   
(16 Aug – 15 Oct)  
1 2.5 
2. Koothirkaalam  
(16 Oct- 15 Dec)  
1 2.5 
3. Mupanikaalam  
(16 Dec - 15Feb)  
22 55 
4. Pinpani kaalam –  
(16 Feb –  15 Apr) 
11 27.5 
5. Ilavenirkaalam -  
(16 Apr- 15 Jun) 
4 10 
6. Muthuvenilkaalam – 
(16 Jan –  15Aug) 
1 2.5 
 Total 40 100 
 
 
Inference 
  Out of 40 patients, 22 cases (55%) were admitted in Munpanikalam and 11 
patients (27.5%) were admitted in pinpanikalam and 4 patients (10%) were admitted in 
Elavenil kalam and  1 case (2.5%) were admitted in other kaalam. 
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Table: 7 
THINAI 
S.No Thinai  No of Cases Percentage 
1 Kurinji (Hill area) 0 0 
2. Mullai (Forest area) 0 0 
3. Marutham (Fertile land) 34 85 
4. Neithal (Coastal area) 6 15 
5. Palai (Desert land) 0 0 
 Total 40 100  
 
 
 
Inference 
 Among the 40 patients, 34(85%) cases were from marutham and 6(15%) cases 
were from Neithal thinai. 
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Table: 8 
SOCIO ECONOMIC STATUS 
S.No Socio economic status No of Cases Percentage (%) 
1 Poor 20 50 
2. Middle class 15 37.5 
3 Rich 5 12.5 
 Total 40 100 
 
 
Inference 
 About 50 % of them were from low socio economic status. 
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Table :9 
DIETARY HABITS 
 
S.No Dietary habits No of Cases Percentage (%) 
1 Vegetarian 5 12.5 
2. Mixed diet 35 87.5 
 Total 40 100 
 
 
Inference 
 All the cases except five were mixed diet.   
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Table 10 
PRECIPITATING FACTORS 
S.No Precipitating factor No of Cases Percentage (%) 
1 Skin Injury 2 5 
2. Infection 4 10 
3. Reaction to certain medicine 2 5 
4. Psychomatic 10 25 
5. Alcohol 2 5 
6. Smoking 8 20 
7. Unknown 12 30 
 
 
Inference 
 Among the 40 patients, 12 of them (30%) were unknown, 10 of them (25%) had 
the psychomatic disorders and 8 (20%) cases caused for smoking, 4 of them  (10%) were 
infected. 
 
 
  
5
10
5
25
5
20
30
0
5
10
15
20
25
30
35
P
e
rc
e
n
ta
g
e
 (
%
)
PRECIPITATING FACTOR
65 
 
 
Table :11 
MODE OF ONSET 
 
S.No Dietary habits No of Cases Percentage (%) 
1 Acute 0 0 
2. Chronic 40 100 
 
 
Inference 
According to this study 100% of cases were reported as chronic onset. 
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Table :12 
CLINICAL FEATURES 
S.No Clinical features No of Cases Percentage (%) 
1 Red patches with silvory scaling 40 100 
2. Scalp lesions 30 75 
3. Auspitz sign 40 100 
4. Koebner’s phenomenon 40 100 
5. Nai changes 20 50 
6. Palm and sole lesions 2 5 
7. Joint involvement 5 12.5 
8. Itching 40 100 
9. Candle grease sign 18 45 
 
 
Inference 
 Among the forty (40) cases all of them had scaling, itching, positive auspitz sign, 
koebhers phenomenon 30 patients had scalp and 20 patients had nail changes, 18 of them 
had candle grease sign and 5 of them has joint involvement and 2 of them had palm and 
sole lesions. 
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Table :13 
OTHER GENERAL CLINICAL FEATURES 
S.No Clinical features No of Cases Percentage (%) 
1 Constipation 7 17.5 
2. Cough 8 20 
3. Insomnia 30 75 
4. Anemia 3 7.5 
5. Epigastric pain 2 5 
 
 
Inference 
 Among 40 patients, 30 had sleep disturbances, 7 of them had constipations, 8 of 
them had cough, 3 of them had anemia, 2 of them had epigastric pain. 
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Table :14 
DISTURBANCES OF KANMENTHIRIUM 
S.No Kanmenthirium No of Cases Percentage (%) 
1 Vaai 0 0 
2. Kai 15 37.5 
3. Kaal 13 32.5 
4. Eruvai 7 17.5 
5. Karuvai 0 0 
 
 
Inference 
 Among the all  kanmenthirium (kai, kaal, vaai, eruvai, karuvai) Kaal was affected 
13 patients (32.5%) and eruvai was affected in 7 cases (17.5%) and kai was affected in 15 
cases (37.5%). 
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Table: 15 
TABLE SHOWING THE DERANGEMENT OF VATHAM 
S.No Vatham Number of cases Percentage 
1. Praanan 0 0 
2. Abaanan 7 17.5 
3. Viyaanan 40 100 
4. Udhaanan 8 20 
5. Samaanan 40 100 
6. Naagan 0 0 
7. Koorman 0 0 
8. Kirukaran 10 25 
9. Dhevathathan 12 30 
10. Dhananjeyan 0 0 
 
 
Inference 
 Among the vadham 17.5% of them were affected by abanan, 30% of them were 
affected by devathathan.  100% of them were affected viyanan and samanan.  25% of 
them were affected by kirukaran, 20% of them were affected by Uthanan. 
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Table: 16 
DISTURBANCES IN PITHAM 
S.no Pitham Number of cases Percentage 
1. Analpitham 2 5 
2. Ranjaga pitham 40 100 
3. Saathagam  13 32.5 
4. Prasagam 40 100 
5. Alosagam 0 0 
 
 
Inference 
 Ranjaga pitham and Prasagam was affected in all 40 cases (100%) and Sathagam was 
affected in 13 cases (32.5%), Anarpitham was affected in 2 cases (5%). 
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Table 17 
TABLE SHOWING THE DERANGEMENT OF KABHAM 
S.No Kabham Number of cases Percentage 
1. Avalambagam 25 62.5 
2. Kilethagam 2 5 
3. Pothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 5 12.5 
 
 
Inference 
 Avalambagam was affected in 25 cases and Santhigam was affected in 5 cases, 
Kilethagam was affected in 2 cases. 
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Table 18 
TABLE SHOWING THE CONDITION OF UDAL KATTUKAL 
S.No Udal kattukal NUMBER OF CASES PERCENTAGE 
1. Saaram 40 100 
2. Senner 40 100 
3. Oon 0 0 
4. Kozhuppu 5 12.5 
5. Enbu 5 12.5 
6. Moolai 0 0 
7. Sukkilam 0 0 
 
 
Inference 
 In all the cases Saaram, senneer were affected (100%) enbu and kozhuppu were 
affected in 5 cases. 
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Table : 19 
ENVAGAITHERVUGAL 
S.No. Envagai thervugal Number of cases Percentage 
1. Sparisam 40 100 
2. Naa 0 0 
3. Niram  40 100 
4. Mozhi 0 0 
5. Vizhi 0 0 
6. Malam 7 17.5 
7. Moothiram 0 0 
8. Naadi 40 100 
 
Naadi :  Pitha vatham 15 cases (37.5%) 
  Vathapitham 8 cases (20%) 
  Pithakabam 17 cases (42.5%)   
 
Inference 
 Sparisam was affected in all the 40 cases niram was affected in all cases (100%) 
malam was affected in 7 cases (17.5). 
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Table: 20 
SELECTION OF PATIENTS 
TREATMENT OPTIONS NO. OF PATIENTS 
Trial drugs only 15 
Trial drugs + Complement therapies 25 
 
 
Inference 
 This clinical study includes 40 patients, i.e 30 from OP ward and 10 patients from 
IP ward, Out of this 2 patients from In patient Department and 13 patients from Out 
patient department i.e. totally 15 patients, were selected for treating trial drug alone. 
 Another 17 patients from OP and 8 patients from IP ie totally 25 patients were 
selected for treating with trial drug and complementary therapies. 
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Table: 21 
EFFECT OF THERAPY IS ASSESSED FROM BELOW THE TABULATED 
DATA 
 
S.No Effect of Therapy No.of patients Percentage 
1. Good 9 60 
2. Moderate 3 20 
3. Mild 2 13.3 
4. No 1 6.7 
 Total 15 100 
 
 
Inference 
 By heating alone with trial drugs 60% of patients had good improvement, 20% of 
patients had moderate improvement, 13.3% had mild improvement, and 6.7% had no 
improvement. 
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Table: 22 
EFFECT OF THERAPY IS ASSESMENT FROM THE BELOW TABULATED 
DATA 
 
S.No Effect of Therapy No.of patients Percentage 
1. Good 18 72 
2. Moderate 5 20 
3. Mild 1 4 
4. No 1 4 
 Total 25 100 
 
 
Inference 
 Among the patients who were selected for treating both with trial drug and 
complement therapies72% of patients had good improvement, 20% of patients had 
moderate improvement, 4% had mild improvement, and 4% had no improvement. 
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Table: 23 
COMPARISON BETWEEN EFFECTIVE OF TRIAL DRUG AND TRIAL DRUG 
WITH COMPLEMENTARY THERAPIES 
 
S.No Effect of Therapy Trial drug alone 
(%) 
Trial drug along with 
compelment therapy (%) 
1. Good 60 72 
2. Moderate 20 20 
3. Mild 13.3 4 
4. No 6.7 4 
 
 
 
Inference 
 From the above data it clearly shows that effect of therapy is seen best when trial 
drug is given with complement therapy compared to giving trial drug alone. 
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Table: 24 
OVERALL RESULTS AFTER TREATMENT 
S.No Effect of Therapy No.of patients Percentage 
1. Good improvement 27 67.5 
2. Moderate improvement 8 20 
3. Mild improvement 3 7.5 
4. No improvement 2 5 
 
 
Inference 
 Out of 40 patients,  good improvement was observed in 67.5% patients,  Moderate 
improvement was observed in 20% patients, Mild improvement was observed in 7.5% 
patients and no improvement was observed 5% patients. 
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List of  Out Patients of PG-III Sirappu Maruthuvam Department Given  
1. Oma legiyam- Internal 2. Thagarai lebam - External 
 
S.NO OP.NO NAME AGE/SEX OCCUPATION DATE OF ADMISSION DATE OF DISCHARGE 
TOTAL NO. OF 
DAYS  
 
GRADE   RESULTS 
1 11832 Sabari 33/M COOLIE 18.12.2017 04.02.2018  48 Grade I GOOD 
2 112002 Mariappan 36/M COOLIE 19.12.2017 06.02.2018 49 Grade I GOOD 
3 112003 Kumar 43/M Farmer & manual labour 19.12.2017 05.02.2018 48 Grade II MODERATE 
4 113813 Mariammal 48/F HOME MAKER 25.12.2017 12.02.2018 49 Grade I GOOD 
5 113814 Eassaki 50/M FARMER 25.12.2017 06.02.2018 43 Grade I GOOD 
6 11512 Mariappan 34/M Farmer & manual labour 26.12.2017 08.02.2018 44 Grade II MODERATE 
7 1503 Senthil 53/M COOLIE 04.01.2018 21.02.2018 48 Grade II MODERATE 
8 1504 Kamaraj 36/M Former & manual labour 04.01.2018 22.02.2018 49 Grade I GOOD 
9 1963 Chelliah 56/M FARMER 05.01.2018 22.02.2018 48 Grade I GOOD 
10 3091 Ramar 53/M FARMER 08.01.2018 24.02.2018 47 Grade I GOOD 
11 3144 Kasthuri 41/F HOME MAKER 08.01.2018 25.02.2018 48 Grade I GOOD 
12 6007 Manthiram 37/M COOLIE 18.01.2018 08.03.2018 49 Grade I GOOD 
13 6008 Chellammal 36/F HOME MAKER 18.01.2018 09.03.2018 50 Grade I GOOD 
14 6009 Rajam 33/F COOLIE 18.01.2018 07.03.2018 48 Grade II MODERATE 
15 6443 Mohamed kadhar 38/M BUSINESSMAN 19.01.2018 05.03.2018 45 Grade I GOOD 
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16 6444 Ramuthai 46/F COOLIE 19.01.2018 07.03.2018 47 Grade I GOOD 
17 7350 Petchiammal 44/F FARMER 22.01.2018 11.03.2018 48 Grade I GOOD 
18 7351 Chellaiah 55/M COOLIE 22.01.2018 08.03.2018 45 Grade I GOOD 
19 9720 Ayirathammal 52/F HOME MAKER 29.01.2018 10.03.2018 48 Grade I GOOD 
20 9721 Perumal 45/M BUSINESSMAN 29.01.2018 10.03.2018 48 Grade I GOOD 
21 12153 Mari 51/F HOME MAKER 05.02.2018 24.03.2018 48 Grade IV NO 
22 12269 Kadhar 33/M BUSINESSMAN 08.02.2018 26.03.2018 47 Grade I GOOD 
23 13460 Rajam 36/F HOMEMAKER 16.02.2018 04.04.2018 48 Grade III MILD 
24 13461 Nagaraj 42/M Farmer & manual labour 16.02.2018 04.04.2018 48 Grade III MILD 
25 14733 Nambi 58/M FARMER 19.02.2018 06.04.2018 47 Grade I GOOD 
26 26206 Vickram 48/M COOLIE 18.03.2018 29.04.2018 43 Grade I GOOD 
27 27471 Piraguammal 40/F COOLIE 22.03.2018 08.05.2018 48 Grade II MODERATE 
28 28218 Ponnamal 50/F HOME MAKER 24.03.2018 10.05.2018 48 Grade I GOOD 
29 32646 Kannan 52/M COOLIE 09.04.2018 26.05.2018 48 Grade II MODERATE 
30 33828 Sethu 21/M STUDENT 11.04.2018 02.06.2018 53 Grade I GOOD 
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List of  In Patients of PG-III Sirappu Maruthuvam Department Given  
1. Oma legiyam- Internal 2. Thagarai lebam - External 
 
S.NO IP.NO NAME AGE/SEX OCCUPATION 
DATE OF 
ADMISSION 
DATE OF 
DISCHARGE 
TOTAL NO. OF 
DAYS  
 
 
GRADE   
RESULTS 
IP OP TOTAL 
1 2074 Balasubramanian 40/M Farmer & manual 
labour 
19.07.2017 
31.07.2017 
 
12 
36 48 Grade I 
GOOD 
2 2556 Shanmugam 45/M FARMER 14.09.2017 17.10.2017 34 14 48 Grade I GOOD 
3 3157 Pravinkumar 35/M COOLIE 30.11.2017 04.12.2017 5 35 40 Grade III MILD 
4 505 Subbuthai 58/F HOMEMAKER 25.02.2018 04.03.2018 8 35 43 Grade II MODERATE 
5 550 Thangamani 54/F HOMEMAKER 28.02.2018 24.03.2018 25 21 46 Grade I GOOD 
6 912 Veerachami 42/M Farmer & manual 
labour 
05.04.2018 26.04.2018 22 
 
28 
 
50 
Grade I 
GOOD 
7 1304 Arumugam 45/M COOLIE 16.05.2018 05.06.2018 21 20 41 Grade I GOOD 
8 1305 Kaliappan 52/M Farmer & manual 
labour 
16.05.2018 01.06.2018 17 
19 36 Grade 
IV 
NO 
9 1309 Muthaiah 57/M FARMER 17.05.2018 27.05.2018 11 30 41 Grade I GOOD 
10 1312 Malliga 30/F COOLIE 17.05.2018 28.05.2018 12 28 40 Grade II MODERATE 
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Blood Investigation of OP Patients 
S.No OP.No 
WBC 
TOTAL 
WBC DIFFERENTIAL 
COUNT (DC) 
  
BT AT HB  
gms % 
E.S.R. (mm) 
BT AT 
BT AT BT AT BT AT 
B.S B.U CH S.C. B.S B.U CH S.C. 
P L E P L E 1 hr 1 hr ½hr 1hr ½hr 1hr 
1 11832 8000 8600 66 28 6 68 28 4 12.2 13 4 8 5 10 123 22 180 0.9 130 22 180 0.9 
2 112002 8600 9000 64 28 8 64 30 6 10.5 11 8 16 9 18 120 20 160 0.8 130 18 140 0.6 
3 112003 8100 8600 70 26 4 72 26 2 9.6 11.2 35 72 25 56 110 26 185 0.9 120 25 185 0.9 
4 113813 8000 8400 68 22 10 68 26 6 10 10.5 8 16 9 18 130 18 140 0.4 130 18 140 0.6 
5 113814 7000 10600 78 20 2 76 22 2 9.5 11.2 11 22 10 20 112 26 160 0.6 120 24 160 0.4 
6 11512 7500 7300 65 30 5 58 39 3 12 12.5 - 50 - 30 115 20 180 0.9 118 22 185 0.8 
7 1503 8000 8100 60 31 9 58 30 7 9.9 10.2 15 30 13 21 98 25 192 0.7 100 25 196 0.6 
8 1504 8200 8200 64 31 5 64 28 7 13.8 14 11 22 9 18 132 43 140 0.7 130 23 160 0.7 
9 1963 8700 9000 68 30 2 68 30 2 13.5 14 4 9 10 20 97 29 205 0.8 100 22 200 0.9 
10 3091 8000 8200 58 38 4 58 39 3 11.5 12.8 15 30 10 20 130 19 200 0.5 126 22 194 0.4 
11 3144 7000 7200 60 35 5 62 35 3 14.6 15 10 20 12 24 75 17 167 0.4 100 18 160 0.6 
12 6007 8400 8300 70 23 7 65 32 3 11.3 12.1 15 30 10 22 117 22 155 0.7 112 22 194 0.6 
13 6008 9500 10000 60 35 5 65 25 10 12.3 13 5 10 6 12 110 37 119 0.7 120 35 120 0.8 
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14 6009 8000 8400 56 40 4 56 40 4 11.8 12 5 10 6 12 111 31 199 1.0 120 32 200 0.9 
15 6443 10200 10000 70 27 3 70 27 3 13.1 14 4 8 4 8 101 42 189 0.7 110 32 190 0.7 
16 6444 9800 9600 57 40 3 60 35 5 13.3 14 6 12 7 14 91 25 190 0.7 100 22 160 0.8 
17 7350 8600 8900 64 30 6 65 30 5 10.8 11 13 26 10 20 80 20 152 0.6 90 22 160 0.8 
18 7351 8600 9000 67 26 7 66 26 7 12.3 14 10 20 12 24 140 19 180 0.6 120 20 180 0.6 
19 9720 9600 9000 65 28 4 65 28 4 11.3 12 8 16 9 18 110 18 160 0.8 120 19 170 0.9 
20 9721 9000 9100 72 25 3 72 25 3 10.9 11 34 68 14 28 136 21 176 0.5 140 22 176 0.7 
21 12153 7300 7600 59 37 4 58 39 3 12.4 12 22 44 11 22 87 36 170 0.9 92 40 168 0.8 
22 12269 8600 8400 62 36 2 65 32 10 10 11 20 40 10 20 110 26 150 0.3 112 28 150 0.5 
23 13460 8000 8000 57 31 12 65 28 7 11.3 12 34 68 12 24 91 17 115 0.6 120 17 120 0.8 
24 13461 9200 9000 68 28 4 66 28 8 12.6 13 9 18 8 15 128 23 100 0.8 130 24 120 0.9 
25 14733 9300 9400 70 28 2 65 33 2 9.7 10.2 30 67 18 36 89 32 168 0.5 118 30 164 0.6 
26 26206 6900 7300 71 27 2 69 29 2 10.6 10.9 26 52 20 40 93 31 151 0.9 110 28 156 0.7 
27 27471 9300 9400 68 28 4 70 29 3 11.4 11.8 8 17 8 18 105 32 147 0.5 115 30 164 0.2 
28 28218 9900 9700 54 40 6 58 40 2 9.7 10.6 13 26 10 20 115 29 150 0.6 120 28 150 0.7 
29 32646 8000 8200 63 34 3 64 34 2 10.4 11 25 50 14 28 94 36 202 0.6 100 29 192 0.9 
30 33828 7500 8100 58 40 2 57 39 4 11.2 12 15 32 7 14 94 22 116 0.6 118 21 132 0.7 
BT – Before Treatment AT- After Treatment ESR – Erythrocyte Sedementstion Rate HB – Haemoglobin BS – Blood sugar BU- Blood urea                                           
SC – Serum creatinine P-Polymorph  L-Lymphocytes   E – Eosinophils CH - Cholesterol 
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Blood Investigation of IP Patients 
S.No IP.No 
WBC TOTAL WBC DIFFERENTIAL 
COUNT (DC) 
  
BT AT HB  
gms % 
E.S.R. (mm) 
BT AT 
BT AT BT AT BT AT 
B.S B.U CH S.C. B.S B.U CH S.C. 
P L E P L E 1 hr 1 hr ½hr 1hr ½hr 1hr 
1 2074 8400 8500 61 33 6 60 34 6 9.2 9.8 9 18 9 18 82 52 139 0.7 110 50 142 0.5 
2 2556 9200 9200 64 31 5 62 22 8 9.5 10.2 12 25 8 16 92 34 152 0.9 98 32 150 0.7 
3 3157 8800 8700 52 42 16 60 38 2 7.4 9.2 - 72 - 57 110 26 150 0.8 116 24 150 0.5 
4 505 7900 8100 70 26 4 72 26 2 12 12 20 45 16 32 100 29 139 0.6 96 26 142 0.6 
5 550 9400 9500 70 28 2 72 26 2 9.6 10 35 72 24 48 120 26 180 0.1 120 28 180 0.8 
6 912 7600 7800 66 31 3 68 29 3 9.5 10.2 7 15 8 16 92 34 152 0.9 98 32 150 0.7 
7 1304 8100 8400 70 26 4 70 28 2 9.6 10.2 30 62 18 32 80 28 182 0.8 110 40 180 0.9 
8 1305 8200 8200 62 30 8 68 28 4 10.2 11 64 32 11 22 80 28 147 0.5 100 30 140 0.6 
9 1309 7300 8000 71 24 3 65 33 2 10.5 12 12 42 11 22 100 12 100 0.9 110 22 150 0.9 
10 1312 10600 9800 78 20 2 72 26 2 9.6 10 35 72 24 48 120 26 180 0.1 120 28 180 0.8 
 
BT – Before Treatment AT- After Treatment ESR – Erythrocyte Sedementstion Rate HB – Haemoglobin BS – Blood sugar BU- Blood urea                                           
SC – Serum creatinine P-Polymorph  L-Lymphocytes   E – Eosinophils CH - Cholesterol 
85 
 
URINE ANALYSIS OF OP PATIENTS 
S.No O.P. No Albumin Sugar Deposit 
BT AT BT AT BT AT 
1 11832 NIL NIL NIL NIL 1-2 puscells NIL 
2 112002 NIL NIL NIL NIL NAD NAD 
3 112003 NIL NIL NIL NIL NIL NIL 
4 113813 NIL NIL NIL NIL Few pus cells NAD 
5 113814 NIL NIL NIL NIL NIL NIL 
6 11512 NIL NIL NIL NIL Few pus cells NAD 
7 1503 NIL NIL NIL NIL NAD NAD 
8 1504 NIL NIL NIL NIL Few pus cells NAD 
9 1963 NIL NIL NIL NIL 5-10 pus cells NAD 
10 3091 Traces NIL NIL NIL Few pus cells NIL 
11 3144 NIL NIL NIL NIL NAD NAD 
12 6007 NIL NIL NIL NIL 1-2 puscells NAD 
13 6008 NIL NIL NIL NIL NIL NIL 
14 6009 NIL NIL NIL NIL 1-2 cells NAD 
15 6443 NIL NIL NIL NIL NAD NAD 
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16 6444 NIL NIL NIL NIL 1-2 puscells NIL 
17 7350 NIL NIL NIL NIL Few pus cells NIL 
18 7351 NIL NIL NIL NIL NAD NAD 
19 9720 NIL NIL NIL NIL NAD NAD 
20 9721 NIL NIL NIL NIL 1-2 puscells NIL 
21 12153 NIL NIL NIL NIL 1-2 pus cells NIL 
22 13269 NIL NIL NIL NIL NAD NAD 
23 13460 NIL NIL NIL NIL 1-4 puscells NIL 
24 13461 NIL NIL NIL NIL NAD NAD 
25 14733 NIL NIL NIL NIL NAD NAD 
26 26206 NIL NIL NIL NIL 1-2 epithelial cells NIL 
27 27471 NIL NIL NIL NIL NIL NIL 
28 28218 NIL NIL NIL NIL Few pus cells NIL 
29 32646 NIL NIL NIL NIL NAD NAD 
30 33828 NIL NIL NIL NIL 1-2 pus cells NIL 
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URINE ANALYSIS OF IP PATIENTS 
S.No I.P. No Albumin Sugar Deposit 
BT AT BT AT BT AT 
1 2074 NIL NIL NIL NIL - NAD 
2 2556 NIL NIL NIL NIL NAD NIL 
3 3157 NIL NIL NIL NIL NIL NAD 
4 505 TRACES NIL NIL NIL 1-2 puscells NIL 
5 550 TRACES NIL NIL NIL 1-5 puscells NAD 
6 912 NIL NIL NIL NIL Few puscells NIL 
7 1304 NIL NIL NIL NIL 1-2 Epithelial cells NAD 
8 1305 NIL NIL NIL NIL NAD NAD 
9 1309 NIL NIL NIL NIL 2-4 pus cells NIL 
10 1312 NIL NIL NIL NIL NAD NAD 
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DISCUSSION 
 Psoriasis is a common, chronic and non infectious skin disease characterized by 
well defined slightly raised, dry erythematous macules with silvery scales and typical 
extensor distribution. 
 It can have a profound social impact of life difficulties in the work place, 
socialization with family members and friends, exclusion from public facilities and 
getting a job are some of the psycho social impact. 
 The major clinical features are itching, scaling, erythema, auspitz, sign with this 
background, the disease Psoriasis is taken for the study. 
 To gratifying the most important intend of this study, the trial drugs given below 
was used in treating the disease psoriasis.  They are 
1. OMA LEGIYAM as a internal medicine. 
2. THAGARAI LEBAM  as a external medicine. 
  A thourough study of the disease psoriasis was done and it is interrelated with 
signs and symptoms of psoriasis indicated in the siddha literatures. 
 To achieve the primary goal of this, a complete open clinical trial was done by 
treating the disease psoriasis with trial drugs. 
 The clinical appraisal was done as per the protocol and the data were collected by 
using prescribed forms.  The disease psoriasis was studied under various criteria it fullfil 
secondary objective of the study and the results were pragmatic and tabulated. 
 The assorted criteria and the results were discussed here under. 
Gender distributions 
 Out of 40 cases, entered in tabulation, 26 cases were male and 14 were cases 
female. 
 Hence it comes to interference that prevalence may be high in males. 
 However men reported greater due to work related stress.  Hence its correlated 
with research studies.  (MADUKKAA GUPTA 2007 VOL 34 700-703). 
Age distribution 
 From the above study it came to know, the incidence of this disease is high in age 
group 41 to 50 when compared to other age groups.  
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 Hence it infers, the result shown in my study is more or less equal to the global 
epidemiological studies.  Paris et al.(2012), Raval 10(2):189-96. 
Kaalam distribution 
 From the above study, it infers that the disease in highly prevalent in pitha kaalam, 
when compared to other kaalams. 
Occupational status 
 From the above data it was clear that there was no connection between the 
occupational status and the Psoriasis incidence. 
 Luigi Naadi M.X et al(2007) also accepted the same result in his study. 
Dietary Habits. 
 Out of the 40 patients selected among them 35 were non vegetarian and 5 of them 
were vegetarian. 
Seasonal variations 
 Among the 40 patients selected, the disease had occured in munpani kaalams 
when compared to other kaalams. 
 It is evident from the tome “Practice of dermatology”. 
 According to the above mentioned data 55% of cases came in munpanikaalam, 
27.5% cases Pinpanikaalam. 
Thinai 
 From the above mentioned data, 34(85%) cases were from Marutham and 6(15%) 
cases were from Neithal thinai. 
 Hence the disease was studied in single area not globally, so its difficult to come 
to conclusion by this above data for evaluating the thinai distribution scientifically. 
Socio economic status 
 From the above data, 50% are from low socio economic status (poor) 37.5% were 
middle and 12.5% were in rich.  There is no accurate evidences for correlation between 
psoriasis and socio economic status but as per research evidences by exposure to 
antigenic surfaces result in higher prevalence of psoriasis.  Therefore peoples from low 
socio evonomic status were easily exposed to antigenic exposure due to infection so they 
have high prevalence of psoriasis. 
Mode of onset 
 From the above tabulation it shows that’s 100% of the cases were reported to be 
have chronic onset.  The above result coincides.  with tome “Text book of dermatology”.  
Hence it inferes that these disease is a chronic onset. 
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Clinical features 
 According to this study, 100% of them had scaling, positive auspitz sign, 
koebner’s phenomenon, 100% patients had itching, (which is correlated with the study 
research gerald kruegae Arch Decmatol 2001) and 12.5% of patients had joint 
involvement, 50% of them had nail changes and candle greese sign.  Petty at et.al.J AM 
Acad Decmatol 2003.  Radtke AM et.al.  This infers that joint involvement in this studies 
coincides with reaserch studies. 
Disturbances in kanmenthiriums 
 Among 40 patients kaal have been affected in 13 cases and eruvai have been 
affected in 7 patients and 15 cases affected in kai kanmenthirium. 
Distribution of three thodams 
a. Vadham 
 From the above tabulation, samanan, viyanan are pretentious in 100% of cases and 
abanan were affected in 17% of cases and uthanan were affected 20% of cases. 
b. Pitham 
 Ranjagam and Prasagam were affected in 100% cases, Saathagam were in affected 
in 32.5% cases. 
c. Kahbam 
 Santhigam was affected 5 cases and avalambagam are pretentious in 62.5% cases. 
Udal kattugal 
 From the seven udal kattugal, saaram, seneer have been affected in all of the 40 
cases enbu and kozhuppu have been affected 12.5% of cases. 
Envagai Thervugal 
 Among the 40 cases, sparisam, niram and naadi have been affected in all cases 
white malam have been affected in 7 patients. 
 In naadi, pitha vatham were present in 15 cases (37.5%), vadha pitham 8 were 
present in cases (20%) Pitha kabham were present in 17 cases (42.5%). 
Investigations 
 Laboratory investigations were done in all the cases before and after treatment,  
The significant variation occur in parameters like ESR and HB, while other parameteres 
have insignificatn variation. 
Pre clinical studies 
 The biochemical study of OMA LEGIYAM had revealed the presence of 
Iron(ferrous), starch, tannic acid, unsaturated compounds reducing sugar and amino acid. 
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Pharmacological studies 
 The pharmacological studies done in OMA LEGIYAM revealed the presence of 
actions such as 
1. Anti inflammatory action 
2. Anti histamin action 
 Toxicity studies 
 Acute toxicity studies have done for OMA LEGIYAM in rats and it is analyzed 
that they have no toxicity. 
Line of treatment 
 According to our humoral pathology, three dosham are deranged in all diseases.  
Therefore the line of tretment starts with regularize the deranged vadham for psoriasis to 
normalize the deranged vadha kutram purgative had to be given.  So the purgative vellai 
ennai – 15ml were given to all 40 patients while be beginning the treatment. 
 Next day trial drug OMA LEGIYAM – 5.1g (Bd) was given along with external 
medicine. 
 THAGARAI LEBAM -10g (external) for 15 for patients i.e. 13 OP and  2 IP. 
 While another 25 patients i.e.17 OP and 8 IP trial drug along with complement 
therapies Pranayamam, asanas were given. 
 During the treatment period the patients  are strictly advised to follow dietary 
regimen to overcome the adverse effect of trial drug given and also for earlier prognosis. 
 
Clinical outcome 
 The clinical outcome was assessed by signs of psoriasis (Auspitz sign, koebner’s 
phenomenon, candle grease sign) plaques, itching, erythema, scaling and these are 
classified into four grades described above.  
According to that gradations 
1. 67.5% had Good improvement 
2. 20% had moderately improved 
3. 7.5% had mild improved and 
4. 5% had no improvement 
There is no adverse affect observed while giving the trial medicines. 
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SUMMARY 
 The disease psoriasis was reasonably studied with the disease kalanjaga padai 
with reference to its causes.  Pathogenesis  and clinical features. 
 The aim of this study is to treat the illness and sufferings of Psoriasis.  psoriasis is 
a common and distressing skin condition.  Importantly, it is not simply a cosmetic 
problem- even people with limited disease find the condition affect their everyday lives 
(stern Rs.et.al.2004-9(2) 136-39). 
 The trial medicines are prepared as per siddha literature. 
 The trial medicines were 
1. OMA LEGIYAM 5.1g (B.d) 
2. THAGARAI LEBAM (external) 
The trial drug was given to 40 patients, for 48 days.  The patients was selected based 
on inclusion and exclusion criteria. 
While starting the treatment routine blood analysis, urine analysis, kidney function 
test and liver function test were done.  Siddha methods like udal thathukkal, Envagai 
thervu, Neerkuri and Neikuri were noted in case sheet proforma. 
 Patients were instructed to come for next review once in 7 days. 
Age 
Most of the patients are from the age group (41-50) 
Thinai 
Most of the patients were from marutham thinai. 
Occupation 
The Coolie workers are mostly affected by Psoriasis.  Stress is also a major triggering 
factor for Psoriasis. 
 
Diet and Physical habits 
Most of the patients were non vegetarians and smoke may also have a major impact 
on Psoriasis. 
Udal  kattugal 
 From the seven udal kattugal, saaram, seneer have been affected in all of the 40 
cases enbu and kozhuppu have been affected 12.5% of cases. 
  
93 
 
Pre clinical studies 
 The pharmacological analysis of OMA LEGIYAM shows that these medicines 
have 
1. Anti inflammatory effect 
2. Anti histaminic effect 
Result the clinical outcome was assessed by gradations.  
Hence the result shows that 67.5% had good improvement. 
Particularly the results were marvelous when it is given trial drug along with 
complement therapies. 
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CONCLUSION 
KALANJAGAPADAI (PSORIASIS) is primarly due the derangement of vadham.  
The trial medicine “OMA LEGIYAM” predominates with kaippu taste respectively 
neutralizes the vatham. 
 Preclinical studies shows that these medicines have anti inflammatory and anti 
histamine, effect and moderate analgesic effect. 
 The “OMA LEGIYAM do not produce any toxicity in preclinical study.  So it is 
not toxic and safe drug for psoriasis. 
 No contraindications were reported during the course of treatment. 
 The overall outcome of this disease is astounding. The clinical signs in this study 
were found to have 67.5% good improvement.  When trial medicines are given along with 
complement therapy were found to have wonderful effect compared to giving trial 
medicines alone. 
 Therefore the author concluded that the trial medicine “OMA LEGIYAM” is very 
positive remedy for “Kalanjagapadai”. 
ASSESSMENT OF RESULTS 
CLASSIFICATION OF PSORIASIS BASED ON THE SEVERITY OF 
SYMPTOMS 
SYMPTOM 
1 Severe marked plaque elevation, scaling and or crythema, affecting more than 
10% of the body surface. 
2. Moderate Moderate plaque elevation, scaling and erythema /affecting 3-10% of 
the body surface 
3 Mild Slight plaque elevation, scaling and or erythema/affecting less than 3% 
of the body surface. 
4 Clear No signs of psoriasis. 
- F Alzeni et al.(2011) 
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OVERALL RESULTS AFTER TREATMENT 
 Based on the outcome, all the 40 patients have been classified into 4 grades.  The 
gradation is as follows, 
Grade I (Good Improvement) – No signs of psoriasis (Post inflammatory hyper 
pigmentation may be present). 
Grade II (Moderate improvement) – Slight plaque elevation reduction in size of all 
lesions, mild scaling.  Itching and/or erythema. 
Grade III (Mild Improvement) – No new lesions, moderate plaque elevation, scaling, 
Itching and/or erythema. 
Grade IV (No Improvement) – Very marked plaque elevation, scaling, Itching and/or 
erythema with or without new lesions. 
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OP. NO. 3144   PATIENT NAME :  KASTHURI  AGE :  41/F 
 
 
 
 
 
 
 
 
BEFORE TREATMENT 
 
 
 
 
 
 
 
AFTER  TREATMENT 
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IP. NO. 2074     PATIENT NAME :  BALASUBRAMANIAM AGE :  40/M 
 
 
 
 
 
 
 
 
 
BEFORE TREATMENT               AFTER  TREATMENT 
OP. NO. 11832     PATIENT NAME :  SABARI AGE :  33/M 
 
 
 
 
 
 
 
 
BEFORE TREATMENT               AFTER  TREATMENT 
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ANNEXURE – I 
PREPARATION OF TRIAL MEDICINES 
STANDARD OPERATING PROCEDURE FOR PREPARATION OF OMA 
LEGIYAM (Internal) AND THAGARAI LEBAM (External). 
Source of Raw drugs 
 The required drugs for preparation of OMA LEGIYAM (Internal) and 
THAGARAI LEBAM (External) are purchased from a well reputed country shop and 
raw drugs were authenticated by medical botanist of Government Siddha medical college, 
palayamkottai, then purified and the medicines were prepared in the gunapadam 
laboratory of Government Siddha medical college, palayamkottai. 
PURIFICATION OF INGREDIENTS OF INTERNAL MEDICINE 
1. Omam 
 It is made free of dust, dried and fried with heat. 
2. Amukkura kizhangu 
 Roots are washed with water and made mud free 
3. Kukil 
 It is boiled in tender coconut and dried 
4. Parangi pattai 
 It is boiled in milk and dried. 
5. Karboga arisi 
 It is dried and fried with heat. 
 
Internal medicine 
INTERNAL MEDICINE: OMA LEGIYAM 
Ingredients :  
S.NO. INGREDIENTS BOTANICAL NAME QUANTITY 
1 Omam Trachyspermum  
roxburghianum 
100 palam 
(3.5kg) 
2 Sarkarai Jaggery 10 palam (350gm) 
3 Amukkra Kizhangu Withania somnifera 35gm 
4 Kukkil Shorea robusta 35gm 
99 
 
5 Parangipattai Smilux china 35gm 
6 Karboha arisi Psoralia corrylifolia 35gm 
7 Neer Water 21.5 lit 
Preparation:        
Purified raw drug is taken and powdered then it is filtered using pure white cloth. 
 The omam is maked kasayam and then added to Naatu sarkarai to make semi fluid form 
then added to chooranam is added to Naatusarkarai semi fluid and make legium form. 
Dosage 
Kalanju (5.1g) – Morning and night. 
Indication 
It is indicated internally for psoriasis. 
Drug storage 
The trial drug is stored in clean dry air tight container as glass bottles. 
EXTERNAL MEDICINE:  THAGARAI LEBAM 
Ingredients: 
S.NO. INGREDIENTS BOTANICAL NAME QUANTITY 
1 Thagarai ilai Cassia tora 20gm 
2 Vaividangam Embelia ribes 20gm 
3 Vetpalaipattai wrightia tinctoria 20gm 
4 Senkaluneer kizhangu Nymphaea alba 20gm 
5 Maramanjal Coscinium fenestratum 20gm 
6 Kondrai kolunthu Cassia fistula 20gm 
7 Kodiveli ver Plumbago indica 20gm 
8 Manjal Curcuma longa 20gm 
9 Erukkam ver Calotropis gigantia 20gm 
10 Kostam Costus speciosus 20gm 
11 Nelli paruppu Phyllanthus emblica 20gm 
12 Karboga arisi Psorallea corylifolia 20gm 
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Method of Preparation: 
Purified raw drugs are make powder mixed with Cow’s urine then apply externally. 
Indication 
 It is indicated externally for psoriasis. 
Drug storage 
 The trial drug is stored in clean, dry and air tight container as narrow bottles. 
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OMA LEGIYAM – INGREDIENTS 
(INTERNAL MEDICINE) 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Yll<<<<! nLg<gqvi!gqpr<G< << << < !
Gg<gqz<< << << <! hxr<gqh<hm<jm< < << < << < < !
gii<Ohigiqsq<<< ! si<g<gjv< << << < !
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THAGARAI LEBAM – INGREDIENTS 
(EXTERNAL MEDICINE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
kgjv! uib<uqmr<gl<< < << < << < <!
osr<gPfQi<gqpr<G< Q < << Q < << Q < < ! lR<st<< << << <!
oum<hijz<<< ! lvlR<st<< << << <!
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ogie<jxogiPf<K< << << < ! ogicOuzq!
wVg<ge<!Oui<< < << < << < <! Ogi]<ml<< << << <!
ofz<zqhVh<H< << << < ! gii<Ohigiqsq<<< !
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THAGARAI LEBAM 
 
 
Cow Urine 
  
106 
 
PROPERTIES OF TRIAL DRUGS 
Internal Medicine 
2/!Yll<<<<!
OuXohbi<gt<< << << <!
! nsl<kigl<?!nsl<ki!!Yll<!
Botanical name : Trachyspermum roxburghianum 
English name  : Aprum involucreatum 
Family   :  Apiaceae 
Sju! ! ! ;! giIh<H?!sqXjgh<H!
ke<jl! ! ;! ouh<hl<!
hqiqU! ! ! ;! giIh<H!
hbe<hMl<!dXh<H! ;!uqk<K!
osb<jg<<< !
o Stomachic 
o Carminative 
Chemical constituents 
 Eugeno,  Myristicin, Elemicin, Apiol, Sabinene, α-pinene, β – pinene, β- myrcene. 
2. si<g<gjv!)< << << < Sugarcane) 
Medicinal uses 
 Decreased chance of diabetes 
 Wound healing 
 Fight of the common cold and flu. 
 Organ strength 
 Sugarcane is beneficial for cancer patient 
 Beneficial for kidney stone patients 
 Delay aging 
!
4/!nLg<vi<<< !
OuXohbi<<<<!
! nLg<gqiq?!nSugf<kl<?!nSul<?!-Vtqosuq?!gqcs<osuq?!uviggi<eq!
Botanical name : Withania somnifera 
English name  : Winter cherry 
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Family   : Solanaceae 
Sju! ! ! ;! jgh<H!
ke<jl! ! ;! ouh<hl<!
hqiqU! ! ! ;! giIh<H!
Partused  (hbe<hMl<!dXh<H*< < << < << < < !
! -jz?!uqjk?!Oui<)gqpr<G*!
osb<jg<<< !
gqpr<G! .! Alternative, Aphrodisiac, Deobstruent, Diuretic, Tonic, 
Soporific,  
Sedative. 
G{l<<<<!
! “ogiR<sf<!Kuh<hir<!ogicbgbl<!$jzbiq!
! lqR<Sgvh<!hie<hi{<M!ouh<hkh<H!uqR<sq!
! LSUX!OkimLl<Ohi!Oligl<ne!Z{<mil<!
! nSugf<!kqg<oge<!xxq”/!
. ngk<kqbi<!G{uigml<!
Chemical constituents 
 Alkaoids, Streoidal lactones, withanolides, withaferin A, tropine 
5/!Gg<gqz<< << << <!
OuXohbi<gt<;< << << < !Gr<gqzqbl<?!Gg<GZ?!Gg<gqz<?!Gg<gqzqbl<!
Botanical name - Shorea robusta 
English name  - Sal tree 
Family   - Burseraceae 
Sju! ! .! jgh<H!
ke<jl! .! ouh<hl<!
hqiqU! ! .! giIh<H!
Part used (hbe<hMl<!dXh<H*!;! hqsqe<!
! !
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osb<jg<<< !
! Stimulant 
Expectorant 
Diuretic 
G{l<<<<!
! “ohVl<hiM!Olgl<Ohil<!Ohvi!Kmtz<!
! nVl<hqb!H{<!{iXlqju!bz<ziz<!.!GVl<hil<!
! wZl<HVg<gq!H{<sQPl<!WGl<!dzgqz<!
! szl<hVGr<!Gr<gqzbk<!kiz<”!
. ngk<kqbi<!G{uigml<!
Chemical constituent 
 Alkaloids, flavinodis, Terpenoids, Resins, Tannins. 
!
6/!hvr<gqh<hm<jm< < << < << < < !
OuXohbi<gt<!! ;!lK^<lqgl<?!lK^<lQgq?!sqeh<hm<jm?!hxr<gqs<sg<jg!
Botanical name : Smilax china 
English name  : China root 
Family   : Liliaceae 
Sju! ! .! -eqh<H!
ke<jl! .! km<hl<!
hqiqU! ! .! -eqh<H!
Part used (hbe<hMl<!dXh<H*!;!gqpr<G!
osb<jg<<< !
! Alterative 
 Anti syphlitic 
 Aphrodisac 
 Depurative 
! !
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G{l<!
! “kigl<!hzuikf<!kiKfm<ml<!H{<hqtju!
! Olgr<!gcgqvf<kq!uQp<&zf<!.!OkgLme<!
! Gm<jm!hgf<kOlx<!ogit<ulel<!Ohil<hxr<gqh<!
! hm<jmbqje!Bs<siqk<Kh<!hiI”!
. Okve<!G{uigml<!
Chemical cosntituents 
 7-0-beta-D-gluco pyranoside, engeletin, isoengeletin, kaempferol, rutin, vanillic 
acid. 
6. giIOhig!niqsq!
Botanical Name : Psoralea corylifolia 
OuXohbi<gt<!! ;! giIHui!niqsq?!hiGsq?!gih<Hui!niqsq!
Family   : Fabaceae 
Sju! ! ! ;!! jgh<H!
ke<jl! ! ;! ouh<hl<!
hqiqU! ! ! ;! giIh<H!
Part used  :  Grains or seeds 
osb<jg<<< !
! Laxative 
Stimulant 
G{l<<<<!
! “giIOhig!liliqsq!g{<mix<!gvh<hie<H{<< < < < << < < < << < < < <!
! hQIsGu!fR<sqju!Ohil<!hqk<kL{<mil<!Q < < < < <Q < < < < <Q < < < < < .!hiIlQkqz<Q <Q <Q <!
! uik!ghfjhs<sz<!ue<osixqsqvr<GlXR< < < << < < << < < < << <<!
! sQk!liIg<Gpzib<!osh<H/Q < < <Q < < <Q < < < ”!
Chemical constituents 
 A compounds isoflavin, conylinin, isopsoralen, psoralen, sophoracoumestan A, 
neobavaisoflavone, daidzin, uracil are present. 
 It has antioxidant, anti inflamatory, antidepresent antimicrobial, antitumour and 
osteoblastic activity are present. 
!
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7.  ofb<!)<<< Cow’s ghee) 
Medicinal uses of Ghee 
 It gives energy and weight management 
 Digestion and immune strengthening 
 Provide healthy digestive treat 
 Provide healthy immune system 
 Anti-inflammatory and anti cancer 
 Gives strong appetite 
 
8. Oke<!)<<< Honey) 
Medicinal uses of honey 
 Heals chronic ulcers 
 Provide anti bacterial activity 
 Cures common cold 
 Having antidiabetes activity 
 Helps prevent cancer and heart disease 
 Heals wound and burns 
 Increase anthelmintic performance 
 Reduces cough and throat irritation. 
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EXTERNAL MEDICINE 
2/!kgjvuqjk!
OuXohbi<! ! .! fivk<kgjv!
Botanical name - Cassia tora 
English name  - Foetid cassia 
Family   - Fabaceae 
Sju! ! ! .! jgh<H?!dui<h<H!
ke<jl! ! .! ouh<hl<!
hqiqU! ! ! .! giIh<H!
hbe<hMl<!dXh<H!! .!-jz?!Oui<?!uqjk!
osb<jg<<< !
o Aperient 
o Germicide 
o Febrifuge 
G{l<<<<!
! “kgjvh<!hmi<ki!ljvjbs<!osixqjbk!
! kgv!ucg<Glf<kf<!ke<Oei!–!cgzie!
! Sk<kq!Svk<jkBl<!kR<osb<H!lql<&t!
! Bk<klli!ole<Ox!Bjv”/!
. ngk<kqbi<!G{uigml<!
Chemical constituents 
 Anthroquinones, ennodin, obtusin, obtusifoline, glycosides. 
!
3/uib<uqtr<gl<< < << < << < <!
OuXohbi<gt<!! ;! Ogvtl<?!uib<uqzr<gl<?!ui<eje?!uib<uqmr<gl<!
Botanical name : Embelia ribes 
English name  : Emebelia 
Family   : Myrsinaceae!
Sju! ! ! ;! jgh<H!
ke<jl! ! ;! ouh<hl<!
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hqiqU! ! ! ;! giIh<H!
hbe<hMl<!dXh<H! ;!! uqjk!
osb<jg<<< !
 Anthelmintic 
 Carminative 
 Stomachic 
 Stimulant 
G{l<<<<!
! “uikGV!uiBml<H!uiklXk<!kh<hcOb!
! OujkBOzi!gr<gtqOz!Ou{<ceix<!.!hik!
! uqvkLkx<!jgbim!oue<xi!uqjsBl<!
! ui<eje!fQlek<kqz<!ju/”!
Chemical constituents 
 Embelin, volatile oil, resin, tannin, phenolic acid, vanillic acid, chinamic acid. 
!
4/!oum<hijzh<hm<jm< < << < << < < !
OuXohbi<gt<!;! gqiqlz<zqjg?!Gmsl<?!ux<sl<!
Botanical name: wrightia tinctoria 
English name : Pala indigo plant 
Family  : Apocynaceae 
Sju! ! ;! Kui<h<H?!-eqh<H?!sqXjgh<H!
ke<jl! ;! ouh<hl<!
hqiqU! ! ;! giIh<H!
hbe<hMl<!dXh<H! ;!-jz?!hm<jm?!uqk<K!
osb<jg<<< !
o Aphrodisiac 
o Astringent 
! !
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G{l<<<<!
! “ng<eqjb!juk<kqVg<G!liIf<kui!kl<Ohig<Gf<!
! kqg<Gciq!Okimk<jk!kQIf<KuqMl<!.!osig<guqM!
! gm<hijzg<!%x<jxjuk<k!kie!lmlbqOz"!
! oum<hijz!fe<lVf<kil<!uqt</”!
. ngk<kqbi<!G{uigml<!
Chemical constituents 
 Lipid, saponin, lannins, alkaloids, phenols, steroids, flavinoids. 
 
5/!osr<gP<<< fQIgqpr<GQ <Q <Q < !
OuXohbi<gt<!! ;!! dx<hzl<?!Gujt?!Guzbl<?!osr<gPfQi<!
Botanical name : Nymphaea alba 
English name  : Water lily 
Family   :  Nymphaeaceae 
Sju! ! .! -eqh<H!
ke<jl! .! km<hl<!
hqiqU! ! .! -eqh<H!
hbe<hMl<!dXh<H! .!LPuKl<!
osb<jg<<< !
o Antiseptic 
o Refrigerant 
G{l<<<<!
! “dmx<Gg<!Gtqi<s<sqbki!Lt<Tpjz!lix<Xl<!
! nmx<ghu!Ovigk<jk!bix<Xl<!.!gmx<Gt<!
! wPfQIg<!Glqpq!bqgP!Ljzbil<!
! gPfQI!lzoveOu!gi{<”!
. ngk<kqbi<!G{uigml<!
Chemical consitituents 
 Alkaloids, glycosides, flavinoids, glycosides, Tannins, lignans, phytosterols, 
triterpene saponins. 
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5. lvlR<st<< << << < 
OuXohbi<gt<!! ;! giOzbgl<?!kiXuq!
Botanical name : Coscinium fenestratum 
English name  : Tree turmeri 
Family   : Menispermaceae 
Sju! ! .! jgh<H!
ke<jl! .! ouh<hl<!
hqiqU! ! .! giIh<H!
hbe<hMl<!dXh<H! .! sg<jg!
osb<jg<<< !
o Febrifuge 
o Stomachic 
o Tonic 
G{l<<<<!
! “npe<xg{!&zl<!nVsq!BmOe/!
! dpe<x!g{s<SvLl<!YMR<!.!Spe<Xt<Ot!
! uQXSv!Lf<kjtBl<!uQSlv!lR<sTg<Gk<!
! OkX!olipqbeOl!osh<H/”!
. ngk<kqbi<!G{uigml<!
Chemical constituents 
 Alkaloids, Ceryl-alcohol, Saponine, Sitosterol, glucoside, palmitic acid, oliec acid. 
7/!ogie<jxogiPf<K< << << < !
OuXohbi<gt<< << << <!
! ogie<jx?!kill<?!lkjz?!-kpq?!Ng<Gukl</!
Botanical name : Cassia fistula 
English name  : Indian ladurnam 
Family   : Caesaepiniaceae 
Sju! ! ;! Kui<h<H?!uqXjgh<H!
ke<jl! ;! ouh<hl<!
hqiqU! ! ;! giIh<H!
hbe<hMl<dXh<H! ;!-jz?!H,?!Htq?!uqjk?!hm<jm!
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osb<jg<<< !
! Laxative, vermifuge 
G{l<<<<!
! “hi{<mvr<gI!H,{ib<h<!hxg<gck<K!Olgk<jk!
! bi{<mir<gg<!jgGt<us!lig<GOl!–!gi{<!
! Gkuqsqz!osb<Kmjz!Obil<HlqK!fQhiI!
! -kpqvbEr<!ogie<jxHuq!bqz</”!
. Okve<!ou{<hi!
Chemical constituents 
 Carbohydrates, Linouic, oleic and stearic acid, oxalic acia, Tannins, 
anthroquinones, Glycosides fistulic acia & flavinoids. 
8/!ogicOuzq!
Botanical name :  Plumbago zeylanica 
OuXohbi<! ! ;!! ou{<sqk<kqv&zl<?!ou{<ogic&zl<!
Family   :  Plumbaginaceae 
Sju! ! ! ;! giIh<H!
ke<jl! ! ;! ouh<hl<!
hqiqU! ! ! ;! giIh<H!
Part used  :  Root 
osb<jg<<< ! !
 Antiperiodic 
 Diaphoretic 
G{l<<<<!
! “gm<cuqv!{r<gqvf<kq!giz<gt<!njvbih<Hg<< < < < < < << < < < < < << < < < < < <!
gm<cs<$!jzuQg<gr<!gip<&zl<!Lm<cvk<kg<< < Q < < < < < < << < Q < < < < < < << < Q < < < < < < <!
! gm<MfQ!Ovx<xr<!gek<k!< Q < < << Q < < << Q < < < ohVubqXl<<<<!
! nm<Mr<!ogicOuzq!bil</#< < << < << < < !
Chemical constituents 
 It has isoschinanolone, plumbagic acid, beta-sitosterol, 4-hydroxybenzaldehyde, 
Trans cinnamic acid, vanillic acid, 2.5 dimethyl 7 hydroxychromone, indole – 3 
carbonaldehyde are present. 
 It has anticonvulsant, hepatoprotective activity  
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9/!lR<st<< << << <!
OuXohbi<gt<!! ;!niqsel<?!gie<seq?!fqsq?!hQkl<!
Botanical name :  Curcuma longa 
English name  : Turmeric 
Family   : Zingiberaceae 
Sju! .! giIh<H?!jgh<H!
ke<jl!.! ouh<hl<!
hqiqU! .! giIh<H!
hbe<hMl<!dXh<H! .! gqpr<G!
osb<jg<<< !
o Carminative 
o Stimulant 
o Hepatic tonic 
G{l<<<<!
! “ohie<eqxlil<!Oleq!Hzieix<x!Ll<OhiGl<!
! le<E!HVm!usqblil<!.!hqe<eqobPl<!
! uif<kqhqk<k!Okimjlbl<!uikl<Ohif<!.!kQhelir<!
! %If<klR<s!tqe<!gqpr<Gg<G”!
. ngk<kqbi<!G{uigml<!
Chemical constituents 
 Phenolic compound and terpenoids, mono, di and triterpenoids, alkaloids, sterols. 
:/!wVg<gl<Oui<< < << < << < <!
OuXohbi<!! ;! nVg<ge<!
Botanical name : Calotropis gigantea 
English name  : Mudar 
Family   : Asclepiadaceae 
Sju! ! ;! jgh<H?!givl<?!lKvl<!
ke<jl! ;! ouh<hl<!
hqiqU! ! ;! giIh<H!
!
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hbe<hMl<!dXh<H< < << < << < < ! !
! -jz?!H,?!hiz<?!hm<jm?!Oui</!
G{l<<<<!
! -z<jz!
osb<jg<<< !
! Febrifuge, Alterative, Stimulant, Tonic, Diaphoetic, Emetic. 
Chemical constituents 
 Wax and resin present in Stembark. 
 Triterpene alcohols 
 Valatile fatty acid. 
21/Ogi]<ml<< << << <!!
 Botanical name :  Saussurea lappa 
OuXohbi<! ! ;!! Ogim<ml<?!Gvi!yzq!
Family   :  Asteraceae 
Sju! ! ! ;! jgh<H!
ke<jl! ! ;! ouh<hl<!
hqiqU! ! ! ;! giIh<H!
Part used  : Root, Rhizome 
osb<jg<<< !
 Stomachic 
 Expectorant 
 Tonic 
 Stimulant 
 Diaphoretic 
G{l<<<<!
! fim<cZX!oum<jm!fMg<gl<!wEOfib<gt<< < < < < << < < < < << < < < < <!
! Ogim<moles<!osie<eiz<!GjzBr<gi{<!< < < < < << < < < < << < < < < < .!%m<cx<< << << <!
! SvOkimf<!oki{<jmOfib<!Okizik!hqk<kl<< < < < << < < < << < < < <!
! hvOksl<!OhiOl!hxf<K/< << << < !
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Chemical constituents 
 Diosgenin, Tigogenin, dioscin, gracillin, β-sitosterol glucoside. 
 The seeds contain fatty acids.  It contain palmtic stearic, oleic, linoleic, arachidic 
acids are present. 
!
22/ofz<zqhVh<H< << << < !
OuXohbi<gt<!! ;!Nlzgl<?!Nzgl<?!Nl<hz<?!lQKf<K!
Botanical name : Phyllanthus emblica 
English name  : Indian Goseberry 
Family   : Euphorbiaceae 
Sju! ! ;! Htqh<H?!Kui<h<H?!-eqh<H!
ke<jl! ;! km<hl<!
hqiqU! ! ;! -eqh<H!
hbe<hMl<!dXh<H! ;! LPuKl<!
osb<jg!   : Astringent 
G{l<<<<!
! “-z<zi!lzg!lqv{<M!lbqe<xiOe!
! bqz<zi!lzglqVg<GOl!.!-z<zilz<!
! uijpg<!geqBl<!ujmBlqPK!L{<hie<!
! uijpg<!geqBe<!juk<kue<”!
! ! ! ! .Okve<!blg!ou{<hi!
Chemical constituents 
 Two flavonoids and tannins 
 Kaempferol 3-0-α-L-(6”-metheyl)  rhamnopyranoside. 
 Kaempferol 3-0-α-L-(6”-etheyl)  rhamnopyranoside 
23/!giIOhigniqsq!
Botanical Name : Psoralea corylifolia 
OuXohbi<gt<!! ;! giIHui!niqsq?!hiGsq?!gih<Hui!niqsq!
Family   : Fabaceae 
Sju! ! ! ;!! jgh<H!
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ke<jl! ! ;! ouh<hl<!
hqiqU! ! ! ;! giIh<H!
Part used  :  Grains or seeds 
osb<jg<<< !
! Laxative 
Stimulant 
G{l<<<<!
! “giIOhig!liliqsq!g{<mix<!gvh<hie<H{<< < < < << < < < << < < < <!
! hQIsGu!fR<sqju!Ohil<!hqk<kL{<mil<!Q < < < < <Q < < < < <Q < < < < < .!hiIlQkqz<Q <Q <Q <!
! uik!ghfjhs<sz<!ue<osixqsqvr<GlXR<< < < < << < < < << < < < <!
! sQk!liIg<Gpzib<!osh<H/Q < < <Q < < <Q < < < ”!
Chemical constituents 
 A compounds isoflavin, conylinin, isopsoralen, psoralen, sophoracoumestan A, 
neobavaisoflavone, daidzin, uracil are present. 
 It has antioxidant, anti inflamatory, antidepresent antimicrobial, antitumour and 
osteoblastic activity are present. 
!
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ANNEXURE - II 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
BIO-CHEMICAL ANALYSIS OF OMA LEGIYAM 
Preparation of the extract:   
  5gms of the drug was weighed accurately and placed in a 250ml clean 
beaker.  Then 50ml of distilled water is added and dissolved well.  Then it is 
boiled well for about 10 minutes.  It is cooled and filtered in a 100ml 
volumetric flask and then it is make up to 100ml with distilled water.  This 
fluid is taken for analysis. 
 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  
TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube. To this 
add 2ml of 4% Ammonium oxalate 
solution 
No white 
precipitate is 
formed 
Absence of 
calcium 
2. 
TEST FOR SULPHATE 
2ml of the extract is added to 5% 
Barium chloride solution. 
No white 
precipitate is 
formed 
Absence of 
sulphate 
3.  
TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
No white 
precipitate is 
formed 
Absence of 
chloride 
4. 
TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
No Brisk 
effervessence is 
formed 
Absence of 
carbonate 
5. 
 
TEST FOR STARCH 
The extract is added with weak 
iodine solution 
 Blue colour is 
formed 
Indicates the 
presence of  
starch 
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6.  
TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro 
cyanide. 
No blue colour is 
formed 
Absence of 
ferric iron 
7. 
TEST OF FERROUS IRON  
The extract is treated with 
concentrated Nitric acid and 
Ammonium thio cyanate solution 
Blood red colour 
is formed 
Indicates the 
presence of 
ferrous iron 
8.  
TEST FOR PHOSPHATE 
The extract is treated with 
Ammonium Molybdate and 
concentrated nitric acid 
No yellow 
precipitate is 
formed 
Absence of 
phosphate 
9.  
TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is 
formed 
Absence of 
Albumin 
10.  
TEST FOR TANNIC ACID 
The extract is treated with ferric 
chloride. 
Blue black 
precipitate is 
formed 
Indicates the 
presence of 
tannic acid 
11.  
TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets 
decolourised. 
 
Indicates the 
presence of 
unsaturated 
compound 
12.  
TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and add 8-
10 drops of the extract and again 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing 
sugar 
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boil it for 2 mts. 
13.  
TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying, 1% Ninnhydrin 
is sprayed over the same and dried 
it well. 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
14. 
TEST FOR ZINC 
The extract is treated with 
Potassium Ferrocyanide. 
No white 
precipitate is 
formed 
Absence of 
Zinc. 
 
Inference: 
  The given sample of “OMA  LEGIUM” contains starch, ferrous Iron, 
tannic acid, reducing sugar, unsaturated compound  and amino acid. 
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ANNEXURE – III 
PHARMACOLOGICAL ANALYSIS 
EFFECT OF OMA LEGHIYAM WITH HONEY/GHEE ON CARRAGEENAN-
INDUCED LOCALISED INFLAMMATORY PAIN IN RATS 
SUMMARY 
  The study plan was developed based on the guidelines of Vogel1 and also it has 
reference to Chao Ma and Jun-Ming Zhang2 and Walker et al. 3, Winter CA, Risley EA, 
Nuss GW. Carrageenin induced edema in hind paw of the rat as an assay for anti-
inflammatory drugs. Proc Soc Exp Biol Med. 1962;111:544–7. 
Objective 
  To study the anti-inflammatory effect of OMA LEGHIYAM were prepared 
WITH HONEY/GHEE in the rat model of Carrageenan-induced localized inflammation.  
Methods: 
Test System 
Species : Rat   
Strain : Albino Wister 
Age : 6-8 weeks at the time of dosing 
Total no. of Rats : 24 
Sex : Male 
Weight                   :    150 gm 
 
 The animals were housed in polypropylene cages with stainless steel top grills 
having facilities for holding pellet food and drinking water in bottle with stainless steel 
sipper tube. Each cage contained 6 rats. All rats had free access to potable water and 
standard pelleted laboratory animal diet ad libitum. Paddy husk was used as bedding 
material. The animals were divided into 5 groups (6 rats/group). Localized inflammatory 
pain was induced in all groups of animals by intraplantar injection of carrageenan (50 µl 
of 3% suspension).  
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 One day before the experiment, three basal readings of hind paw in each rat were 
recorded. Group 1 received vehicle orally, Group 2 received a standard drug Diclofenac 
sodium (10 mg/kg i.p), whereas groups 3,4and 5 received OMA LEGHIYAM. The 
doses of OMA LEGHIYAM were prepared WITH HONEY/GHEE, whereas 
Diclofenac sodium was dissolved in normal saline. After 30 min, the rats were challenged 
with subcutaneous injection of 0.1 ml of 1% w/v solution of carrageenan into the sub 
plantar region of left paw. The paw was marked with ink at the level of lateral malleolus 
and immersed in mercury up to the mark. The paw volume was measured at 0, 1, 2, 3, 4, 
5 and 6th hr after carrageenin injection using Digital Plethysmometer. The difference 
between initial and subsequent reading gave the actual edema volume.  
DOSAGE SCHEDULE: 
  The required dose for mice/rat will be calculated by using the standard dose 
calculation procedure from recommended clinical dose. 
 
CONVERSION FORMULA: 
Human dose is 6000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 150 gm of Rat 
6000 mg x 2(a) x 0.018 (b) = 108 (c) /150 gm of Rat 
108/1000x150 = 16.2 mg  
Experimental Doses Calculated as per the standard procedures are 
 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of administration 
 
1 Vehicle Control -- 1 ml 
 
2 Therapeutic Dose 16.2 mg /kg 
 
1 ml 
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3 Middle  Dose 81mg/kg 1 ml 
 
4 High Dose 405mg/kg 1 ml 
 
EXPERIMENTAL DESIGN: 
Group-I:   Served as a negative control (0.1ml of 1% carrageenin) 
Group-II: Served as standard received Diclofenac sodium (10mg/kg, i.p) + 
                  (0.1ml of 1% carrageenin) 
Group-III: Received OMA LEGHIYAM were prepared WITH HONEY/GHEE  
        (16.2 mg /kg) + (0.1ml of 1% carrageenin) 
Group IV: Received OMA LEGHIYAM were prepared WITH HONEY/GHEE  
                   (81 mg/kg ) + (0.1ml of 1% carrageenin) 
Group V: Received OMA LEGHIYAM were prepared WITH HONEY/GHEE  
                   (405 mg/kg ) + (0.1ml of 1% carrageenin) 
 
TABLE: EFFECT OF OMA LEGHIYAM WITH HONEY/GHEE ON Carrageenin 
-INDUCED PAW EDEMA IN RATS (BODY WEIGHT in gms) 
 
 
Group 
Control Standard LD MD HD 
 
INITIAL 
BODY 
WEIGHT 
152±2.309 
 
 
138.7±1.764 
 
 
148.7±1.764 
 
 
153±2.887 
 
 
138±2 
 
 
Values are expressed as the mean ± S.D. Statistical significance (p) calculated by 
one way ANOVA  followed by dunnett’s. ns- not significant **P< 0.05 calculated by 
comparing treated group with control group 
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TABLE: EFFECT OF OMA LEGHIYAM WITH HONEY/GHEE ON Carrageenin 
-INDUCED PAW EDEMA IN RATS 
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Values are expressed as the mean ± S.D. Statistical significance (p) calculated by 
one way ANOVA  followed by dunnett’s. ns- not significant **P< 0.05 calculated by 
comparing treated group with control group 
 
 
 
Grou
p 
Mean 
paw 
volume 
before 
carrage
enan 
injectio
n 
Paw Volume after induction with carrageenin  
Increase in paw volume (ml) after carrageenan injection (mean ± 
SEM)/Percent  inhibition of edema 
0 min 30 
min 
1h 2h 3h 4h 5h 6h 
 
Contr
ol 
 
3.83±0.1
8 
 
6.88±
0.19 
 
7.18±0.
13 
 
7.42±0.
12 
 
7.55±0
.09 
 
7.40±0.
09 
 
7.15±0.
083 
 
6.92±0.
06 
 
Stand
ard 
 
3.60±0.1
2 
 
6.88±
0.15 
 
7.23±0.
15** 
 
7.37±0.
12** 
 
7.37±0
.06 
 
6.85±0.
14** 
 
6.66±0.
14* 
 
6.30±0.
09** 
 
LD 
 
3.64±0.1
1 
 
6.64±
0.24 
 
 
6.83±0.
22 
 
7.30±0.
14* 
 
7.21±0
.09* 
 
6.99±0.
07* 
 
6.55±0.
14** 
 
6.26±0.
09** 
 
MD 
 
3.89±0.1
6 
 
 
6.93±
0.25 
 
7.07±0.
22 
 
7.25±0.
17 
 
7.17±0
.10* 
 
6.99±0.
07* 
 
6.67±0.
10* 
 
6.27±0.
12** 
 
HD 
 
4.17±0.1
6 
 
6.90±
0.17 
 
7.18±0.
14* 
 
7.38±0.
11** 
 
7.19±0
.09* 
 
6.84±0.
10** 
 
6.55±0.
12** 
 
6.55±0.
12** 
  
 
 
 
 
 
 
 
 
 
0
1
2
3
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7
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0min 30min 1st hrs
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2nd hrs 3rd hrs 4th hrs 5th hrs 6th hrs
PAW VOLUME
 
Only Carrageenan
Carrageenan + STD
Carrageenan + L.D
Carrageenan + M.D
Carrageenan + H.D
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FIG: EFFECT OF OMA LEGHIYAM WITH HONEY/GHEE ON Carrageenin -INDUCED PAW 
EDEMA IN RATS 
 
       
                  Only Carrageenin                                     Carrageenin+ STD   
 
      
                 Carrageenin + L.D                                                                   Carrageenin + M.D 
 
 
Carrageenin + H.D 
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EVALUATION OF SPASMOLYTIC ACTIVITY OF OMA LEGIUM WITH HONEY  
/  GHEE ON GUINEA PIG ILEUM 
AIM:  
              To study the effect of OMA LEGIUM WITH HONEY  /  GHEE on Guinea pig ileum 
APPARATUS: 
          Organ bath, Oxygen delivery tube cum tissue holder, Isotonic frontal writing lever, 
Sherrington’s recording drum, pinch cork, screw clip etc. 
DRUGS USED: 1. OMA LEGIUM WITH HONEY  /  GHEE (1mg/ml) 
                           2.   Acetylcholine (1mg/ml) 
                           3.   Histamine (10µg/ml) 
 EXPERIMENTAL CONDITION 
Physiological salt Solution :  Tyrode          
Composition of De Jalon sol 
1. Nacl,         2. Kcl  
 3. NaHCO3,   4. Cacl2,  
  5.  Glucose.  6. MgCl2    7. NaH2PO4 
                                                                                       
Temperature                   :            370 C   
                                                     Tension of lever             :            0.5gm 
                                                  Magnification                 :           10 times 
                                                    Aeration                         :            air 
 
 
 
131 
 
PROCEDURE: 
1. The Guinea pig ileum (either sex) is sacrificed by a blow on the head and carotid 
bleeding. 
2. The assembly is set up and the arrangements are made for above mentioned 
experimental conditions. 
3. The Guinea pig ileum was sacrificed as per the CPCSEA recommended guidelines. 
The abdominal cavity was opened and cut and remove a few Centimetres long of the ileal 
portion were quickly separated and placed in the Petridish. The ileal was made free from 
adhering adipose and connective tissues. 
4. One end of the tissue was tied to the aeration tube cum tissue holder and the other end 
was tied (after keeping in the organ tube) to the isotonic frontal writing lever. 
5. The tissue was allowed to stabilize for about half an hour during which the tyrode of 
organ bath was changed after every 10min. 
6. After the tissue was stabilized drugs were administered and the following cycle was 
followed: 
         0sec          : Start the drum and record a base line 
         30 sec       : Add the drug to the organ bath 
        60 sec        :  Stop the drum and give a wash 
        120 sec      : Give a second wash 
       150 sec       : consider as 0sec and repeat as 0 
 
 
 
 
 
 EVALUATION OF SPASMOLYTIC ACTIVITY OF
GHEE 
 
Histamine 
 
Concentration 
(µg/ml) 
 
Height of
 response 
(cm) 
 
 
0.1(µg/ml) 
 
76
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 OMA LEGIUM 
ON HISTAMINE INDUCED ISOLATED 
 
 
Histamine + OMA LEGIYAM 
 
% of 
response 
 
 
Concentratio
n 
(µg/ml) 
 
Height of 
Response
(cm) 
 
 
 
 
94.85% 
 
0.1(µg/ml) 
 
 
34
 
 
 
92.89.% 
 
0.2(µg/ml) 
 
 
39
 
 
 
85.95% 
 
0.4(µg/ml) 
 
 
44
 
 
 
100% 
 
0.8(µg/ml) 
 
54
 51.82 % 
 
 
 
IC50 =18.93%
 
0.2 0.4
Concentration (µg/ml)
ON HISTAMINE INDUCED ISOLATED 
WITH HONEY  /  
 
 
 
 
 
% of response 
 
 
 
46% 
 
 
52% 
 
 
56 % 
 
 
67% 
 
 
 
0.8
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ACUTE TOXICITY STUDY IN FEMALE WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF OMA LEGHIYAM WITH HONEY/GHEE 
 
Table 1. Test substance details 
Name of the test substance 
 
OMA LEGHIYAM  
With Honey/Ghee 
Colour of the test substance -Light brown 
Nature of the test substance Powder 
 
Table 2. Experimental protocol 
 
Name of the study Acute toxicity 
Guideline followed OECD 423 method-acute toxic class 
method 
Animals Healthy young adult female wister rats, 
nulliparous, non-pregnant 
Body weight 150-200 g 
Sex                       female 
Administration of dose and volume 6000 mg/kg in 200g body weight, single dose in 1 ml 
Number of groups and animals 5 groups and 3 animals in each group 1000,2000,3000,5000and 6000mg/kg 
Route of administration Oral Cavage (po) 
Vechicle Honey/Ghee 
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Table3. Housing and feeding conditions 
Room temperature 22°C  ±  3°C 
Humidity 40-60% 
Light 12 h : 12h (light : dark cycle) 
Feed 
Standard laboratory animal food pellets 
with water ad libitum 
 
Table 4. Study period and observation parameters 
Initial once observation First 30 minutes and periodically 24 h 
Special attention First 1-4 h after drug administration 
Long term observation Upto 14 days 
Direct observation parameters 
Tremors, convulsions, salivation, diarrhea, 
lethargy, sleep and coma. 
Additional observation parameters 
Skin and fur, eyes and mucous membrane, 
respiratory, circulatory, autonomic and 
central nervous systems, somato motor 
activity and behavior pattern etc. 
  
  The time of death, if any, is recorded. (Complete observations: annexure I). After 
administration of the drug, food is withheld for a further 1-2 hours. 
Study procedure 
  Acute oral toxicity was performed as per organization for economic co-operation 
for development (OECD) guideline 423 method. The OMA LEGHIYAM with Honey/Ghee 
was administered in a single dose by tuberculin syringe. Animals are fasted 3 h prior to 
dosing (food was withheld for 3 h but not water). Following the period of fasting animals 
was weighed and test substance was administered orally at a dose of 
1000,2000,3000,5000 and 6000mg/kg. After the OMA LEGHIYAM with Honey/Ghee 
administration, food was withheld 2 h in mice. Animals are observed individually after at 
least once during the first 30 minutes, periodically during the first 24 hrs, with special 
attention given during the first 4 hrs, and daily thereafter, for a total of 14 days.  
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REPORT 
Toxicological evaluation of OMA LEGHIYAM with Honey/Ghee 
Table:5 Effect of OMA LEGHIYAM  With Honey/Ghee on acute toxicity test in 
female rats. 
 
RESULT: 
  From acute toxicity study it was observed that the administration of 
OMA LEGHIYAM with Honey/Ghee to Female Wister rats did not induce 
drug-related toxicity and mortality in the animals up to 6000mg/kg in 200g 
S.N 
 
 
Response 
Head Body Tail 
Before After Before After Before After 
1 Alertness Normal Normal Normal Normal Normal Normal 
2 Grooming Absent Absent Absent Absent Absent Absent 
3 Touch 
response 
Absent Absent Absent Absent Absent Absent 
4 Torch response Normal Normal Normal Normal Normal Normal 
5 Pain response Normal Normal Normal Normal Normal Normal 
6 Tremors Absent Absent Absent Absent Absent Absent 
7 Convulsion Absent Absent Absent Absent Absent Absent 
8 Righting reflux Normal Normal Normal Normal Normal Normal 
9 Gripping 
strength 
Normal Normal Normal Normal Normal Normal 
10 Pinna reflux Present Present Present Present Present Present 
11 Corneal reflux Present Present Present Present Present Present 
12 Writhing Absent Absent Absent Absent Absent Absent 
13 Pupils Normal Normal Normal Normal Normal Normal 
14 Urination Normal Normal Normal Normal Normal Normal 
15 Salivation Normal Normal Normal Normal Normal Normal 
16 Skin colour Normal Normal Normal Normal Normal Normal 
17 Lacrimation Normal Normal Normal Normal Normal Normal 
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female Wister rats. So No-Observed-Adverse-Effect- Level (NOAEL) of 
OMA LEGHIYAM  with Honey/Ghee is 6000 mg/kg equal to human dose 
 
DISCUSSION 
OMA LEGHIYAM with Honey/Ghee was administered single time at 
the doses of 1000,2000,3000,5000 and 6000mg/kg to female Wister rats and 
observed for consecutive 14 days after administration. Doses were selected 
based on the pilot study and literature review. All animals were observed 
daily once for any abnormal clinical signs. Weekly body weight and food 
consumption were recorded. No mortality was observed during the entire 
period of the study. Data obtained in this study indicated no significance 
physical and behavioral signs of any toxicity due to administration of OMA 
LEGHIYAM with Honey/Ghee at the doses of 1000,2000,3000,5000 and 
6000mg/kg to female Wister rats  
At the 14th day, all animals were observed for functional and 
behavioral examination. In functional and behavioral examination, home 
cage activity, hand held activity were observed. Home cage activities like 
Body position, Respiration, Clonic involuntary movement, Tonic involuntary 
movement, Palpebral closure, Approach response, Touch response, Pinna 
reflex, Sound responses, Tail pinch response were observed. Handheld 
activities like Reactivity, Handling, Palpebral closure, Lacrimation, 
Salivation, Piloercetion, Papillary reflex, abdominal tone, Limb tone were 
observed. Functional and behavioral examination was normal in all treated 
groups. Food consumption of all treated animals was found normal as 
compared to normal group. 
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SUMMARY & CONCLUSION: 
Summary: 
The present study was conducted to know single dose toxicity of OMA 
LEGHIYAM with Honey/Ghee on female Wister rats. The study was 
conducted using 15 female Wister rats. The female animals were selected for 
study of 8- 12 weeks old with weight range of within ± 20 % of mean body 
weight at the time of randomization. The groups were numbered as group I, 
II, III, IV and V and dose with 1000,2000,3000,5000 and 6000mg/kg of OMA 
LEGHIYAM with Honey/Ghee. The drug was administered by oral route 
single time and observed for 14 days. Daily the animals were observed for 
clinical signs and mortality.  
There were no physical and behavioral changes observed in Female 
Wister rats during 14 days. Mortality was not observed in any treatment 
groups. 
Conclusion: 
The study shows that OMA LEGHIYAM with Honey/Ghee did not 
produce any toxic effect at dose of 1000,2000,3000,5000 and 6000mg/kg to rats. 
So No-Observed-Adverse-Effect-Level (NOAEL) of OMA LEGHIYAM with 
Honey/Ghee is 6000 mg/kg. 
 
7.0 ABBREVIATIONS 
No.   Number 
Mg  Milligram 
Kg   Kilogram 
LD50  Lethal Dose 50 
p.o  peros 
ML  Milliliter 
%   percentage 
R&D   Research and Development 
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g%   Gram percentage 
g  Gram 
NOAEL  No-Observed-Adverse-Effect-Level 
MLD   Minimum Lethal Dose 
MTD   Maximum Tolerated Dose 
OECD Organisation of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of 
Experiments on Animals 
 
8.0 REFERENCES: 
1. OECD. Guideline for Testing of Chemicals 423, Acute oral toxicity (acute toxic 
class method). December 2001. 
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SUB-ACUTE TOXICITY STUDY IN WISTER RATS TO EVALUATE 
TOXICITY PROFILE OF OMA LEGHIYAM WITH HONEY/GHEE  
      Objective 
 The objective of this study is to evaluate the toxic effects, if any, as a result of the 
repeated once daily oral administration of OMA LEGHIYAM WITH 
HONEY/GHEE to Wister Albino rats for a minimum period of 28 consecutive days. 
This study will provide information on any major toxic effects, target organs and a 
rationale for concluding the No-Observed-Adverse-Effect-Level (NOAEL) and/or No 
Observed Effect Level (NOEL) / LOEL (Low Observed Effect Level) and risk 
assessment in humans. 
1. Test Guidelines  
This study plan is prepared as per the following guidelines: 
Schedule – Y, Amendment version 2005, Drugs and Cosmetics Rules, 1945. 
OECD – 407 – Repeated dose 28-day Oral Toxicity Study in Rodents, Adopted 3 
October, 2008. 
1.1. Test System Details 
Species : Rat 
Strain  : Wister Albino  
Source    : Sree Venkateshwara Enterprises Pvt Ltd, Bangalore  
Age : 6-8 weeks  
Sex : Male / Female (nulliparous and non-pregnant) 
Body weight   : 160.0to 180.0 g 
1.2.  Acclimatization 
Animals will be allowed to acclimatize to the experimental room conditions for 
five days prior to the commencement of dosing. During the acclimatization 
period, the animals will be observed daily for any apparent adverse clinical signs. 
Prior to assignment to the study and commencement of treatment, a detailed 
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physical health examination will be performed on all animals by a veterinarian 
and animals with any evidence of ill health or poor physical condition will not 
selected for the study. 
1.3. Randomization and Grouping 
On the starting day of dosing, the animals will be weighed and health examination 
will be performed by veterinarian. Animals will be randomly allocated to different 
groups according to their body weight by using MS-Excel sheet as described in 
the randomization SOP. Animals will be divided into four groups (vehicle control, 
low, intermediate, and high dose). At the initiation of the treatment, the body 
weight variation between the groups did not exceed ±20% of the mean weight of 
each sex. 
1.4. Animal Identification 
In each cage, animals will be identified with numbers by marking at the base of 
the ear. The cages will be identified with an attached colored cage label showing 
study number, study code, group number, sex, dose, strain, species, cage number, 
route of administration and animal number. 
2. Animal Husbandry 
2.1. Animal Welfare and approval 
The study was approved by the IAEC (SLS) and Committee for the Purpose of 
Control and Supervision of Experiments on Animals (CPCSEA registration 
number: Abc14).Their recommendations regarding animal care and handling will 
be followed. 
2.2. Environmental Conditions 
The temperature of the experimental room will be maintained at 22±30C and the 
relative humidity between 30-70 %. The photoperiod will be 12 hours light and 12 
hours dark cycles  
2.3. Housing Conditions 
Two animals will be housed in autoclaved polypropylene rat cages (Size in mm=L 
x W x H: 430 x 290 x 160) using paddy husk as the bedding material. Each cage 
will be fitted with a top grill having provision for keeping rodent pellet feed and 
an autoclaved polypropylene water bottle with stainless steel drinking nozzle. 
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Cages will be placed on 3-tier racks and cage rotation will be performed every 
week. Cages will be changed at least twice a week. The cages and water bottles 
will be cleaned and autoclave sterilized. 
2.4. Sanitation 
Each day, the floor of the animal room will be swept and mopped. Cages and 
bedding material will be changed once in three days and water bottles will be 
changed daily. All the experimental procedures will be done in a clean 
environment. 
2.5. Feed 
The experimental animals will be provided with irradiated rodent pellet feed ad 
libitum supplied from Sai feeds Pvt ltd, Chennai . Feed will be withheld for four 
hours prior to blood collection and necropsy. 
2.6. Drinking Water 
Animals will be provided with filtered drinking water ad libitum  passed through 
water filter system (Aquaguard™) in autoclaved polypropylene bottles. Water 
bottles will be changed daily. Microbial analysis of water will be carried out once 
monthly and the report is maintained in the study file. 
3. Personnel Safety 
All personnel handling animals undergo regular medical examination. Protective 
clothing like apron, face mask, head cap, and gloves will be used to maintain hygienic 
conditions. 
4. Materials and Methods  
4.1. Preparation of Dose formulation 
The dose formulation will be prepared under aseptic conditions as per SLS, SOP.  
4.2. Route of Administration and Justification 
Administration will be by oral gavage, as it is one of the possible routes of exposure. 
4.3. Frequency and Duration of Administration  
Once daily for 28 consecutive days 
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4.4. Dosing Procedure 
The test item will be administered in once daily by oral gavage using a suitable 
intubation cannula fitted with a graduated syringe. The scheme of dosing and 
sacrifice time points are presented in the below below Table. 
4.5. Experimental Procedures 
All experimental procedures will be performed in accordance with the Study plan 
and Standard Operating Procedures (SOPs) of SLS. 
4.6 DOSAGE SCHEDULE: 
  The required dose for mice/rat will be calculated by using the standard dose 
calculation procedure from recommended clinical dose. 
 
CONVERSION FORMULA: 
Human dose is 6000 mg /kg day 
Total clinical dose (a) x conversion factor (b) 0.018 = (c) per 150 gm of Rat 
6000 mg x 2(a) x 0.018 (b) = 108 (c) /150 gm of Rat 
108/1000x150 = 16.2 mg  
Experimental Doses Calculated as per the standard procedures are 
 
S.No 
 
Groups 
 
Dose /kg, weight 
 
Volume of 
administration 
 
1 Vehicle Control -- 1 ml 
 
2 Therapeutic Dose 16.2 mg /kg 
 
1 ml 
3 Middle  Dose 81mg/kg 1 ml 
 
4 High Dose 405mg/kg 1 ml 
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Experimental Design 
 
5. Observations 
Animals will be observed daily throughout the treatment period at regular intervals. 
During the treatment period, animals will be observed twice daily for any clinical 
signs of toxicity, morbidity and mortality. All the surviving animals will be sacrificed 
at the end of scheduled period and subjected to gross necropsy and histopathological 
evaluations. 
5.1.Clinical Signs 
All the animals will be subjected to cage-side (home-cage) observations twice a 
day for any clinical signs of toxicity, preferably at the same time each day and 
considering the peak period of anticipated effect. In addition to home cage 
observations, a detailed clinical examination will be performed once prior to 
dosing and weekly thereafter during treatment period.  
5.2. Morbidity/ Mortality 
All animals will be examined twice a day for mortality and signs of morbidity.  
Group 
No. Group 
Dose                          
(mg/kg  
b.wt /day) 
No. of Animals 
Male Female 
G1 Vehicle control HONEY/GHEE 5 
5 
G2 Low dose of  OMA LEGHIYAM WITH HONEY/GHEE 
               
16.2m g /kg 
 
5 5 
G3 
Intermediate dose OMA 
LEGHIYAM WITH 
HONEY/GHEE   
81mg/kg 5 5 
G4 High dose  OMA LEGHIYAM WITH HONEY/GHEE   
405mg/kg 5 5 
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5.3. Body Weights 
Body weights will be recorded at the beginning of acclimatization, before 
randomization, there after at weekly intervals and at the time of necropsy. 
5.4. Feed Consumption 
Feed consumption will be calculated on a weekly basis throughout the study 
period. 
5.5. Hematology and Clinical Biochemistry  
Hematology and clinical biochemistry tests will be performed with terminally 
collected blood samples on day-29 from all animals. Animals will be deprived of 
feed overnight and blood samples will be collected by tapping the ear for visibility 
of the vein site and inserted the needle into the marginal ear vein and collected the 
blood into micro centrifuge tube. Approximately 0.5 ml of blood will be collected 
in vials containing 1% EDTA (20µl) as an anticoagulant for hematological 
analysis. 
Approximately 2 ml blood will be collected from each animal in micro centrifuge 
tubes containing 15µl of heparin (19 units) and the plasma will be separated by 
centrifugation at 4000 rpm for ten minutes at 4oC. The plasma will be stored at -20 
oC ± 2 and used for all clinical chemistry analysis. 
5.6. Hematology 
Erythrocyte count (RBC), Total Leucocyte count (WBC), Hemoglobin (Hb), 
Hematocrit (HCT), Mean Corpuscular Volume (MCV), Mean Corpuscular 
Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC) and 
Platelet (PLTC). 
5.7. Clinical Biochemistry  
Glucose, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), 
Alkaline phosphatase (ALP), Total protein, Albumin, Creatinine, Urea, 
Cholesterol, Triglycerides, Sodium, Potassium, Calcium, and  Chloride. 
5.8 Pathology 
All animals will be euthanized by CO2 asphyxiation and subjected to necropsy 
under the supervision of the veterinary pathologist. Different tissues/organs of 
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thoracic, abdominal and cranial cavities will be examined for any gross 
pathological changes. Tissues from vehicle control and high dose groups will be 
subjected to detailed histopathological analysis (Ovaries/ testes,  kidneys, liver, 
lungs). The organs will be fixed using Bouin’s (reproductive organs) and 10% 
neutral buffered formalin (kidneys, liver, spleen, lungs).Processing of tissue will 
be done by spin tissue processer, embedding of the tissue by tissue embedder. The 
tissues will be initially trimmed to 10-20µ thickness and later 3-6µ to obtain 
thinner tissue sections by using rotary microtome. Haematoxylin and Eosin 
staining will be performed for all tissues. 
5.8. Organ Weights 
Absolute weights of adrenal glands, brain, ovaries/testes, epididymis/uterus, 
heart, kidneys, liver, spleen and lungs will be recorded for all the animals after 
trimming adherent tissue immediately after dissection from the animal. Paired 
organs will be weighed together. Relative weights of these organs against fasting 
animal body weights will be calculated and reported. 
6. Data Compilation  
Data will be summarised in a tabular form showing the number of animals, 
experimental design, dose groups, dose volume and concentrations, test item and 
vehicle control details. All findings like clinical signs, mortality and morbidity data, 
time of death, body weights, feed consumption, clinical signs, and necropsy and 
pathology observations will be recorded and given in the final report. One original 
copy of the final report is issued to the sponsor.  
7. Statistical Analysis 
All the parameters of treated groups of both sex, viz. body weight, feed consumption, 
organ weights (absolute and relative), biochemical parameters, and hematology 
parameters will be analyzed using SPSS software, version 16.0 by using one-way 
ANOVA test with multiple comparison (vehicle controls treated groups) in the study 
report, and p value < 0.05 is considered as statistically significant.  
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MATERIALS AND METHODS 
         ESTIMATION OF HEMATOLOGICAL PARAMETERS: 1 
Collection of blood for hematological studies 
After the treatment period the animals were anaesthetized by ketamine hydrochloride and the 
blood was collected from Retro-orbital sinus by using capillary into a centrifugation tube 
which contains EDTA for haematological parameters The haematological parameters like 
RBC, WBC and Hb percentage, Differential cell count, MCV, MCHC, Hematocrit, MCH, 
platelet count were estimated by the following procedures. 
1. ENUMERATION OF RED BLOOD CELLS: 1    Ramnic 2007) 
Reagents : RBC diluting fluid 
       Procedure: 
         Using a red blood cell pipette of haemocytometer, well mixed blood was drawn up to 0.5 mark and 
RBC diluting fluid was taken up to mark II. The fluid blood mixture was shaken and transferred onto the 
counting chamber. The cells were allowed to settle to the bottom of the chamber for 2 min. See the fluid 
does not get dried. Using 45X or high power objective the RBC’s were counted uniformly in the larger 
corner squares.   
The cells were expressed as number of cells x1012/l 
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2. ENUMERATION OF WBC: 2    John 1972) 
      Reagents: 
 Turk’s fluid: Turk’s fluid was prepared by mixing 2ml of acetic acid with 100 ml of 
distilled water. To this 10 drop of aqueous methylene blue 3 %    w/v) was added. This solution 
haemolysis the red cells due to acidity so that counting of white cells becomes easy. 
Procedure:     
              Using a white blood cell pipette of haemocytometer, well mixed blood was drawn up to 0.5 mark 
and WBC diluting fluid was taken up to mark II. The fluid blood mixture was shaken and transferred onto 
the counting chamber. The cells were allowed to settle to the bottom of the chamber for 2 min. See the fluid 
does not get dried. 
 Using 10X or low power objective the WBC’s were counted uniformly in the larger corner 
squares.  
 The cells were expressed as number of cells/10mm. 
3. DIFFERENTIAL LEUCOCYTE COUNT: 3      John 1972) 
Reagent: 
              Leishmann’s stain: 150mg of powdered leishmann’s stain was dissolved in 133ml of acetone free 
methanol. 
Procedure: 
 A blood film stained with leishmann’s stain was examined under oil immersion and the different 
types of WBCs were identified. The percentage distribution of these cells was then determined. Smears 
were made from anticoagulant blood specimens and stained with leishmann’s stain. The slides were 
preserved for counting the number of lymphocytes and neutrophils, per 100 cells were noted.  
 From the different Leukocyte count and WBC count, absolute lymphocyte and neutrophil count 
were calculated. 
                                 Number of neutrophils  
 Absolute neutrophil count =   _______________________________   x  TWBC 
                             100  
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                                                                  Number of lymphocytes  
 Absolute lymphocyte count =   _______________________________ x TWBC 
                             100 
DETERMINATION OF BIOCHEMICAL PARAMETERS: 
 
For assessment of biochemical parameters, blood samples were collected from the animals by 
puncturing the retro-orbital plexus and centrifuged. The serum collected after centrifugation was analyzed 
for various biochemical parameters like SGOT, SGPT, ALP,TC.TG,HDL All of the above biochemical 
parameters were estimated using semi autoanalyzer (Photometer 5010 V5+, Germany) with enzymatic kits 
procured from Piramal Healthcare limited, Lab Diagnostic Division, Mumbai, India. 
1. Total Cholesterol (TC)  
 Principle 
Determination of cholesterol is done after enzymatic hydrolysis and oxidation. The colorimetric 
indicator is quinoneimine, which is generated from 4-aminoantipyrine and phenol by hydrogen peroxide 
under the catalytic action of peroxidase (trinder’s reaction). 
Cholesterol ester + H2O       CHE       Cholesterol + Fatty acid 
Cholesterol + O2          CHO      Cholesterol-3-one +H2O2 
2H2O2  + 4- Amino antipyrine + Phenol      POD          Quinonelimine + 4 H2O2 
Method  
 CHOD-PAP: Enzymatic photometric test 
Table 6: Reagents 
Goods buffer (pH 6.7) 50 mmol/ l 
Phenol 5 mmol/l 
4-aminoantipyrine 0.3 mmol/l 
Cholesterol estrase >  200 U/l 
Cholesterol oxidase >  100 U/l 
Peroxidase 3 KU/l 
Standard (5.2 mmol/l) 
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Assay procedure 
a. 1 ml (1000 µl) of reagent-1 is taken in a 5 ml test tube. 
b.  Added 0.01 ml (10 µl) of serum. 
c. Mixed well and incubated at 37◦C   for 5 min. 
d. Read the test sample. 
NORMAL RANGE: < 200 mg/dl in serum.      
1. Deeg R, Ziegenhorn J, Kinetic enzymatic method for automated determination of total cholesterol 
in serum, Clin. Chem., 1983, 29:1798-802. 
2. Triglycerides 
Principle 
Determination of triglycerides (TG) alters enzymatic splitting with lipoprotein lipase. Indicator is 
quinoneimine which is generated from 4-aminoantipyrine and 4- chlorophenol by hydrogen peroxidase 
under the catalytic action of peroxidase. 
Triglycerides              LPL           Glycerol + fatty acid 
Glycerol + ATP              GK            Glycerol-3-phosphate+ ADP 
Glycerol-3-phosphate +O2         GPO         Dihydroxyaceton phosphate + H2O2 
2H2O2  + 4- Amino antipyrine + 4- chlorophenol         POD     Quinonelimine + HCL + 4H2O2 
Method 
 Colorimetric enzymatic test using glycerol-3-phosphate-oxidase (GPO). 
Reagents 
Components and concentrations in the test Goods buffer pH 7.2, 50 mmol/ l 
Table 7: Reagents 
4-chloroPhenol 4 mmol/l 
ATP 2 mmol/l 
Mg2+ 15 mmol/l 
Glycerokinase > 0.4 Kµ/l 
Peroxidase > 2 Kµ/l 
Lipoprotein lipase > 4 Kµ/l 
4-aminoantipyrine 0.5 mmol/l 
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Glcerol-3-phosphate- oxidase > 1.5Kµ/l 
Standard (2.3 mmol/l) 
 
Assay procedure 
a.  1 ml (1000 µl) of reagent-1 is taken in a 5 ml test tube. 
b. Added 0.01 ml (10 µl) of serum. 
c. Mixed well and incubated at 37◦C for 15 min. 
d. Read the test sample. 
 Normal Range: < 200 mg/dl in serum. 
1. Cole T.G, Klotzsch S.G, Mcnarmara J, Measurement of triglyceride concentration, In Rifai N, 
Warnick G.R, Dominiczak M.H, Handbook of lipoprotein testing, Washington:AACC, Press, 1997, 
115-26. 
3. HDL Cholestrol 
 Principle  
Chylomicrons, VLDL and LDL are precipitated by adding phosphotungstic acid and magnesium ions 
to the sample. Centrifugation leaves only the HDL in the supernatant. The cholesterol content in it is 
determined enzymatically. 
Method 
Phosphotungstic acid precipitation method. 
Table 8: Reagents 
Phosphotungstic acid 0.55 mmol/l 
Magnesium chloride 25 mmol/l 
Assay procedure 
A.  Preparation of supernatant for the HDL-CHL estimation 
    Added 200 µl of serum to the 500 µl of HDL-Cholesterol precipitating reagent (from HDL kit) in 1.5 ml 
centrifuge tube and mixed well. Centrifuged the above solution at 4000 rpm for 10 min. 
B. Preparation of test sample for the estimation of HDL-Cholesterol 
a. Taken 1000 µl of reagent-1 (from cholesterol kit) in a 5 ml test tube. 
b. Added, 100 µl of supernatant from above centrifuged solution 
c. Mixed well and incubated at 37◦C for 15 min. 
d. Read the test sample.  
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Normal Range: > 60 mg/dl in serum. 
1. Friedewald W.T, Levy R.T, Frederickson D.S, Estimation of VLDL and LDL cholesterol, Clin. 
Chem., 1972, 18:499-502. 
4. ESTIMATION OF SERUM GLUTAMATE PYRUVATE TRANSAMINASES (SGPT/ ALT) 
1. Determination of aspartate aminotransferase (AST) 
      Aspartate aminotransferase, also known as Glutamate Oxaloacetate Transaminase (GOT) 
catalyses the transamination of L-aspartate and α keto glutarate to form oxaloacetate and L- glutamate. 
Oxaloacetate formed is coupled with 2,4- Dinitrophenyl hydrazine to form hydrazone, a brown coloured 
complex in alkaline medium which can be measured colorimetrically. 
Reagents  
Buffered aspartate  (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  working pyruvate standard; 
solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with purified water). 
Procedure  
  Rietman and Frankle method was adopted for the estimation of SGOT. (Reitmann S, 
Frankel S, 1957. A colorimetric method for the determination of serum oxaloacetic and glutamic pyruvate 
transminases. American Journal of Clinical Pathology.28: 56-63.The reaction systems used for this study 
included blank, standard, test (for each serum sample) and control (for each serum sample). 0.25 ml of 
buffered aspartate was added into all the test tubes. Then 0.05 ml of serum was added to the test group tubes 
and 0.05 ml of working pyruvate standard into the standard tubes. After proper mixing, all the tubes were 
kept for incubation at 37oC for 60 min, after which 0.25 ml each of 2,4- DNPH reagent was added into all 
the tubes. Then, 0.05 ml of distilled water and 0.05 ml of each serum sample was added to the blank and the 
serum control tubes respectively. The mixture was allowed to stand at room temperature for 20 min. After 
incubation, 2.5 ml of solution I was added to all test tubes. Mixed properly and optical density was 
measured in a spectrophotometer at 505 nm within 15 min. 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) = [(Absorbance of test - Absorbance of control)/ (Absorbance of standard - 
Absorbance of blank)] x concentration of the standard         
2.  Determination of alanine aminotransferase (ALT) 
 Alanine aminotransferase, also known as Glutathione Peroxidase (GPT) catalyses the 
transamination of L-alanine and α keto glutarate to form pyruvate and L- Glutamate. Pyruvate so formed is 
coupled with 2,4 – Dinitrophenyl hydrazine to form a corresponding hydrazone, a brown coloured complex 
in alkaline medium which can be measured colorimetrically. 
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Reagents 
Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working pyruvate standard, solution I 
(prepared by diluting 1 ml of reagent 3 to 10 ml with purified water). 
Procedure  
 Rietman and Frankle method was dopted for the estimation of SGPT. The reaction systems used 
for this study included blank, standard, test (for each serum sample) and control (for each serum sample). 
0.25 ml of buffered alanine was added into all the test tubes. This was followed by the addition of 0.05 ml 
of serum into the test group tubes and 0.05 ml of working pyruvate standard into the standard tubes. After 
proper mixing, all the tubes were kept for incubation at 37oC for 60 minutes, after which 0.25 ml each of 
2,4- DNPH reagent was added into all the tubes. Then, 0.05 ml of distilled water and 0.05 ml of each serum 
sample was added to the blank and the serum control tubes respectively. The mixture was allowed to stand 
at room temperature for 20 min. After incubation, 2.5 ml of solution I was added to all test tubes. Mixed 
properly and optical density was read against purified water in a spectrophotometer at 505 nm within 15 
min. 
  The enzyme activity was calculated as:- ALT (GPT) activity in IU/L) = [(Absorbance of test - 
Absorbance of control)/ (Absorbance of standard - Absorbance of blank)] x concentration of the standard.        
 3. Determination of alkaline phosphatase (ALP) 
  Alkaline phoshatase from serum converts phenyl phosphate to inorganic phosphate and phenol at 
pH 10.0. Phenol so formed reacts in alkaline medium with 4-aminoantipyrine in presence of the oxidising 
agent potassium ferricyanide and forms an orange-red coloured complex, which can be measured 
spectrometrically. The color intensity is proportional to the enzyme activity. 
Reagents: 
Buffered substrate 
Chromogen Reagent 
Phenol Standard, 10 mg% 
Procedure: 
  ALP was determined using the method of Kind (Kind PRM, King EJ, 1972. In-vitro determination 
of serum alkaline phosphatase. Journal of Clinical Pathology 7: 321-22\). The working solution was 
prepared by reconstituting one vial of buffered substrate with 2.2 ml of water. 0.5 ml of working buffered 
substrate and 1.5 ml of purified water was dispensed to blank, standard, control and test. Mixed well and 
incubated at 370C for 3 min. 0.05 ml each of serum and phenol standard were added to test and standard test 
tubes respectively. Mixed well and incubated for 15 min at 370C. Thereafter, 1 ml of chromogen reagent 
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was added to all the test tubes. Then, added 0.05 ml of serum to control. Mixed well after addition of each 
reagent and the O.D of blank, standard, control and test were read against purified water at 510 nm. 
Serum alkaline phosphatase activity in KA units was calculated as follows  
[(O.D. Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
 
4. Determination of bilirubin  
  In toxic liver, bilirubin levels are elevated. Hyperbilirubinemia can result from impaired hepatic 
uptake of unconjugated bilirubin, such a situation can occur in generalized liver cell injury, certain drugs 
(e.g Rifampin and probenecid) interfere with the rat uptake of bilirubin by the liver cell and may produce a 
mild unconjugated hyperbilirubinemia. Bilirubin level rises in diseases of hepatocytes, obstruction to 
bilirubin excretion into duodenum, in haemolysis and defects of hepatic uptake and conjugation of Bilirubin 
pigment such as Gilbert’s disease.  
Elevation of total serum bilirubin may occur due to:  
1.Excessive haemolysis or destruction of the red blood cells.Eg:Haemolytic disease of the new 
born. 
2.Liver diseases.Eg.Hepatitis and cirrhosis. 
3.Obstruction of the biliary tract.Eg.Gall stones. 
  The method is based on the reaction of Sulfonilic acid with sodium nitrite to form azobilirubin 
which has maximum absorbance at 546nm in the aqueous solution. The intensity of the color Produced is 
directly proportional to the amount of direct or total bilurubin concentration present in the sample. 
Reagents 
1. Diazo A-(Reagent-R1) :Ready to use 
2. Diazo B-(Reagent-R2):Ready to use 
3. Bilirubin Activater :Ready to use 
Procedure 
  Kind & King’s method was followed for the estimation of Bilirubin. Five hundred µl of working 
reagent was added to 50 µl of rat serum & incubated for 5 min at 37°C. Absorbance was measured AT 546 
NM in semi auto analyzer against the standard. 
The Bilirubin content was calculated using the following equation: 
Total bilirubin (mg/dt) = Abs of the sample blank x 15. 
Direct Bilirubin(mg/dt) = Abs of sample blank x 10. 
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5. ESTIMATION OF UREA 
Urea is the nitrogen-containing end product of protein catabolism. States associated with elevated 
levels of urea in blood are referred to as hyper uremia or azotemia.  
Method 
Estimation of urea was done by Urease-GLDH: enzymatic UV test.  
Principle 
Urea + 2H2O     Urease       2NH4 + 2HCO3 
2- Oxoglutarate +NH4+ +NADH      GLDH      L- Glutamate +NAD+ + H2O                                         
Table 14. Reagents 
 
 
 
 
 
 
 
 
Procedure 
a. Take 1000 µl of reagent-1 and 250 µl of reagent-2 in 5 ml test tube. 
b. To this, add 10 µl of serum. 
c. Mix well and immediately read the test sample at 340 nm Hg 334 nm Hg 365 nm optical path 1 cm 
against reagent blank (2-point kinetic). 
d. And note down the value. 
Normal range: 10 – 50 mg/dl. 
6. ESTIMATION OF URIC ACID 
Uric acid and its salts are end products of the purine  metabolism. In gout the most common 
complication of  hyperuricemia, ie. Increased serum levels of uric acid lead to formation of  monosodium 
urate crystal around the joints. 
  
R 1 
TRIS pH 7.8 120  mmol/l 
2-Oxoglutarate 7 mmol/l 
ADP 0.6 mmol/l 
Urease ≥ 6 KU/l 
GLDH ≥ 1 KU/l 
R 2 NADH 0.25 mmol 
R 3 Standard 40 mg/dl 
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Method  
Enzymatic photometric test using  TOOS (N ethyl- N (hydroxyl -3- sulfopropyl)-m- toluidin) 
Principle  
Uric acid + H2O + O2       uricase         Allantoin +CO2 +H2O2 
TOOS + 4 aminoantipyrine + 2H2O2      POD       Indamine + 3H2O 
Table 15.reagents 
R1 Phosphate buffer pH 7.0 100mmol/l 
TOOS 1mmol/l 
Ascorbate oxidase ≥1 KU/l 
R2 Phosphate buffer pH 7.0 100mmol/l 
4- amino antipyrine 0.3mmol/l 
K4 (Fe( CN)6) 10µmol/l 
Peroxidase ≥1KU/l 
Uricase ≥50U/l 
Procedure 
a. Take 800µl of  reagents -1 in a2ml centrifuge tube. 
b. To this add 20µl of serum. 
c. Mix well and incubate at 30°c for 5 minutes. 
d. Then add 200µl of reagent2 
e. Mix well incubate for 5min at 37°c 
f. Measure the not down the values. 
Normal range: 1.9-8.2mg/dl 
7. ESTIMATION OF CREATININE:  
Principle: 
Creatinine forms a coloured complex with picrate in alkaline medium.  
The rate of formation of the complex is measured.  
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Reagents: 
Reagent 1    Standard Creatinine (2mg/100ml) 
Reagent 2    Picric acid solution. 
Reagent 3     sodium hydroxide solution  
Procedure: 
 Take 500 µl of reagent -2 and 500 µl of reagent -3 in a 5ml test tube. To this add 100 µl of serum. 
Mix well and immediately read the test sample at Hg 492 nm 1cm light path and note down the values.  
Normal range is 0.6 -1.1 mg/dl 
TABLE: 1   EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF OMA LEGHIYAM WITH 
HONEY/GHEE ON BODY WEIGHT IN Gram (PHYSICAL PARAMETER) 
GPs Control Low Dose Middle Dose High Dose 
 Male Female Male Female Male Female Male Female 
1stwk 120.7± 
0.6667 
106.7± 
2.404 
110.3± 
0.8819 
114± 
2.309 
119± 
1.732 
116± 
3.786 
117.7± 
2.603 
128.7± 
4.807 
2ndwk 127±1 
 
117.7± 
0.8819 
119.3± 
0.6667 
121± 
3.512 
126.7± 
0.6667 
128± 
6.083 
126.3± 
2.186 
134.7± 
4.807 
3rdwk 135.3± 
1.764 
129.7± 
1.202 
128.3± 
0.3333 
130.7± 
3.712 
134.3± 
0.8819 
136.3± 
4.631 
136.3± 
1.764 
141.3± 
5.897 
 
4thwk 
149.7± 
2.728 
143± 
2.309 
137.3± 
1.453 
145± 
4.583 
105.3± 
44.7 
150.3± 
4.667 
150.3± 
2.404 
154.7± 
4.91 
Values are expressed as the mean ± S.D 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF OMA LEGHIYAM WITH HONEY/GHEE ON 
FOOD INTAKE In Gram  
Groups Control Low Dose Middle Dose High Dose 
 
DAY Male Female Male Female Male Female Male Female 
Day 1 
60 12 58 68 32 72 56 44 
DAY2 
50 14 61 88 58 56 28 38 
DAY3 
32 44 18 40 26 56 77 34 
Day 4 
80 56 22 60 48 56 74 42 
DAY5 
74 62 45 56 64 62 54 38 
Day 6 
44 54 68 58 30 64 58 58 
DAY7 
54 60 38 62 56 72 34 62 
DAY8 
72 56 38 44 57 62 34 58 
Day 9 
38 19 54 50 16 42 56 56 
DAY10 
48 36 64 71 82 34 46 24 
Day 11 
56 78 54 42 56 68 54 70 
DAY12 
56 78 64 58 44 64 40 62 
DAY13 
45 52 34 56 72 56 64 54 
Day 14 
50 48 62 56 88 58 68 56 
DAY15 
16 35 20 75 35 61 88 74 
Day 16 
56 64 68 56 64 53 24 62 
DAY17 
34 18 58 64 78 42 58 64 
DAY18 
67 58 18 28 64 56 14 74 
Day 19 
46 64 30 42 34 78 22 74 
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DAY20 
88 80 34 80 55 44 26 56 
DAY21 
52 46 58 42 56 64 64 80 
Day 22 
56 80 56 45 32 38 74 56 
DAY23 
24 74 62 36 58 34 62 64 
DAY24 
28 15 10 18 34 28 64 64 
Day 25 
62 56 31 28 38 62 58 56 
DAY26 
30 44 52 66 38 30 56 45 
DAY27 
18 34 24 18 44 65 48 56 
DAY28 
34 10 18 6 44 58 78  
 
Values are expressed as the mean ± S.D 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF OMA LEGHIYAM WITH HONEY/GHEE ON 
WATER INTAKE IN ml 
Groups Control Low Dose Middle Dose High Dose 
 
DAY Male Female Male Female Male Female Male Female 
Day 1 
80 65 80 95 70 50 140 70 
DAY2 
75 60 70 50 60 70 125 65 
DAY3 
125 110 85 60 70 60 50 70 
Day 4 
90 60 50 70 110 40 140 105 
DAY5 
50 70 40 110 60 140 165 130 
Day 6 
110 60 85 75 60 125 90 70 
DAY7 
75 85 140 70 100 50 75 60 
DAY8 
60 85 60 50 85 140 70 85 
Day 9 
60 85 60 70 150 165 90 55 
DAY10 
90 40 55 80 100 90 30 60 
Day 11 
210 60 70 130 70 75 20 70 
DAY12 
70 90 50 65 60 70 60 70 
DAY13 
80 50 130 60 70 90 60 40 
Day 14 
60 50 70 75 50 70 20 55 
DAY15 
40 80 55 130 20 130 170 140 
Day 16 
60 65 80 95 70 50 185 140 
DAY17 
75 60 70 50 60 70 75 50 
DAY18 
125 110 85 60 70 60 95 85 
Day 19 
90 60 50 70 110 40 90 60 
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DAY20 
50 70 40 110 60 140 70 50 
DAY21 
110 60 85 75 60 125 60 70 
Day 22 
75 85 140 70 100 50 70 60 
DAY23 
60 85 60 50 85 140 85 140 
DAY24 
60 85 60 70 150 165 85 60 
Day 25 
90 40 55 80 100 90 85 60 
DAY26 
210 60 70 130 70 75 85 140 
DAY27 
70 90 50 65 60 70 85 60 
DAY28 
80 50 130 60 70 90 85 60 
 
Values are expressed as the mean ± S.D 
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EFFECT OF SUB-ACUTE DOSES (28 DAYS) OF OMA LEGHIYAM WITH 
HONEY/GHEE ON ORGAN WEIGHT in gm 
 
 
Values arae expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group. 
 
GROUP CONTROL 
 
Low Dose 
 
Middle Dose 
 
High Dose 
LIVER  WEIGHT 6.835±0.055 6.664±0.118 5.906±0.0295 6.579±0.2535 
KIDNEY 
WEIGHT 
L 0.8145±0.025
5 0.8585±0.0145 0.7445±0.0125 0.7265±0.0385 
R 0.776±0.108 0.703±0.026 0.643±0 0.63±0.052 
HEART WEIGHT 0.708±0.02 0.6435±0.0115 0.7285±0.0165 0.7615±0.0265 
LUNGS  WEIGHT 1.181±0.1975 0.7305±0.1625 0.7505±0.0175 1.174±0.3845 
TESTIS WEIGH 3.041±0.0575 2.725±0.057 2.621±0.273 2.161±0.179 
UTERUS 0.5135±0.054
5 0.4045±0.0165 0.48±0.043 0.3575±0.0315 
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F OMA LEGHIYAM WITH HONEY/GHEE ON 
HAEMATOLOGICAL PARAMETERS 
Groups Control Low Dose Middle Dose High Dose 
Rbc (X103/µl)  
 
5.32±0.7614 
 
6.98±0.4179 
 
5.8±0.3553 
 
5.217±0.726 
 
Wbc(X106/µl)  
 
11.33±0.7753 
 
12.1±1.222 
 
13.1±0.9074 
 
12.03±1.053 
 
 
Hb (g/dl) 
 
15.2±1.365 
 
17.73±1.059 
 
12.5±1.3 
 
13.7±1.266 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 
0.05 calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F OMA LEGHIYAM WITH HONEY/GHEE ON 
BIOCHEMICAL PARAMETER (LIVER PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
Total 
Bilirubin(mg/dl) 
 
0.5725±0.06277 
 
0.815±0.08665 
 
0.7725±0.04697 
 
0.84±0.112 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 
0.05 calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F OMA LEGHIYAM WITH HONEY/GHEE ON 
BIOCHEMICAL PARAMETER (LIVER PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
 
SGOT (U/L) 
 
77.73±6.929 
 
116.2±19.57 
 
85.83±3.636 
 
81.13±1.255 
 
SGPT (U/L) 61.96±8.474 
 
55.79±4.079 
 
54.67±10.04 
 
39.27±1.796 
 
ALP (U/L) 296.3±13.05 
 
301.9±15.44 
 
270±16.31 
 
263.8±2.509 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p) calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 
0.05 calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F OMA LEGHIYAM WITH HONEY/GHEE ON 
BIOCHEMICAL PARAMETER (KIDNEY PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
Urea (mg/dl) 33.03±4.969 
 
30.23±2.277 
 
38.87±0.5048 
 
29.66±2.116 
 
Uric acid 
(mg/dl) 
1.483±0.1082 
 
0.9525±0.1752* 
 
1.473±0.119 
 
1.553±0.07364 
 
Creatinine 
(mg/dl) 
0.3325±0.02056 
 
0.2275±0.03425 
 
0.2025±0.02056* 
 
0.28±0.03742 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 
0.05 calculate by comparing treated group with CONTROL group.         
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EFFECT OF SUB ACUTE DOSES (28 DAY) 0F OMA LEGHIYAM WITH HONEY/GHEE ON 
BIOCHEMICAL PARAMETER (LIPID PROFILE) 
Groups Control Low Dose Middle Dose High Dose 
Total 
cholesterol 
(mg/dl) 
38.43±3.23 
 
48.85±2.857 
 
50.83±5.302 
 
45±2.724 
 
Triglycerides 
(mg/dl) 
103.5±2.552 
 
73.9±2.585 
 
92.05±16.84 
 
91.93±8.302 
 
HDL-
Cholesterol 
(mg/dl) 
8.47±1.149 
 
8.45±1.515 
 
5.825±1.017 
 
7.625±2.655 
 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 
0.05 calculate by comparing treated group with CONTROL group.         
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RESULTS: 
    CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   
period of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout the 
dosing period of 28 days. 
 Body weight: 
Results of body weight determination of animals Table-1 from control and 
different dose groups exhibited comparable body weight gain throughout the dosing 
period of 28 days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food consumed 
by animals from different dose groups was found to be comparable with that by control 
animals. 
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Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in Table 
No.4 Comparison of organ weights of treated animals with respective control animals on 
day 29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations (Table 4) conducted on day 29 
revealed following significant changes in the values of different parameters investigated 
when compared with those of respective controls; however, the increase or decrease in the 
values obtained was within normal biological and laboratory limits or the effect was not 
dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on days 29 and recorded in Table 
2 revealed the following significant changes in the values of hepatic serum enzymes 
studied. When compared with those of respective control. However, the increase or 
decrease in the values obtained was within normal biological and laboratory limits. 
Histopathology: 
In histopathological examination, revealed normal architecture in comparison with 
control and treated animal. 
 DISCUSSION: 
1)  All the animals from control and all the treated dose groups up to 500 mg/kg survived 
throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during the 
dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain with 
that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
177 
 
5)   Haematological analysis conducted at the end of the dosing period on day 29, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found to be 
comparable with that of respective controls. 
8) Histopathological examination revealed normal architecture in comparison with 
control and treated animal. 
 SUMMARY AND CONCLUSION:  
In conclusion OMA LEGHIYAM WITH HONEY/GHEE can be considered 
safe, as it did not cause either any lethality or adverse changes with general behavior of 
rats and also there were no observable detrimental effects (100 to 300 mg/kg body 
weight) over a period of 28 days. Our results have demonstrated that the OMA 
LEGHIYAM WITH HONEY/GHEE is relatively safe when administered orally in rats. 
9.0 ABBRVIATION 
No.   Number 
Mg  Milligram 
Kg   Kilogram 
LD50  Lethal Dose 50 
p.o.  peros 
mL  Milliliter 
%   percentage 
R&D   Research and Development 
EDTA  Ethylene Diamine Tetra Acetic Acid 
M   Male 
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g%   Gram percentage 
g  Gram 
NOAEL  No-Observed-Adverse-Effect-Level 
MLD   Minimum Lethal Dose 
MTD   Maximum Tolerated Dose 
OECD  Organisation of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of Experiments on 
Animals 
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HISTOPATHOLOGY   -  TOXICITY STUDY 
SPECIMEN     : A) Liver.    Group –    : Oma legiyam . 
                                                       
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
 Section from liver shows lobular architecture with interface hepatitis. Individual Hepatocytes 
shows reactive atypia. Portal triad shows no significant pathology. Central vein and Sinusoids 
show dilatation. 
SPECIMEN    :  B) spleen. 
10x shows normal lobular architecture with  
portal tract 
10x shows normal lobular architecture 
40x shows central vein congestion 40x shows individual hepatocytes shows no 
significant pathology 
40x shows mild periportal inflammation 40x shows sinusoidal dilatation 
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Group – :  Oma legiyam  
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
        Section studied from spleen shows normal white pulp and red pulp. Red pulp shows 
pigment laden macrophages and congested vessels. White pulp shows lymphocytic infiltrates 
forming germinal centre. The pencillar artery shows normal morphology. Megakaryocytes 
10x shows normal spleen with white pulp shows 
germinal centre formation and pencillar artery 
10x shows normal spleen 
40x shows normal pencillar artery 40x shows normal red pulp 
40x shows red pulp 40x shows white pulp with lymphocytic 
infiltration 
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    SPECIMEN  :  C)  Kidney. 
Group – :  Oma legiyam  
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE: 
 
 Section from kidney shows both cortex and medulla. Glomeruli and tubules shows no significant 
pathology. Interstitium shows no significant pathology. Blood vessels show congestion. There is 
no evidence of toxic changes. 
  
10x shows normal kidney 10x shows kidney with both cortex and 
medulla and blod vessels congestion 
10x shows normal glomeruli and tubules 10x shows normal interstitium 
10x shows normal interstitium 10x shows normal interstitium 
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SPECIMEN  :  D) Testis 
Group – :  Oma legiyam  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MICROSCOPIC APPEARANCE:  
           Section from testes with seminiferous tubules showing maturation arrest with lacking of 
spermatogenesis.  
  
 
10x shows normal seminiferous tubules 40x shows leydig cell 
40x shows normal maturation 40x shows normal semini ferous tubules 
40x shows normal spermatogenesis 40x shows varying stages of maturation 
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Name   : 
Ref. No. : [H0 330A/18] 
 
 
Rec.On :  21/03/2018 
Rep.On :  18/04/2018 
 
HISTOPATHOLOGY 
              TOXICITY STUDY            
 
 
SPECIMEN                   :  A) Liver 
    
Group –                   : Dr.Murugavel - OMA legyam. 
 
GROSS APPEARANCE: 
 
                     Received a specimen of liver measuring 3.5x2.3x1.4cms.                     
  
(PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section from liver shows normal lobular architecture. Individual Hepatocytes shows 
no pathology. Portal triad shows mild periportal inflammation. Central vein shows congestion. 
Sinusoids show dilatation. 
 
 
        
                                                                                                                             
Dr.C.R.Ajeethkumar.M.D. (Path). 
             
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path),   Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
Checked 
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Name   : 
Ref. No. : [H0 330B/17] 
 
Rec.On :  21/03/2018 
Rep.On :  18/04/2018 
 
HISTOPATHOLOGY 
         Toxicity study                
 
SPECIMEN                   :  B) spleen. 
    
Group –                   : Dr.Murugavel - OMA legyam 
 
GROSS APPEARANCE:  
 
                     Received a specimen of spleen measuring 2.5x0.7x0.3cms. 
 
 (PE): Two bits – One block. 
 
MICROSCOPIC APPEARANCE:  
 
                     Section studied from spleen shows normal white pulp and red pulp. Red pulp shows 
pigment laden macrophages and congested vessels. White pulp shows lymphocytic infiltrates 
forming germinal centre. The pencillar artery shows normal morphology. There is no evidence of 
toxic changes. 
 
                                                                                      
                                                                                Dr.C.R.Ajeeth kumar. M.D. (Path), 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path), Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
Checked 
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Name   :   
Ref. No. : [Ho 330C/18]                      
 
Rec.On :  21/03/2018 
Rep.On :  18/04/2018 
 
HISTOPATHOLOGY 
                                 Toxicity study 
SPECIMEN                          : C) Kidney. 
 
Group –                       : Dr.Murugavel - OMA legyam 
 
GROSS APPEARANCE    : 
 
Received specimen of kidneys each measuring 1.4x0.7x0.5cms and 1.3x0.8x0.4cms. 
 
PE : Two bits – One block.                                                            
 
MICROSCOPIC APPEARANCE:  
 
                     Section from kidney shows both cortex and medulla. Glomeruli and tubules shows 
no significant pathology. Interstitium shows no significant pathology. Blood vessels show 
congestion. There is no evidence of toxic changes. 
 
 
                                                                       
Dr. C.R.Ajeeth kumar.M.D. (Path). 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path),   Dr. C.R.Ajeeth kumar.M.D. (Path), 
 
 
Checked 
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Name   :   
Ref. No. : [Ho 330D/18]                      
 
Rec.On :  21/03/2018 
Rep.On :  18/04/2018 
 
HISTOPATHOLOGY 
                                 Toxicity study 
SPECIMEN                          : D) Testis. 
 
Group –                       : Dr.Murugavel - OMA legyam  
 
GROSS APPEARANCE    : 
 
Received specimen of both testis measuring each 1.1x0.7x0.5cms and 1.0x0.6x0.4cms. 
 
PE : Two bits – One block.                                                            
 
MICROSCOPIC APPEARANCE:  
 
                     Section from testes with seminiferous tubules showing normal spermatogenesis. 
Sertoli cells, leydig cell and interstitium shows normal morphology. No evidence of toxic 
changes. 
 
 
 
                                                                       
Dr. C.R.Ajeeth kumar.M.D. (Path). 
 
 
 
Consultant pathologists: 
Dr.S.Kalyani.M.D. (Path),   Dr. C.R.Ajeeth kumar.M.D. (Path), 
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ANNEXURE –V 
ASSESSMENT FORMS 
 
FORM I  : Screening and Selection Proforma 
FORM I A  : History Proforma on Enrollment 
FORM II  : Clinical assessment on enrollment 
FORM II A  : Clinical assessment during and after trial 
FORM III  : Laboratory Investigation on enrollment and conclusion  
  of trial 
FORM IV A  : Consent Form 
FORM IV B  : Withdrawal form 
FORM IV C  : Patient information sheet 
FORM IV D  : Dietary Advice form 
FORM IV E  : Adverse Reaction form 
FORM IV F  : Discharge proforma 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “OMA LEGIYAM” INTERNAL & “VETTIVER THYLAM” 
EXTERNAL IN “KALANJAGAPADAI” (PSORIASIS). 
 
FORM I – SCREENING & SELECTION PROFORMA 
 
1. OP / IP NO    : ___________ 
2. NAME   : ___________ 
3. RELIGION    : H / C / M / O 
4. AGE / GENDER  : ___________ 
5. OCCUPATION  : ___________ 
6. INCOME   : ___________ 
7. CONTACT NO  : ___________ 
8. INCLUSION CRITERIA :  
 
INCLUSION CRITERIA 
 Macules 
 Papules 
 Pustules 
 Plaques of erythema 
 Candle-grease sign 
 Auspitz sign 
 Itching 
 Keobner’s phenomenon 
  Patients wtih Silvery white patches, Coin shaped lesions, Scaling with or without 
itching.  
EXCLUSION CRITERIA 
 Cardiac disease 
 Malignancy  
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 Tuberculosis 
 Hypertension   
 Diabetes mellitus 
 Use of narcotic drugs 
 Pregnancy and lactation 
 Evidence of any skin condition other then psoriasis 
 
ADMITTED TO TRIAL: 
    YES  NO 
If Yes Serial Number : 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
190 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI, TIRUNELVELI – 627002 
BRANCH – III SIRAPPU MARUTHUVAM 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
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FORM I A – HISTORY PROFORMA 
1. SL.NO     : ___________ 
2. OP / IP NO     : ___________ 
3. NAME    : ___________ 
4. RELIGION     : H / C / M / O 
5. AGE / GENDER   : ___________ 
6. OCCUPATION   : ___________ 
7. INCOME    : ___________ 
8. CONTACT NUMBER  : ___________ 
9. MARITAL STATUS   : Married / Unmarried 
10. COMPLAINTS & DURATION : 
 
11. PERSONAL HISTORY: 
PERSONAL HABITS YES NO IF YES SPECIFY DURATION 
Smoking    
Tobacco Chewing    
Alcohol    
Narcotic Drug Addiction    
12. DRUG HISTORY: 
 Whether the Patient has underwent any allopathic Treatment  
1. Yes    2. No. 
 If yes specify the nature of the drug and treatment duration _____ 
13. FAMILY HISTORY: 
 Whether this problem runs in family? 
1. Yes  2. No 
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If yes, mention the relationship of affected person(s) 
1. ___________ 
2. ___________ 
14. DIETARY HABITS : 
 
   1. Pure vegetarian 
   2. Non-Vegetarian 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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FORM II AND II-A  CLINICAL ASSESSMENT ON ENROLLMENT AND ON 
VISITS 
 
1. OP / IP No     :  
2. BED No    :  
3. SL. NO    : 
4. NAME    : 
5. AGE     : 
6. GENDER    : 
7. OCCUPATION   : 
8. SOCIAL STATUS   : 
9. DATE OF ADMISSION  : 
10. DATE OF DISCHARGE  : 
11. POSTAL ADDRESS   : 
12. COMPLAINTS & DURATION : 
13. HISTORY OF PRESENT ILLNESS : 
14. PAST HISTORY   : 
15. FAMILY HISTORY   : 
 
16. MENSTRUAL HISTORY (If Applicable): 
  
193 
 
17. HABITS: 
1. Smoker    : 
2. Alcoholic    : 
3. Tobbaco chewer   :  
4. Betel nut chewer   : 
5. Non-Vegetarian   : 
6. Drug addiction   : 
 
18. GENERAL EXAMINATION: 
1. Body weight (Kg)   : 
2. Height (Cm)   :  
3. Body Temperature (F)  :  
4. Blood Pressure (mmHg)  : 
5. Pulse Rate (/min)   : 
6. Heart Rate (/min)   : 
7. Respiratory Rate (/min)  :  
8. Pallor    :  
9. Jaundice    : 
10. Clubbing    : 
11. Cyanosis    : 
12. Pedal Oedema   :  
13. Lymphadenopathy  :  
14. Jugular venous pulsation  : 
19. CLINICAL EXAMINATION: 
I. INSPECTION: 
1. Attitude    : 
2. Muscular spasm   : 
3. Muscle wasting – Proximal :  
4. Muscle wasting – Distal  : 
5. Minor Joint Swelling  : 
6. Major Joint Swelling  : 
7. Nodules    : 
8. Deformity    : 
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II. PALPATION: 
1. Swelling    : 
2. Tenderness   :  
3. Joint Stiffness   : 
4. Muscle wasting   : 
5. Local heat    : 
6. Local Lymphadenopathy  : 
7. Pitting Oedema   : 
8. Nodules    : 
III. MOVEMENTS: 
Restriction of joint movements 
1. Neck              :            Full            Partial    
2. Shoulder  : 
3. Elbow joint  : 
4. Knee joint  : 
5. Ankle joint  : 
6. Hip joint  : 
7. Minor joints  : 
IV. PAIN: 
1. Onset :   Sudden : Gradual : 
2. Early morning stiffness :  Present  : absent  : 
3. Nature of pain:  Mild  : Moderate :     Severe: 
4. Aggravating factor –Movements  : 
5. Relieving factor – rest   : 
6. Stiffness     : 
7. Tenderness    :  
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V. CLINICAL ASSESSMENT :  
1. Arthritis of three or more Joints  : 
2. Arthritis of hand joints   : 
3. Morning Stiffness    : 
4. Fever     : 
5. Anorexia     : 
6. Anaemia     : 
7. Spindle appearance of fingers  : 
8. Restricted movements   : 
9. Rheumatoid Nodules   : 
10. Numbness     : 
20. EXAMINATION OF OTHER SYSTEMS:  
1. CVS    : 
2. RS     : 
3. CNS    : 
4. ABDOMEN   : 
5. GENITO – URINARY  : 
 
EXAMINATION – SIDDHA ASPECTS 
1. NILAM: 
 1. Kurinji 2. Mullai 3. Marutham 4. Neithal 5. Paalai 
2. KAALAM: 
 1. Kaar Kaalam 2. Koothir Kaalam 3. Munpani Kaalam 
 4. Pinpani Kaalam 5. Elavenir Kaalam 6. Mudhuvenir Kaalam 
3. YAAKKAI:  
 1. Vatham   2. Pitham   3. Kabam 
 4. Vathapitham  5. Pithavatham  6. Kabavatham 
 7. Vathakabam  8. Pithakabam   9. Kabapitham 
4. GUNAM:  
 1. Sathuvam   2. Rasatham   3. Thamasam 
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5. KANMENDHIRIUM / KANMAVIDAYAM 
 1. Kai   : 
 2. Kaal   : 
 3. Vaai   : 
 4. Eruvaai  : 
5. Karuvaai  : 
 
6. UYIR THATHUKKAL: 
I. VATHAM: 
1. Piraanan  : 
2. Abaanan  : 
3. Viyaanan  : 
4. Uthaanan  : 
5. Samaanan  : 
6. Naagan  : 
7. Koorman  : 
8. Kirukaran  : 
9. Devathathan : 
10. Dhananjeyan : 
 
II. PITHAM : 
1. Analagam  : 
2. Ranjagam  : 
3. Saathagam  : 
4. Aalosagam : 
5. Praasagam  : 
 
III. KABAM: 
1. Avalambagam : 
2. Kilethagam : 
3. Pothagam  : 
4. Tharpagam : 
5. Santhigam  : 
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7. UDAL THAATHUKKAL: 
1. Saaram  : 
2. Senneer  : 
3. Oon  : 
4. Kozhuppu  : 
5. Enbu  : 
6. Moolai  : 
7. Sukkilam / Suronitham: 
 
8. ENVAGAI THERVUGAL: 
1. Naadi  : 
2. Sparisam  : 
3. Naa  :  
4. Niram  : 
5. Mozhi  : 
6. Vizhi  : 
7. Malam :  
i. Niram:  ii. Thanmai: iii. Irugal: iv.Ilagal: 
8. Moothiram : 
 
I. NEERKURI: 
 a. Niram : 
 b. Manam : 
 c. Edai  : 
 d. Nurai : 
 e. Enjal : 
 
II. NEIKURI: 
 Vatha Neer  :  Pittha Neer   :    Kaba Neer : 
   
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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FORM III – LABORATORY INVESTIGATION 
1. BLOOD: 
1. TC   : (Cells / Cumm) 
2. DC (%)  : N : L : M : E : 
3. ESR (mm)  : ½ hr : 1 hr : 
4. Hb   : 
5. Blood Sugar : a) Fasting : b) Post Prandial : 
6. Renal function tests: 
Blood Urea:  Serum creatinine: 
7. Lipid profile : 
HDL:   LDL:  VLDL: 
Total Cholesterol : TGL : 
8. Liver Function tests: 
Serum Bilirubin :  Total  Direct  Indirect 
 
SPECIFIC INVESTIGATIONS 
 RA factor   : 
 ASO titre   : 
 C-Reactive Protein  : 
 SGOT    : 
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SGPT    : 
 Serum albumin & globulin : 
 Total protein   : 
II. URINE: 
1. Albumin   : 
2. Sugar   : 
3. Epithelial cells  : 
4. Pus cells   : 
5. Red blood cells  : 
6. Casts / Crystals  : 
III. MOTION: 
1. Ova   : 
2. Cyst   : 
3. Occult blood  : 
4. Pus cells   : 
IV. X-RAY FINDINGS 
 
 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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FORM IV A – CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
Signature ______________ 
Date      ______________ 
Name    ______________ 
CONSENT BY PATIENT 
 I have been informed to my satisfaction, by the attending physician, the purpose 
of the clinical trial, and the nature of drug treatment and follow-up including the 
laboratory investigations to be performed to monitor and safeguard my body functions. 
 I am aware of my right to opt out of the trial at any time during the course of the 
trial without having to give the reasons for doing so. 
 I exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of “OMA LEGIYAM” (Internal drug) and “VETTIVER 
THYLAM” (External drug) for the treatment of “KALANJAGAPADAI” (PSORIASIS)”. 
 
Place :        Signature  :  
Date :         Name  : 
        Witness Signature: 
        Name  : 
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FORM VI B WITHDRAWAL FORM 
1. SL.NO    : ___________ 
2. OP / IP NO    : ___________ 
3. NAME   : ___________ 
4. RELIGION    : H / C / M / O 
5. AGE / GENDER  : ___________ 
6. OCCUPATION  : ___________ 
7. SOCIAL STATUS  : ___________ 
8. CONTACT NO  : ___________ 
9. DATE OF TRIAL COMMENCEMENT  : ___________ 
10. DATE OF WITHDRAWAL FROM TRIAL : ___________ 
11. REASONS FOR WITHDRAWAL   : ___________ 
 Long absence at reporting   :  Yes / No 
 Irregular treatment    :  Yes / No 
 Shift of locality    :  Yes / No 
 Increase in severity of symptoms  :  Yes / No 
 Development of severe adverse drug reactions:  Yes / No 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD 
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A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION “OMA LEGIYAM” INTERNAL & “VETTIVER THYLAM” 
EXTERNAL IN “KALANJAGAPADAI” (PSORIASIS). 
FORM IV-C  DRUG COMPLIANCE FORM 
Name of the Drug : NARKARANHTHAI LEGIYAM 
Drugs issued  : (Mg / Gram) 
Drugs returned : (Mg / Gram) 
 
S. NO DATE DRUG TAKEN TIME 
MORNING / TIME EVENING / TIME 
Day 1    
Day 2    
Day 3    
Day 4     
Day 5    
Day 6    
Day 7    
Day 13    
Day 14    
Day 15    
Day 16    
Day 17    
Day 18    
Day 19    
Day 25    
Day 26    
Day 27    
Day 28    
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Day 29    
Day 30    
Day 31    
Day 37    
Day 38    
Day 39    
Day 40    
Day 41    
Day 42    
Day 43    
Day 44    
Day 45    
Day 46    
Day 47    
Day 48     
 
 
Date  :  
Station: 
Signature of the Investigator : 
Signature of the Lecturer :    Signature of the HOD  
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